Protein,Protein_definition,Trait_category,Trait,sample_size,Estimated_effect,se,lowerCI,upperCI,Pvalue
PLA2G1B,Phospholipase A2,Lifestyle factors,X1050.Time spend outdoors in summer,46591,-0.0749776447533139,0.0187113210495818,-0.111651834010494,-0.0383034554961336,6.15711571556997e-05
PLA2G1B,Phospholipase A2,Lifestyle factors,X1060.Time spent outdoors in winter,40639,-0.0425700046919136,0.0210629267023474,-0.0838533410285145,-0.00128666835531267,0.043277318606816
PLA2G1B,Phospholipase A2,Physical activities,X1070.Time spent watching television (TV),48995,-0.0317410377297759,0.0189073387957675,-0.0687994217694803,0.00531734630992842,0.0932036215298282
PLA2G1B,Phospholipase A2,Physical activities,X1080.Time spent using computer,40630,-0.00833382730115197,0.0192158024730758,-0.0459968001483805,0.0293291455460765,0.664511113334318
PLA2G1B,Phospholipase A2,Physical activities,X1090.Time spent driving,35266,-0.0323057572606239,0.0209004701199933,-0.0732706786958106,0.00865916417456292,0.122187163236076
PLA2G1B,Phospholipase A2,Lifestyle factors,X1160.Sleep duration,51616,-0.0313052124658686,0.0171198938760133,-0.0648602044628548,0.00224977953111755,0.0674672964386524
PLA2G1B,Phospholipase A2,Health and medical history,X120039#0.Location of pain during the past week_None of the given areas,17275,-0.015522558420616,0.0114447171010565,-0.0379542039386867,0.00690908709745466,0.175019013202014
PLA2G1B,Phospholipase A2,Health and medical history,X120039#1.Location of pain during the past week_Left shoulder,17275,0.00660782658365913,0.0111158315333422,-0.0151792032216916,0.0283948563890098,0.552217731309943
PLA2G1B,Phospholipase A2,Health and medical history,X120039#10.Location of pain during the past week_Upper right leg,17275,0.0118811574320876,0.0126883542220531,-0.0129880168431365,0.0367503317073118,0.349089199340554
PLA2G1B,Phospholipase A2,Health and medical history,X120039#11.Location of pain during the past week_Lower left leg,17275,0.0125994679448751,0.0129793057730687,-0.0128399713703396,0.0380389072600899,0.331693800537421
PLA2G1B,Phospholipase A2,Health and medical history,X120039#12.Location of pain during the past week_Lower right leg,17275,0.022715141334818,0.0132051198858123,-0.00316689364137412,0.0485971763110101,0.0854182263305993
PLA2G1B,Phospholipase A2,Health and medical history,X120039#13.Location of pain during the past week_Left jaw pain,17275,0.0420713167054273,0.0280904286333379,-0.0129859234159149,0.0971285568267696,0.134226890518995
PLA2G1B,Phospholipase A2,Health and medical history,X120039#14.Location of pain during the past week_Right jaw pain,17275,0.0189007559521436,0.0289844922942986,-0.0379088489446818,0.0757103608489689,0.514346047539968
PLA2G1B,Phospholipase A2,Health and medical history,X120039#15.Location of pain during the past week_Chest pain,17275,-0.0232806346264124,0.0200122943652237,-0.0625047315822508,0.015943462329426,0.24471714634223
PLA2G1B,Phospholipase A2,Health and medical history,X120039#16.Location of pain during the past week_Abdomen,17275,0.0148376161486968,0.0146758696382656,-0.0139270883423038,0.0436023206396973,0.312020428360501
PLA2G1B,Phospholipase A2,Health and medical history,X120039#17.Location of pain during the past week_Neck pain,17275,-0.00946172264048062,0.0100512546522601,-0.0291621817589105,0.0102387364779493,0.346540022736474
PLA2G1B,Phospholipase A2,Health and medical history,X120039#18.Location of pain during the past week_Upper back,17275,0.0227470427068425,0.0145871901487909,-0.00584384998478776,0.0513379353984728,0.118923663013493
PLA2G1B,Phospholipase A2,Health and medical history,X120039#19.Location of pain during the past week_Lower back,17275,-0.0016608747378112,0.0081455115482396,-0.0176260773723608,0.0143043278967384,0.838433575567185
PLA2G1B,Phospholipase A2,Health and medical history,X120039#2.Location of pain during the past week_Right shoulder,17275,0.00400154502829865,0.0105315256626799,-0.0166402452705539,0.0246433353271512,0.703980731404535
PLA2G1B,Phospholipase A2,Health and medical history,X120039#3.Location of pain during the past week_Upper left arm,17275,0.0123253777492807,0.0155945974982285,-0.0182400333472472,0.0428907888458085,0.429327227925036
PLA2G1B,Phospholipase A2,Health and medical history,X120039#4.Location of pain during the past week_Upper right arm,17275,0.00588413736493025,0.0147179259696515,-0.0229629975355867,0.0347312722654472,0.689313253814476
PLA2G1B,Phospholipase A2,Health and medical history,X120039#5.Location of pain during the past week_Lower left arm,17275,0.0160320311123999,0.0196422332226235,-0.0224667460039421,0.054530808228742,0.414395845342618
PLA2G1B,Phospholipase A2,Health and medical history,X120039#6.Location of pain during the past week_Lower right arm,17275,0.0092814903459265,0.0184783690145943,-0.0269361129226783,0.0454990936145313,0.615470316302121
PLA2G1B,Phospholipase A2,Health and medical history,X120039#7.Location of pain during the past week_Left hip,17275,-0.00994079765915954,0.0114182405360476,-0.0323205491098128,0.0124389537914938,0.383980999044357
PLA2G1B,Phospholipase A2,Health and medical history,X120039#8.Location of pain during the past week_Right hip,17275,0.011331772133908,0.0108217235176908,-0.00987880596076591,0.032542350228582,0.295053401118998
PLA2G1B,Phospholipase A2,Health and medical history,X120039#9.Location of pain during the past week_Upper left leg,17275,-0.00896662229045546,0.0135121652224479,-0.0354504661264534,0.0175172215455425,0.506957615008211
PLA2G1B,Phospholipase A2,Health and medical history,X120040.Fatigue severity over the past week,17285,-0.0238776225062936,0.0320079028792729,-0.0866131121496685,0.0388578671370813,0.455682722389621
PLA2G1B,Phospholipase A2,Health and medical history,X120041.Waking unrefreshed severity over the past week,17285,0.00335016156162442,0.0318877930529429,-0.0591499128221436,0.0658502359453924,0.916328672042737
PLA2G1B,Phospholipase A2,Health and medical history,X120042.Cognitive symptoms severity over the past week,17285,-0.0323298278247649,0.0343177544176287,-0.0995926264833171,0.0349329708337873,0.346168475439121
PLA2G1B,Phospholipase A2,Health and medical history,X120098.Mobility problems today,17294,-0.0282841085412811,0.0370341970948093,-0.100871134847107,0.044302917764545,0.445038890885018
PLA2G1B,Phospholipase A2,Health and medical history,X120099.Self-care problems today,17294,-0.0511255452370335,0.0568705232454378,-0.162591770798092,0.0603406803240247,0.368675072012701
PLA2G1B,Phospholipase A2,Health and medical history,X120100.Problems doing usual activities,17294,-0.00407994467956382,0.035409489280311,-0.0734825436689735,0.0653226543098458,0.908270668105425
PLA2G1B,Phospholipase A2,Health and medical history,X120101.Pain or discomfort today,17294,0.0251750530862981,0.0320829466915266,-0.037707522429094,0.0880576286016901,0.432648196502658
PLA2G1B,Phospholipase A2,Health and medical history,X120102.Anxiety or depression today,17294,0.0109204520482414,0.038945544942817,-0.0654128160396798,0.0872537201361627,0.779171606099138
PLA2G1B,Phospholipase A2,Health and medical history,X120103.Scale to indicate how health is today,17238,-0.00273504469668135,0.00353374976473646,-0.00966119423556481,0.00419110484220211,0.438954404051961
PLA2G1B,Phospholipase A2,Health and medical history,X120104.Little interest or pleasure in doing things over the last two weeks,17253,-0.0279326837906418,0.0392835206755887,-0.104928384314796,0.0490630167335121,0.477060721893263
PLA2G1B,Phospholipase A2,Health and medical history,"X120105.Feeling down, depressed, or hopeless over the last two weeks",17228,0.00194748490521582,0.040562934068294,-0.0775558658686403,0.081450835679072,0.961707681776161
PLA2G1B,Phospholipase A2,Health and medical history,"X120106.Trouble falling or staying asleep, or sleeping too much over the last two weeks",17264,0.0153323697150469,0.0318511472847213,-0.0470958789630069,0.0777606183931007,0.630255579763602
PLA2G1B,Phospholipase A2,Health and medical history,X120107.Feeling tired or having little energy over the last two weeks,17263,-0.0384993414797256,0.0325137031653973,-0.102226199683904,0.0252275167244531,0.236391435066528
PLA2G1B,Phospholipase A2,Health and medical history,X120108.Poor appetite or overeating over the last two weeks,17271,-0.0073226788470455,0.0423357560188594,-0.0903007606440099,0.0756554029499188,0.862679578709207
PLA2G1B,Phospholipase A2,Health and medical history,X120109.Feeling bad about self over the last two weeks,17223,-0.0462881934866534,0.0427759691797092,-0.130129093078883,0.0375527061055767,0.279219965027089
PLA2G1B,Phospholipase A2,Health and medical history,X120110.Trouble concentrating over the last two weeks,17269,-0.000166141718962775,0.0425666614509482,-0.0835967981628213,0.0832645147248958,0.99688583387759
PLA2G1B,Phospholipase A2,Health and medical history,X120111.Moving or speaking slower or faster than usual over the last two weeks,17252,-0.00262933529851417,0.0614989936570717,-0.123167362866375,0.117908692269346,0.965898033423781
PLA2G1B,Phospholipase A2,Health and medical history,X120112.Thoughts of being better off dead or of hurting self over the last two weeks,17178,-0.0741022133637104,0.0848792561540481,-0.240465555425645,0.092261128698224,0.382658450365468
PLA2G1B,Phospholipase A2,Health and medical history,"X120113.Level of difficultly depression has made to do work, take care of things at home, or get along with other people",12027,0.0225137997471578,0.0429051790799304,-0.0615803512495059,0.106607950743821,0.599777907722744
PLA2G1B,Phospholipase A2,Lifestyle factors,X1269.Exposure to tobacco smoke at home,46691,-0.0760767229503836,0.0410374830284346,-0.156510189686115,0.0043567437853482,0.0637690718709777
PLA2G1B,Phospholipase A2,Lifestyle factors,X1279.Exposure to tobacco smoke outside home,43573,-0.0819978342690961,0.0253245888786226,-0.131634028471196,-0.0323616400669959,0.00120513974668179
PLA2G1B,Phospholipase A2,Diet and food preferences,X1289.Cooked vegetable intake,50124,-0.0401170492588923,0.0178464994125978,-0.0750961881075839,-0.00513791041020058,0.0245872428685757
PLA2G1B,Phospholipase A2,Diet and food preferences,X1299.Salad  or  raw vegetable intake,48771,-0.0303628164502759,0.0187987137736135,-0.0672082954465584,0.00648266254600665,0.106283834800037
PLA2G1B,Phospholipase A2,Diet and food preferences,X1309.Fresh fruit intake,50030,0.129865378001463,0.0186467915701662,0.0933176665239376,0.166413089478989,3.33654044736737e-12
PLA2G1B,Phospholipase A2,Diet and food preferences,X1319.Dried fruit intake,47246,0.118021143156705,0.0191894392762891,0.0804098421751785,0.155632444138232,7.79464324049688e-10
PLA2G1B,Phospholipase A2,Health and medical history,X134.Number of self-reported cancers,52055,-0.0215979567516513,0.0327690580415716,-0.0858253105131317,0.042629397009829,0.509837007752638
PLA2G1B,Phospholipase A2,Health and medical history,X135.Number of self-reported non-cancer illnesses,52056,0.00475844943147465,0.0178513038412754,-0.0302301060974251,0.0397470049603744,0.789808759390126
PLA2G1B,Phospholipase A2,Health and medical history,"X136.Number of operations, self-reported",52056,-0.0127468712004042,0.0174619143548458,-0.046972223335902,0.0214784809350935,0.465404891855162
PLA2G1B,Phospholipase A2,Health and medical history,X137.Number of treatments or medications taken,52056,0.0110469206400692,0.017470430176903,-0.0231951225066607,0.0452889637867992,0.527179893528342
PLA2G1B,Phospholipase A2,Diet and food preferences,X1438.Bread intake,50544,0.00248996105630754,0.00225365193806393,-0.00192719674229776,0.00690711885491283,0.269227214758451
PLA2G1B,Phospholipase A2,Diet and food preferences,X1458.Cereal intake,49417,0.240800132123406,0.0177662914729146,0.205978200836493,0.275622063410318,8.9413606298026e-42
PLA2G1B,Phospholipase A2,Diet and food preferences,X1488.Tea intake,50243,0.0239923566818,0.00215486165268681,0.0197688278425338,0.0282158855210661,9.25546657424251e-29
PLA2G1B,Phospholipase A2,Diet and food preferences,X1498.Coffee intake,47964,-0.0906823915211315,0.0177493217266783,-0.125471062105421,-0.055893720936842,3.25000393705346e-07
PLA2G1B,Phospholipase A2,Diet and food preferences,X1528.Water intake,48113,-0.0223013681594926,0.0179908727270825,-0.0575634787045744,0.0129607423855891,0.215131849146331
PLA2G1B,Phospholipase A2,Lifestyle factors,X1568.Average weekly red wine intake,35426,-0.135294889141488,0.0211748245249602,-0.176797545210411,-0.0937922330725664,1.68579412599939e-10
PLA2G1B,Phospholipase A2,Lifestyle factors,X1578.Average weekly champagne plus white wine intake,35415,-0.101514685540179,0.021712429944121,-0.144071048230656,-0.0589583228497014,2.94436059211166e-06
PLA2G1B,Phospholipase A2,Lifestyle factors,X1588.Average weekly beer plus cider intake,35516,-0.118896979993856,0.0239302379213537,-0.165800246319709,-0.0719937136680023,6.77919805064617e-07
PLA2G1B,Phospholipase A2,Lifestyle factors,X1598.Average weekly spirits intake,35371,-0.0855324556068668,0.0232056984885369,-0.131015624644399,-0.0400492865693345,0.000228291378418738
PLA2G1B,Phospholipase A2,Lifestyle factors,X1608.Average weekly fortified wine intake,35491,0.00967049530691274,0.0381721417120035,-0.0651469024486142,0.0844878930624397,0.800007666469094
PLA2G1B,Phospholipase A2,Lifestyle factors,X1737.Childhood sunburn occasions,39048,-0.0272197747674146,0.0211200395427516,-0.0686150522712077,0.0141755027363785,0.197470854956849
PLA2G1B,Phospholipase A2,Health and medical history,X1807.Father's age at death,38352,0.00473253974436663,0.00250946240528691,-0.000186006569995713,0.00965108605872898,0.0593189602284752
PLA2G1B,Phospholipase A2,Health and medical history,X1845.Mother's age,19801,0.0102450287583214,0.00546094877918447,-0.000458430848880203,0.0209484883655229,0.0606627261476479
PLA2G1B,Phospholipase A2,Health and medical history,X1873.Number of full brothers,51117,-0.0299490019994564,0.0171734076386787,-0.0636088809712667,0.00371087697235391,0.0811795313514323
PLA2G1B,Phospholipase A2,Health and medical history,X1883.Number of full sisters,51126,0.0162817063272413,0.0172054345611285,-0.0174409454125706,0.0500043580670533,0.343994033110971
PLA2G1B,Phospholipase A2,Physical measures,X20015.Sitting height,51648,-0.0150420727426085,0.00283149757119583,-0.0205918079821523,-0.00949233750306467,1.08632661418184e-07
PLA2G1B,Phospholipase A2,Cognitive function,X20016.Fluid intelligence score,16686,0.00665877589832677,0.0286837332636567,-0.0495613412984404,0.0628788930950939,0.816428499267757
PLA2G1B,Phospholipase A2,Cognitive function,X20018.Prospective memory result,17379,-0.0808621559962032,0.0371174918344722,-0.153612439991769,-0.00811187200063773,0.0293788290856934
PLA2G1B,Phospholipase A2,Physical measures,X20019.Speech-reception-threshold (SRT) estimate (left),16470,-0.000353646835446877,0.00387785271308826,-0.00795423815309986,0.00724694448220611,0.92733751668106
PLA2G1B,Phospholipase A2,Physical measures,X20021.Speech-reception-threshold (SRT) estimate (right),16449,0.00244040963697356,0.00387783848681473,-0.00516015379718332,0.0100409730711304,0.529146923320796
PLA2G1B,Phospholipase A2,Cognitive function,X20023.Mean time to correctly identify matches,51428,0.00219607139627174,0.00227769953662402,-0.00226821969551134,0.00666036248805482,0.334969235093257
PLA2G1B,Phospholipase A2,Health and medical history,X20107#1.Illnesses of father_Heart disease,45279,0.00597856401373172,0.00481472655500779,-0.00345830003408355,0.015415428061547,0.214344654400288
PLA2G1B,Phospholipase A2,Health and medical history,X20107#10.Illnesses of father_Alzheimer's disease or dementia,44386,-0.0201149831409516,0.0106170417680691,-0.0409243850063669,0.00069441872446379,0.05815271184572
PLA2G1B,Phospholipase A2,Health and medical history,X20107#11.Illnesses of father_Parkinson's disease,44318,-0.004792901601826,0.0142426198833609,-0.0327084365732134,0.0231226333695614,0.736481681160318
PLA2G1B,Phospholipase A2,Health and medical history,X20107#12.Illnesses of father_Severe depression,44358,-0.00184469540256995,0.0119904222452101,-0.0253459230031817,0.0216565321980418,0.877730751424132
PLA2G1B,Phospholipase A2,Health and medical history,X20107#13.Illnesses of father_Prostate cancer,44383,0.0124720964621204,0.00857267131646134,-0.00433033931814385,0.0292745322423846,0.145713164009234
PLA2G1B,Phospholipase A2,Health and medical history,X20107#2.Illnesses of father_Stroke,44724,-0.000953872743705928,0.00619653805862171,-0.0130990873386045,0.0111913418511926,0.877660580099675
PLA2G1B,Phospholipase A2,Health and medical history,X20107#3.Illnesses of father_Lung cancer,44604,-0.00474935211104937,0.0078212895341284,-0.020079079597941,0.0105803753758423,0.543698792912688
PLA2G1B,Phospholipase A2,Health and medical history,X20107#4.Illnesses of father_Bowel cancer,44405,-0.00568636723457907,0.00976154970390532,-0.0248190046542335,0.0134462701850754,0.560214652174294
PLA2G1B,Phospholipase A2,Health and medical history,X20107#6.Illnesses of father_Chronic bronchitis or emphysema,44685,-0.0241381958657214,0.00715836447262156,-0.0381685902320597,-0.0101078014993832,0.000746804889565971
PLA2G1B,Phospholipase A2,Health and medical history,X20107#8.Illnesses of father_High blood pressure,44835,0.00377048114015348,0.00538937121515811,-0.00679268644155641,0.0143336487218634,0.484171843893788
PLA2G1B,Phospholipase A2,Health and medical history,X20107#9.Illnesses of father_Diabetes,44558,-0.015656906656976,0.00747862064170456,-0.0303150031147169,-0.000998810199235041,0.0363052434366224
PLA2G1B,Phospholipase A2,Health and medical history,X20110#1.Illnesses of mother_Heart disease,47480,0.0240545833257738,0.00552087353115741,0.0132336712047053,0.0348754954468423,1.32118633349122e-05
PLA2G1B,Phospholipase A2,Health and medical history,X20110#10.Illnesses of mother_Alzheimer's disease or dementia,47184,0.00363665675694684,0.00791651326238674,-0.0118797092373312,0.0191530227512248,0.645966245958142
PLA2G1B,Phospholipase A2,Health and medical history,X20110#11.Illnesses of mother_Parkinson's disease,47036,0.00354325672063867,0.0172754328764164,-0.0303165917171374,0.0374031051584147,0.837491924823148
PLA2G1B,Phospholipase A2,Health and medical history,X20110#12.Illnesses of mother_Severe depression,47109,0.0174375553965141,0.00888443104387089,2.40705505271666e-05,0.034851040242501,0.0496858400613043
PLA2G1B,Phospholipase A2,Health and medical history,X20110#2.Illnesses of mother_Stroke,47355,-0.00178168294622007,0.00629021389910716,-0.0141105021884701,0.01054713629603,0.776988895360613
PLA2G1B,Phospholipase A2,Health and medical history,X20110#3.Illnesses of mother_Lung cancer,47137,-0.0354678654125712,0.011106576111285,-0.0572367545906898,-0.0136989762344526,0.00140694937787961
PLA2G1B,Phospholipase A2,Health and medical history,X20110#4.Illnesses of mother_Bowel cancer,47100,0.00194925119993598,0.00994607064312696,-0.0175450472605929,0.0214435496604648,0.844625070289294
PLA2G1B,Phospholipase A2,Health and medical history,X20110#5.Illnesses of mother_Breast cancer,47139,-0.00915813510272484,0.00811704395842379,-0.0250675412612355,0.00675127105578579,0.259215922531801
PLA2G1B,Phospholipase A2,Health and medical history,X20110#6.Illnesses of mother_Chronic bronchitis or emphysema,47191,-0.00817185327177079,0.00933553045173928,-0.0264694929571798,0.0101257864136382,0.381388145659155
PLA2G1B,Phospholipase A2,Health and medical history,X20110#8.Illnesses of mother_High blood pressure,47559,0.00564767729977994,0.00477284255902676,-0.0037070941159125,0.0150024487154724,0.236698455421258
PLA2G1B,Phospholipase A2,Health and medical history,X20110#9.Illnesses of mother_Diabetes,47255,-0.0222886481860898,0.00737743402827039,-0.0367484188814998,-0.00782887749067985,0.00251915923801914
PLA2G1B,Phospholipase A2,Health and medical history,X20111#1.Illnesses of siblings_Heart disease,40714,0.00741405338012081,0.00771777996211462,-0.00771279534562386,0.0225409021058655,0.336735967815134
PLA2G1B,Phospholipase A2,Health and medical history,X20111#10.Illnesses of siblings_Alzheimer's disease or dementia,40419,-0.0361531889315773,0.0307319927714697,-0.0963878947636578,0.0240815169005032,0.239441058398605
PLA2G1B,Phospholipase A2,Health and medical history,X20111#11.Illnesses of siblings_Parkinson's disease,40409,-0.00618231240391409,0.0312319617355807,-0.0673969574056523,0.0550323325978241,0.843086543160975
PLA2G1B,Phospholipase A2,Health and medical history,X20111#12.Illnesses of siblings_Severe depression,40527,0.0077386000897411,0.00910467688064141,-0.0101065665963161,0.0255837667757983,0.395353024360619
PLA2G1B,Phospholipase A2,Health and medical history,X20111#13.Illnesses of siblings_Prostate cancer,40441,-0.00845956274527413,0.0179964806536977,-0.0437326648265216,0.0268135393359733,0.638309246158315
PLA2G1B,Phospholipase A2,Health and medical history,X20111#2.Illnesses of siblings_Stroke,40488,-0.0153513707275133,0.0130708136747854,-0.0409701655300927,0.0102674240750661,0.240210907935521
PLA2G1B,Phospholipase A2,Health and medical history,X20111#3.Illnesses of siblings_Lung cancer,40441,0.00350439186964505,0.0154328431152728,-0.0267439806362897,0.0337527643755798,0.820367628705205
PLA2G1B,Phospholipase A2,Health and medical history,X20111#4.Illnesses of siblings_Bowel cancer,40441,-0.0166931808458055,0.0149773370091487,-0.046048761383737,0.0126623996921259,0.265044497152405
PLA2G1B,Phospholipase A2,Health and medical history,X20111#5.Illnesses of siblings_Breast cancer,40467,-0.00463772550763192,0.0113816694911244,-0.0269457977102358,0.017670346694972,0.683662615912501
PLA2G1B,Phospholipase A2,Health and medical history,X20111#6.Illnesses of siblings_Chronic bronchitis or emphysema,40488,0.0012416649788174,0.0139792830520928,-0.0261577298032844,0.0286410597609192,0.92922397767788
PLA2G1B,Phospholipase A2,Health and medical history,X20111#8.Illnesses of siblings_High blood pressure,40852,-0.0014731972623861,0.0057737916276128,-0.0127898288525072,0.00984343432773499,0.798606615604422
PLA2G1B,Phospholipase A2,Health and medical history,X20111#9.Illnesses of siblings_Diabetes,40633,-0.0412532647963133,0.00818849023457911,-0.0573027056560883,-0.0252038239365382,4.72540042624322e-07
PLA2G1B,Phospholipase A2,Mental health,X20127.Neuroticism score,41407,0.0301002265149685,0.017866106462924,-0.00491734215236258,0.0651177951822996,0.0920410754291997
PLA2G1B,Phospholipase A2,Cognitive function,X20128.Number of fluid intelligence questions attempted within time limit,16686,-0.0271527362517151,0.0291848205207591,-0.0843549844724031,0.0300495119689728,0.352192054127502
PLA2G1B,Phospholipase A2,Lifestyle factors,X20161.Pack years of smoking,15875,-0.018840801976181,0.00423818705191995,-0.0271476485979441,-0.0105339553544179,8.82883250647143e-06
PLA2G1B,Phospholipase A2,Lifestyle factors,X20162.Pack years adult smoking as proportion of life span exposed to smoking,15875,-0.0198706050511582,0.0041816537904711,-0.0280666464804816,-0.0116745636218349,2.03327693069182e-06
PLA2G1B,Phospholipase A2,Cognitive function,X20191.Fluid intelligence score,12851,0.0705648275421925,0.0338298376034682,0.00425834583939493,0.13687130924499,0.0370096213350448
PLA2G1B,Phospholipase A2,Cognitive function,X20192.Number of fluid intelligence questions attempted within time limit,12852,0.0197525077019984,0.034629371255803,-0.0481210599593755,0.0876260753633723,0.568418098752394
PLA2G1B,Phospholipase A2,Cognitive function,X20240.Maximum digits remembered correctly,11537,0.0457802296426814,0.0363331269171341,-0.0254326991149014,0.116993158400264,0.207690034785163
PLA2G1B,Phospholipase A2,Physical measures,X20255.Spirometry QC measure,38728,-0.0236749012846754,0.0230772387014864,-0.0689062891395887,0.0215564865702379,0.304945906389679
PLA2G1B,Phospholipase A2,Eye measures,X20261.avMSE,11390,-0.015411039563841,0.00460421228652182,-0.0244352956454237,-0.00638678348225821,0.000819084432719314
PLA2G1B,Phospholipase A2,Eye measures,X20262.Myopia diagnosis,11390,0.141001631527751,0.0435590483917155,0.0556258966799888,0.226377366375514,0.00121129696204286
PLA2G1B,Phospholipase A2,NMR metabolomics,X20280.Glucose-lactate,29713,-0.0458766803478932,0.00288363857286711,-0.0515286119507127,-0.0402247487450736,9.37676227591348e-57
PLA2G1B,Phospholipase A2,NMR metabolomics,X20281.Spectrometer-corrected alanine,29777,-0.0182064722721303,0.00290541981308087,-0.0239010951057688,-0.0125118494384918,3.74588887269505e-10
PLA2G1B,Phospholipase A2,Mental health,X20544#11.Mental health problems ever diagnosed by a professional_Depression,16270,0.0105190369745311,0.0153774352136611,-0.0196207360442446,0.0406588099933068,0.493949138803654
PLA2G1B,Phospholipase A2,Mental health,X20544#6.Mental health problems ever diagnosed by a professional_Panic attacks,16267,-0.0157852737006365,0.0301784432694716,-0.0749350225088008,0.0433644751075278,0.600936467842314
PLA2G1B,Phospholipase A2,Mental health,X20546#1.Substances taken for depression_Unprescribed medication (more than once),16266,0.0635266227793712,0.0373711030693762,-0.00972073923660616,0.136773984795348,0.0891714661144266
PLA2G1B,Phospholipase A2,Mental health,X20546#3.Substances taken for depression_Medication prescribed to you (for at least two weeks),16266,0.0098933640696139,0.0146142089076322,-0.0187504853893453,0.0385372135285731,0.498435359346983
PLA2G1B,Phospholipase A2,Mental health,X20546#4.Substances taken for depression_Drugs or alcohol (more than once),16266,-0.0227267198924668,0.0253645652832627,-0.0724412678476617,0.0269878280627282,0.370264572796878
PLA2G1B,Phospholipase A2,Mental health,X20548#1.Manifestations of mania or irritability_I was more talkative than usual,16276,0.0336330127386469,0.0325859512698616,-0.0302354517502818,0.0975014772275756,0.302025495122384
PLA2G1B,Phospholipase A2,Mental health,X20548#2.Manifestations of mania or irritability_I was more restless than usual,16276,0.0229398232246256,0.0211689266961661,-0.0185512730998599,0.0644309195491111,0.27853365228842
PLA2G1B,Phospholipase A2,Mental health,X20548#3.Manifestations of mania or irritability_My thoughts were racing,16276,0.0323961537868525,0.0236352898500087,-0.0139290143191644,0.0787213218928695,0.170497150698698
PLA2G1B,Phospholipase A2,Mental health,X20548#5.Manifestations of mania or irritability_I needed less sleep than usual,16276,0.0161645164243433,0.0367173582514931,-0.0558015057485831,0.0881305385972698,0.659767828813343
PLA2G1B,Phospholipase A2,Mental health,X20548#6.Manifestations of mania or irritability_I was more creative or had more ideas than usual,16276,0.062922173550618,0.0425414243951488,-0.0204590182638737,0.14630336536511,0.139138281978825
PLA2G1B,Phospholipase A2,Mental health,X20548#7.Manifestations of mania or irritability_I was easily distracted,16276,0.0479218553349941,0.0247198283978791,-0.000529008324848923,0.0963727189948372,0.0525673641951424
PLA2G1B,Phospholipase A2,Mental health,X20548#8.Manifestations of mania or irritability_I was more confident than usual,16276,0.0627066999099885,0.0420824301339679,-0.0197748631525887,0.145188262972566,0.136219395207186
PLA2G1B,Phospholipase A2,Mental health,X20548#9.Manifestations of mania or irritability_I was more active than usual,16276,0.0712986419834567,0.0314472112359925,0.00966210796091132,0.132935176006002,0.0233881186332032
PLA2G1B,Phospholipase A2,Mental health,X20549#1.Substances taken for anxiety_Unprescribed medication (more than once),16278,0.0379071530572032,0.0425182301470563,-0.045428578031027,0.121242884145434,0.372647054655659
PLA2G1B,Phospholipase A2,Mental health,X20549#3.Substances taken for anxiety_Medication prescribed to you (for at least two weeks),16278,0.0124403270804336,0.0196526409072041,-0.0260788490976865,0.0509595032585537,0.526735718402655
PLA2G1B,Phospholipase A2,Mental health,X20549#4.Substances taken for anxiety_Drugs or alcohol (more than once),16278,-0.0195111596083298,0.0294096634473079,-0.0771540999650533,0.0381317807483936,0.507066634279453
PLA2G1B,Phospholipase A2,Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,16280,-0.0701268081025958,0.049062779440478,-0.166289855805933,0.0260362396007411,0.152929164490318
PLA2G1B,Phospholipase A2,Diet and food preferences,X20600.Liking for adding salt to foods,18837,-0.0504660219935376,0.0282155664243572,-0.105768532185278,0.00483648819820252,0.0736972846972722
PLA2G1B,Phospholipase A2,Diet and food preferences,X20601.Liking for aniseed,18837,-0.0488907454721127,0.0279861322604804,-0.103743564702654,0.00596207375842889,0.0806600241482178
PLA2G1B,Phospholipase A2,Diet and food preferences,X20602.Liking for apple juice,18837,0.0969065308176195,0.0283234426326742,0.0413925832575781,0.152420478377661,0.000624263536703795
PLA2G1B,Phospholipase A2,Diet and food preferences,X20603.Liking for apples,18837,0.0378382723516702,0.0288229850922008,-0.0186547784290435,0.0943313231323838,0.189272706543138
PLA2G1B,Phospholipase A2,Diet and food preferences,X20604.Liking for asparagus,18837,-0.0849102371897889,0.0288006925152935,-0.141359594519764,-0.0284608798598137,0.00320021648033319
PLA2G1B,Phospholipase A2,Diet and food preferences,X20605.Liking for aubergine,18837,-0.0628720470110515,0.0281714614060455,-0.118088111366901,-0.00765598265520225,0.025642309072584
PLA2G1B,Phospholipase A2,Diet and food preferences,X20606.Liking for avocados,18837,-0.0836649333307208,0.0285383233313719,-0.13960004706021,-0.0277298196012319,0.00337551133188504
PLA2G1B,Phospholipase A2,Diet and food preferences,X20607.Liking for bacon,18837,-0.0858316773234267,0.0285151312054556,-0.14172133448612,-0.0299420201607338,0.00261559720531239
PLA2G1B,Phospholipase A2,Diet and food preferences,X20608.Liking for baked or steamed fish,18837,-0.0510934686676055,0.0284575184828932,-0.106870204894076,0.00468326755886516,0.0726013351915298
PLA2G1B,Phospholipase A2,Diet and food preferences,X20609.Liking for bananas,18837,0.047842662932245,0.0292459682365389,-0.00947943481137135,0.105164760675861,0.101883089517873
PLA2G1B,Phospholipase A2,Diet and food preferences,X20610.Liking for barbequed or grilled meat,18837,-0.10884460988912,0.0282076218245273,-0.164131548665193,-0.0535576711130461,0.000114374475732574
PLA2G1B,Phospholipase A2,Diet and food preferences,X20611.Liking for beef steak,18837,-0.12372653063715,0.0283532122044904,-0.179298826557951,-0.0681542347163489,1.28528425904945e-05
PLA2G1B,Phospholipase A2,Diet and food preferences,X20612.Liking for beetroot,18837,-0.0987156483080751,0.0285306086739616,-0.15463564130904,-0.0427956553071105,0.000541390748810126
PLA2G1B,Phospholipase A2,Diet and food preferences,X20613.Liking for bell pepper,18837,-0.0494632397345363,0.0283323363393367,-0.104994618959636,0.0060681394905636,0.0808580643309725
PLA2G1B,Phospholipase A2,Diet and food preferences,X20614.Liking for bicycling,18837,0.0169006485257843,0.0284220243467662,-0.0388065191938775,0.0726078162454461,0.552096557046082
PLA2G1B,Phospholipase A2,Diet and food preferences,X20615.Liking for biscuits,18837,0.103300989871538,0.028367906486494,0.0476998931580102,0.158902086585066,0.000271809009243367
PLA2G1B,Phospholipase A2,Diet and food preferences,X20616.Liking for bitter foods,18837,-0.12229477492867,0.0283304559893254,-0.177822468667748,-0.0667670811895926,1.59170752729872e-05
PLA2G1B,Phospholipase A2,Diet and food preferences,X20617.Liking for bitter or ale,18837,-0.0928780449973087,0.0289179099970906,-0.149557148591606,-0.036198941403011,0.00132135921103316
PLA2G1B,Phospholipase A2,Diet and food preferences,X20618.Liking for black olives,18837,-0.0992685090565508,0.0284945512610758,-0.155117829528259,-0.0434191885848423,0.000495525258665068
PLA2G1B,Phospholipase A2,Diet and food preferences,X20619.Liking for black pepper,18837,-0.136461907099497,0.0287758340676989,-0.192862541872187,-0.0800612723268075,2.12917342898849e-06
PLA2G1B,Phospholipase A2,Diet and food preferences,X20620.Liking for blue cheese,18837,-0.107765085130162,0.0282293616272641,-0.163094633919599,-0.0524355363407241,0.00013525254070881
PLA2G1B,Phospholipase A2,Diet and food preferences,X20621.Liking for bolognese sauce,18837,-0.080726914901427,0.0283480197621273,-0.136289033635197,-0.0251647961676574,0.00440828546845283
PLA2G1B,Phospholipase A2,Diet and food preferences,X20622.Liking for broad beans,18837,-0.035452846406368,0.028248581980625,-0.090820067088393,0.0199143742756569,0.209483091390167
PLA2G1B,Phospholipase A2,Diet and food preferences,X20623.Liking for broccoli,18837,-0.0742480857096836,0.0293552525534515,-0.131784380714449,-0.0167117907049186,0.0114372984119614
PLA2G1B,Phospholipase A2,Diet and food preferences,X20624.Liking for brown rice,18837,0.0697904228932382,0.0283084270613303,0.0143059058530308,0.125274939933446,0.0136964801625094
PLA2G1B,Phospholipase A2,Diet and food preferences,X20625.Liking for brussel sprouts,18837,-0.0502042416929013,0.0283430200640185,-0.105756561018378,0.00534807763257501,0.0765255456003917
PLA2G1B,Phospholipase A2,Diet and food preferences,X20626.Liking for burgers (meat),18837,-0.0582500406009709,0.0281093470892615,-0.113344360895923,-0.00315572030601839,0.0382542420685182
PLA2G1B,Phospholipase A2,Diet and food preferences,X20627.Liking for burn of spicy foods,18837,-0.0883231733352841,0.0282012877266694,-0.143597697279556,-0.0330486493910121,0.00173954459041808
PLA2G1B,Phospholipase A2,Diet and food preferences,X20628.Liking for butter on bread,18837,-0.01604677699743,0.0285899524505824,-0.0720830838005715,0.0399895298057114,0.574617924308604
PLA2G1B,Phospholipase A2,Diet and food preferences,X20629.Liking for butternut squash,18837,0.0463969272194281,0.0282822760618911,-0.00903633386187837,0.101830188300735,0.100919042472478
PLA2G1B,Phospholipase A2,Diet and food preferences,X20630.Liking for cabbage,18837,-0.133096439740426,0.0285353371102038,-0.189025700476426,-0.0771671790044268,3.1184821623881e-06
PLA2G1B,Phospholipase A2,Diet and food preferences,X20631.Liking for cake,18837,0.165410406433543,0.028262217718248,0.110016459705777,0.220804353161309,4.91675425427556e-09
PLA2G1B,Phospholipase A2,Diet and food preferences,X20632.Liking for cake icing,18837,0.142955832641821,0.0280613063829434,0.0879556721312522,0.19795599315239,3.53208791327166e-07
PLA2G1B,Phospholipase A2,Diet and food preferences,X20633.Liking for capers,18837,-0.135601789424196,0.027964941531922,-0.190413074826763,-0.0807905040216286,1.25081205430042e-06
PLA2G1B,Phospholipase A2,Diet and food preferences,X20634.Liking for cauliflower,18837,-0.0892869381805872,0.0287459577175626,-0.14562901530701,-0.0329448610541646,0.00189874136280253
PLA2G1B,Phospholipase A2,Diet and food preferences,X20635.Liking for cereal or granola bar,18837,0.0823521565623376,0.02820438695403,0.0270715581324389,0.137632754992236,0.00350632173605547
PLA2G1B,Phospholipase A2,Diet and food preferences,X20636.Liking for cheesecake,18837,0.0394754292992254,0.0281944169987085,-0.0157856280182433,0.0947364866166941,0.161495340426523
PLA2G1B,Phospholipase A2,Diet and food preferences,X20637.Liking for cherries,18837,0.010241895732205,0.0296531850919412,-0.0478783470479997,0.0683621385124098,0.729805508310267
PLA2G1B,Phospholipase A2,Diet and food preferences,X20638.Liking for chicken,18837,-0.0312173867352925,0.0294708657653751,-0.0889802836354277,0.0265455101648427,0.289493788526037
PLA2G1B,Phospholipase A2,Diet and food preferences,X20639.Liking for chilli pepper,18837,-0.133147767777895,0.0283398962932134,-0.188693964512594,-0.077601571043197,2.64262354986383e-06
PLA2G1B,Phospholipase A2,Diet and food preferences,X20640.Liking for chips or french fries,18837,-0.0362158508371859,0.0285304847373214,-0.092135600922336,0.0197038992479641,0.204323465271112
PLA2G1B,Phospholipase A2,Diet and food preferences,X20641.Liking for cigarette smoking,18837,-0.00778470671220945,0.0454017455421436,-0.096772127974811,0.0812027145503921,0.863861786689866
PLA2G1B,Phospholipase A2,Diet and food preferences,X20642.Liking for cod,18837,-0.058307633603364,0.0290071716992659,-0.115161690133925,-0.00145357707280274,0.0444336935850674
PLA2G1B,Phospholipase A2,Diet and food preferences,X20643.Liking for coffee with sugar,18837,0.0672895145855673,0.0307098051108759,0.00709829656825057,0.127480732602884,0.028453806636405
PLA2G1B,Phospholipase A2,Diet and food preferences,X20644.Liking for coffee without sugar,18837,-0.0857886296747645,0.0286005267995248,-0.141845662201833,-0.0297315971476959,0.00270735035404899
PLA2G1B,Phospholipase A2,Diet and food preferences,X20645.Liking for coriander,18837,-0.100456142319238,0.0282469964802736,-0.155820255420574,-0.0450920292179018,0.000376969690968246
PLA2G1B,Phospholipase A2,Diet and food preferences,X20646.Liking for corn flakes,18837,0.079591621151353,0.0280934165647196,0.0245285246845027,0.134654717618203,0.00461471459766159
PLA2G1B,Phospholipase A2,Diet and food preferences,X20647.Liking for cream,18837,0.0156120295880427,0.0280491074848791,-0.0393642210823204,0.0705882802584058,0.577809898974122
PLA2G1B,Phospholipase A2,Diet and food preferences,X20648.Liking for croissant,18837,0.0183990344326259,0.028129775190054,-0.03673532493988,0.0735333938051318,0.5130702971137
PLA2G1B,Phospholipase A2,Diet and food preferences,X20649.Liking for cucumber,18837,-0.0732840831949186,0.0285896067417927,-0.129319712408832,-0.0172484539810049,0.0103755842760355
PLA2G1B,Phospholipase A2,Diet and food preferences,X20650.Liking for curry,18837,-0.0844868511765834,0.0286792135846946,-0.140698109802585,-0.0282755925505819,0.00322383561083571
PLA2G1B,Phospholipase A2,Diet and food preferences,X20651.Liking for dairy products,18837,0.0531207896661103,0.0285448221776029,-0.00282706180199141,0.109068641134212,0.0627653267044326
PLA2G1B,Phospholipase A2,Diet and food preferences,X20652.Liking for dark chocolate,18837,0.0658904784251315,0.0283675476197293,0.0102900850904622,0.121490871759801,0.0202036574030547
PLA2G1B,Phospholipase A2,Diet and food preferences,X20653.Liking for diet fizzy drinks,18837,-0.0749808245546729,0.0290075753577015,-0.131835672255768,-0.0181259768535781,0.0097490145247697
PLA2G1B,Phospholipase A2,Diet and food preferences,X20654.Liking for dried fruit,18837,0.0451708419202007,0.0285497744879914,-0.0107867160762624,0.101128399916664,0.113625615841683
PLA2G1B,Phospholipase A2,Diet and food preferences,X20655.Liking for eggs,18837,-0.0437752883308221,0.0290618986869752,-0.100736609757293,0.0131860330956492,0.132012702983272
PLA2G1B,Phospholipase A2,Diet and food preferences,X20656.Liking for exercising alone,18837,0.0937893708957844,0.0280883419913798,0.03873622059268,0.148842521198889,0.000842179526980181
PLA2G1B,Phospholipase A2,Diet and food preferences,X20657.Liking for exercising with others,18837,0.0505637164411852,0.0282521293947248,-0.00481045717247545,0.105937890054846,0.0735132170214924
PLA2G1B,Phospholipase A2,Diet and food preferences,X20658.Liking for extra virgin olive oil,18837,-0.0809488763974441,0.0288441023062965,-0.137483316917785,-0.024414435877103,0.00501456913632479
PLA2G1B,Phospholipase A2,Diet and food preferences,X20659.Liking for fatty foods,18837,-0.0448068334172654,0.0281540794441053,-0.0999888291277117,0.0103751622931809,0.111516963258512
PLA2G1B,Phospholipase A2,Diet and food preferences,X20660.Liking for fresh tomatoes,18837,-0.130964036812808,0.0303387530710263,-0.19042799283202,-0.0715000807935969,1.59170834268373e-05
PLA2G1B,Phospholipase A2,Diet and food preferences,X20661.Liking for fried chicken,18837,-0.0423216426127623,0.0281431226621275,-0.0974821630305322,0.0128388778050076,0.132649521533472
PLA2G1B,Phospholipase A2,Diet and food preferences,X20662.Liking for fried or battered fish,18837,-0.0907695879015347,0.0283099543373884,-0.146257098402816,-0.0352820774002534,0.00134688647806923
PLA2G1B,Phospholipase A2,Diet and food preferences,X20663.Liking for fruit,18837,0.0173915431835601,0.031333936952133,-0.0440229732426206,0.0788060596097408,0.578874885810971
PLA2G1B,Phospholipase A2,Diet and food preferences,X20664.Liking for garlic,18837,-0.145845061807195,0.0286837442307976,-0.202065200499558,-0.0896249231148315,3.71957413972479e-07
PLA2G1B,Phospholipase A2,Diet and food preferences,X20665.Liking for gherkins,18837,-0.0803752514758765,0.0281706788899043,-0.135589782100089,-0.025160720851664,0.00433350213347171
PLA2G1B,Phospholipase A2,Diet and food preferences,X20666.Liking for globe artichoke,18837,-0.0464959780938396,0.0279695761751004,-0.101316347397036,0.00832439120935718,0.0964538805478585
PLA2G1B,Phospholipase A2,Diet and food preferences,X20667.Liking for goat's cheese,18837,-0.0437991299629217,0.028005480714175,-0.0986898721627046,0.0110916122368613,0.117846478749365
PLA2G1B,Phospholipase A2,Diet and food preferences,X20668.Liking for going to a cafe,18837,0.0742345991988693,0.0284597429626385,0.0184535029920979,0.130015695405641,0.00910365656632475
PLA2G1B,Phospholipase A2,Diet and food preferences,X20669.Liking for going to the gym,18837,-0.00071652187754841,0.0281963311571321,-0.0559813309455273,0.0545482871904305,0.979726702156027
PLA2G1B,Phospholipase A2,Diet and food preferences,X20670.Liking for going to the pub,18837,-0.191369592632926,0.028128330593985,-0.246501120597137,-0.136238064668715,1.05218316693698e-11
PLA2G1B,Phospholipase A2,Diet and food preferences,X20671.Liking for grapefruit,18837,0.0101273323710373,0.0281000637679778,-0.0449487926141991,0.0652034573562737,0.718550226147004
PLA2G1B,Phospholipase A2,Diet and food preferences,X20672.Liking for green olives,18837,-0.101219926054154,0.0283933107539272,-0.156870815131851,-0.0455690369764563,0.000364866866285366
PLA2G1B,Phospholipase A2,Diet and food preferences,X20673.Liking for haddock,18837,-0.0769899869993629,0.0287359460184154,-0.133312441195457,-0.0206675328032688,0.00738575704446736
PLA2G1B,Phospholipase A2,Diet and food preferences,X20674.Liking for ham,18837,-0.0898947017618379,0.0283278258249589,-0.145417240378757,-0.0343721631449184,0.00150922236819157
PLA2G1B,Phospholipase A2,Diet and food preferences,X20675.Liking for hard cheese,18837,-0.0645692541166322,0.0287199920705041,-0.12086043857482,-0.00827806965844424,0.0245728200514562
PLA2G1B,Phospholipase A2,Diet and food preferences,X20676.Liking for herring,18837,-0.063221798635387,0.0280932614583439,-0.118284591093741,-0.00815900617703293,0.024433434311633
PLA2G1B,Phospholipase A2,Diet and food preferences,X20677.Liking for honey,18837,0.0211668541879834,0.0282080152627929,-0.0341208557270907,0.0764545641030576,0.453032616636547
PLA2G1B,Phospholipase A2,Diet and food preferences,X20678.Liking for horseradish or wasabi,18837,-0.156567697423917,0.0280829923796732,-0.211610362488076,-0.101525032359757,2.50671680925793e-08
PLA2G1B,Phospholipase A2,Diet and food preferences,X20679.Liking for ice cream,18837,0.104696002081604,0.0285218085995248,0.0487932572265354,0.160598746936673,0.000242522673908883
PLA2G1B,Phospholipase A2,Diet and food preferences,X20680.Liking for jam,18837,0.108070296985973,0.0282996093174553,0.0526030627237608,0.163537531248186,0.000134537544218838
PLA2G1B,Phospholipase A2,Diet and food preferences,X20681.Liking for kiwi fruit,18837,0.00580640415463459,0.0283256534702802,-0.0497118766471147,0.0613246849563839,0.837584129072344
PLA2G1B,Phospholipase A2,Diet and food preferences,X20682.Liking for lager,18837,-0.125510491469946,0.0282829965871387,-0.180945164780738,-0.0700758181591538,9.14560773574095e-06
PLA2G1B,Phospholipase A2,Diet and food preferences,X20683.Liking for lamb,18837,-0.0866871829623938,0.028369439370665,-0.142291284128897,-0.0310830817958903,0.00224884905620831
PLA2G1B,Phospholipase A2,Diet and food preferences,X20684.Liking for lemons,18837,-0.0958286376130368,0.0284526249440131,-0.151595782503303,-0.0400614927227711,0.000758654967157874
PLA2G1B,Phospholipase A2,Diet and food preferences,X20685.Liking for lentils or beans,18837,0.0094246428573963,0.0285341010608209,-0.0465021952218126,0.0653514809366052,0.741181491040371
PLA2G1B,Phospholipase A2,Diet and food preferences,X20686.Liking for liver,18837,-0.0815887682152154,0.0281391598622862,-0.136741521545296,-0.0264360148851345,0.00374221360894282
PLA2G1B,Phospholipase A2,Diet and food preferences,X20687.Liking for mackerel,18837,-0.051052951823306,0.028313305560742,-0.10654703072236,0.00444112707574833,0.0713816802614411
PLA2G1B,Phospholipase A2,Diet and food preferences,X20688.Liking for marzipan,18837,0.0896554778011724,0.0281338747088208,0.0345130833718837,0.144797872230461,0.00144118775385674
PLA2G1B,Phospholipase A2,Diet and food preferences,X20689.Liking for mayonnaise,18837,-0.0513473743477847,0.0280496959049124,-0.106324778321413,0.00363002962584352,0.0671782026065398
PLA2G1B,Phospholipase A2,Diet and food preferences,X20690.Liking for melon,18837,0.0198814105432861,0.0291124026841121,-0.0371788987175738,0.0769417198041459,0.494666487888907
PLA2G1B,Phospholipase A2,Diet and food preferences,X20691.Liking for milk chocolate,18837,0.0763948761525539,0.0283147280593014,0.0208980091563232,0.131891743148785,0.00698067689159715
PLA2G1B,Phospholipase A2,Diet and food preferences,X20692.Liking for mushrooms,18837,-0.0113280719093787,0.0291881412842882,-0.0685368288265837,0.0458806850078262,0.69794251167583
PLA2G1B,Phospholipase A2,Diet and food preferences,X20694.Liking for orange juice,18837,0.00559951998422683,0.0284285509706397,-0.0501204399182269,0.0613194798866806,0.843854565193087
PLA2G1B,Phospholipase A2,Diet and food preferences,X20695.Liking for oranges,18837,0.0103221185544835,0.0289563755425068,-0.0464323775088299,0.0670766146177969,0.721491594491151
PLA2G1B,Phospholipase A2,Diet and food preferences,X20696.Liking for pasta,18837,-0.00545466722067686,0.0287696865925535,-0.0618432529420818,0.0509339185007281,0.849626412827274
PLA2G1B,Phospholipase A2,Diet and food preferences,X20697.Liking for pears,18837,0.0119833422349688,0.0287632417711108,-0.0443926116364084,0.068359296106346,0.676961119563636
PLA2G1B,Phospholipase A2,Diet and food preferences,X20698.Liking for pizza,18837,0.053834430747359,0.0283531688549291,-0.00173778020830206,0.10940664170302,0.0576179682402384
PLA2G1B,Phospholipase A2,Diet and food preferences,X20699.Liking for plain yogurt,18837,0.0374532981802394,0.0284188969852845,-0.0182477399109182,0.0931543362713969,0.18755277327267
PLA2G1B,Phospholipase A2,Diet and food preferences,X20700.Liking for plums,18837,0.0358554442166698,0.028876287495468,-0.0207420792744475,0.0924529677077872,0.214365842055554
PLA2G1B,Phospholipase A2,Diet and food preferences,X20701.Liking for pollock,18837,-0.0723441254106269,0.0282228986706739,-0.127661006805148,-0.0170272440161061,0.0103755531222185
PLA2G1B,Phospholipase A2,Diet and food preferences,X20702.Liking for pork chop,18837,-0.0584344937939495,0.0281107800107587,-0.113531622615037,-0.00333736497286244,0.0376564372697052
PLA2G1B,Phospholipase A2,Diet and food preferences,X20703.Liking for porridge,18837,0.0641630397303903,0.0288602648910934,0.00759692054384734,0.120729158916933,0.0262120507105575
PLA2G1B,Phospholipase A2,Diet and food preferences,X20704.Liking for potato crisps,18837,-0.046145633877477,0.0283602407462429,-0.101731705740113,0.00944043798515917,0.103727469486776
PLA2G1B,Phospholipase A2,Diet and food preferences,X20705.Liking for potatoes,18837,-0.010247664694333,0.0286968743330386,-0.0664935383870886,0.0459982089984226,0.721020665865637
PLA2G1B,Phospholipase A2,Diet and food preferences,X20706.Liking for prawns,18837,-0.11505329065595,0.0287721982369293,-0.171446799200332,-0.0586597821115687,6.39167316004199e-05
PLA2G1B,Phospholipase A2,Diet and food preferences,X20707.Liking for raw carrots,18837,-0.00386631232490177,0.0286558647710752,-0.0600318072762091,0.0522991826264056,0.892674830100258
PLA2G1B,Phospholipase A2,Diet and food preferences,X20708.Liking for red meat,18837,-0.119875660450234,0.0284058958343403,-0.175551216285541,-0.0642001046149271,2.45340785386527e-05
PLA2G1B,Phospholipase A2,Diet and food preferences,X20709.Liking for red wine,18837,-0.221731333754647,0.028416528548076,-0.277427729708876,-0.166034937800418,6.36504904013405e-15
PLA2G1B,Phospholipase A2,Diet and food preferences,X20710.Liking for regular (non-diet) fizzy drinks,18837,0.0706577755202129,0.0291867495670511,0.0134517463687927,0.127863804671633,0.0154921585741799
PLA2G1B,Phospholipase A2,Diet and food preferences,X20711.Liking for roast chicken,18837,-0.0160260280412584,0.0294811461637369,-0.0738090745221827,0.0417570184396658,0.586721403307335
PLA2G1B,Phospholipase A2,Diet and food preferences,X20712.Liking for salad dressing,18837,-0.0785315717055285,0.028164029624353,-0.13373306976926,-0.0233300736417967,0.0053028137675518
PLA2G1B,Phospholipase A2,Diet and food preferences,X20713.Liking for salad leaves,18837,-0.0435437111764076,0.0288537455298932,-0.100097052414998,0.0130096300621831,0.131285383582772
PLA2G1B,Phospholipase A2,Diet and food preferences,X20714.Liking for salami,18837,-0.0976885543436924,0.0279606881920898,-0.152491503200188,-0.0428856054871964,0.000477323822196466
PLA2G1B,Phospholipase A2,Diet and food preferences,X20715.Liking for salmon,18837,-0.051278775947218,0.0294904600981324,-0.109080077739558,0.00652252584512158,0.0820817479717527
PLA2G1B,Phospholipase A2,Diet and food preferences,X20716.Liking for salty foods,18837,-0.0443068216945191,0.0282201791350267,-0.0996183727991715,0.0110047294101332,0.116422526400622
PLA2G1B,Phospholipase A2,Diet and food preferences,X20717.Liking for salty pretzels,18837,-0.0211667662507116,0.0280567048333611,-0.0761579077240993,0.0338243752226762,0.450601652041092
PLA2G1B,Phospholipase A2,Diet and food preferences,X20718.Liking for sardines,18837,-0.0462707792093579,0.028194609985347,-0.101532214780638,0.0089906563619221,0.10078892222909
PLA2G1B,Phospholipase A2,Diet and food preferences,X20719.Liking for sausages (meat),18837,-0.0635861679134127,0.028121373050329,-0.118704059092058,-0.00846827673476789,0.0237623855752022
PLA2G1B,Phospholipase A2,Diet and food preferences,X20720.Liking for savoury biscuits,18837,-0.0602925268984553,0.0283506977975111,-0.115859894581577,-0.00472515921533353,0.0334606401410668
PLA2G1B,Phospholipase A2,Diet and food preferences,X20721.Liking for shellfish (other than prawns),18837,-0.114652178069141,0.0282864305896532,-0.170093582024861,-0.0592107741134206,5.07124743169628e-05
PLA2G1B,Phospholipase A2,Diet and food preferences,X20722.Liking for skimmed milk,18837,0.0149472874265817,0.0281936447500097,-0.0403122562834374,0.0702068311366008,0.596003699757796
PLA2G1B,Phospholipase A2,Diet and food preferences,X20723.Liking for smoked fish,18837,-0.0856588151957011,0.0283525148860413,-0.141229744372342,-0.0300878860190602,0.00252107427904655
PLA2G1B,Phospholipase A2,Diet and food preferences,X20724.Liking for soft cheese,18837,-0.0414438519448846,0.028221992828906,-0.0967589578895403,0.0138712539997712,0.141986564702203
PLA2G1B,Phospholipase A2,Diet and food preferences,X20725.Liking for soy sauce,18837,-0.0832445424123732,0.0283669493849862,-0.138843763206946,-0.0276453216178004,0.00334423460552627
PLA2G1B,Phospholipase A2,Diet and food preferences,X20726.Liking for soya milk,18837,0.0514021089734044,0.0283473697127512,-0.00415873566358794,0.106962953610397,0.0698024504908147
PLA2G1B,Phospholipase A2,Diet and food preferences,X20727.Liking for spicy foods,18837,-0.104302269063492,0.0284496919025585,-0.160063665192506,-0.0485408729344769,0.000246858654081735
PLA2G1B,Phospholipase A2,Diet and food preferences,X20728.Liking for spinach,18837,-0.061693486563272,0.0287595481407224,-0.118062200919088,-0.00532477220745604,0.0319537804551141
PLA2G1B,Phospholipase A2,Diet and food preferences,X20729.Liking for spirits,18837,-0.216262545535997,0.0283438718206066,-0.271816534304386,-0.160708556767609,2.46001954271726e-14
PLA2G1B,Phospholipase A2,Diet and food preferences,X20730.Liking for strawberries,18837,0.0103796906412199,0.0307459584953321,-0.049882388009631,0.0706417692920708,0.735671961638587
PLA2G1B,Phospholipase A2,Diet and food preferences,X20731.Liking for sweet coffee house drinks,18837,0.0254404323995735,0.0291179143608094,-0.0316306797476128,0.0825115445467599,0.382290733071536
PLA2G1B,Phospholipase A2,Diet and food preferences,X20732.Liking for sweet foods,18837,0.172937499110755,0.028270998746639,0.117526341567343,0.228348656654168,9.71552636139077e-10
PLA2G1B,Phospholipase A2,Diet and food preferences,X20733.Liking for taking the stairs,18837,0.0222299999758448,0.0288317672545071,-0.0342802638429892,0.0787402637946787,0.440702070906292
PLA2G1B,Phospholipase A2,Diet and food preferences,X20734.Liking for tea with sugar,18837,0.119576345700514,0.0340650231724919,0.0528089002824302,0.186343791118599,0.000448752517571963
PLA2G1B,Phospholipase A2,Diet and food preferences,X20735.Liking for tea without sugar,18837,0.0422690423580097,0.0296091690987327,-0.0157649290755063,0.100303013791526,0.15343342007555
PLA2G1B,Phospholipase A2,Diet and food preferences,X20736.Liking for tomato ketchup,18837,-0.0329505495919195,0.0280889663370042,-0.0880049236124479,0.0221038244286088,0.240779363080487
PLA2G1B,Phospholipase A2,Diet and food preferences,X20737.Liking for tinned tuna,18837,-0.0357501802388262,0.0283072847403936,-0.0912324583299977,0.0197320978523452,0.206629213019278
PLA2G1B,Phospholipase A2,Diet and food preferences,X20738.Liking for turnip (white),18837,-0.0723690815519188,0.0282057772911921,-0.127652405042655,-0.0170857580611824,0.0103028600304354
PLA2G1B,Phospholipase A2,Diet and food preferences,X20739.Liking for vegetables,18837,-0.0569352907849016,0.0310471974388668,-0.11778779776508,0.00391721619527726,0.0666949779654397
PLA2G1B,Phospholipase A2,Diet and food preferences,X20740.Liking for vinegar,18837,-0.0834058148854911,0.0283446766568661,-0.138961381132949,-0.0278502486380336,0.00325911464097427
PLA2G1B,Phospholipase A2,Diet and food preferences,X20741.Liking for watching television,18837,0.0355411723909649,0.0287235471003122,-0.0207569799256469,0.0918393247075768,0.215971434848656
PLA2G1B,Phospholipase A2,Diet and food preferences,X20742.Liking for whisky,18837,-0.147039365314213,0.0291710414249476,-0.20421460650711,-0.0898641241213157,4.68395737840915e-07
PLA2G1B,Phospholipase A2,Diet and food preferences,X20743.Liking for white bread,18837,0.00441954064558456,0.0279407461766351,-0.0503443218606203,0.0591834031517894,0.874320230471926
PLA2G1B,Phospholipase A2,Diet and food preferences,X20744.Liking for white rice,18837,-0.0302935910050716,0.0284310820467397,-0.0860185118166813,0.0254313298065382,0.286659054895165
PLA2G1B,Phospholipase A2,Diet and food preferences,X20745.Liking for white wine,18837,-0.15117523246045,0.0282842240819325,-0.206612311661037,-0.0957381532598621,9.15407890767263e-08
PLA2G1B,Phospholipase A2,Diet and food preferences,X20746.Liking for whole grain breakfast cereal,18837,0.0522991193779361,0.0287610232836003,-0.0040724862579205,0.108670725013793,0.0690185151175288
PLA2G1B,Phospholipase A2,Diet and food preferences,X20747.Liking for whole milk,18837,0.0576607006705753,0.0281653056729232,0.00245670155164594,0.112864699789505,0.0406499174424563
PLA2G1B,Phospholipase A2,Diet and food preferences,X20748.Liking for wholemeal bread,18837,-0.0321925473170254,0.0295089357018712,-0.090030061292693,0.0256449666586422,0.275312226847915
PLA2G1B,Phospholipase A2,Diet and food preferences,X20749.Liking for working up a sweat,18837,0.0546945277011342,0.0283560174462165,-0.000883266493450198,0.110272321895719,0.0537644083809155
PLA2G1B,Phospholipase A2,Physical measures,X21001.Body mass index (BMI),51811,-0.0895962765886517,0.00932394963695785,-0.107871217877089,-0.0713213353002143,7.62042409366022e-22
PLA2G1B,Phospholipase A2,Physical measures,X21002.Weight,51852,-0.0635567117015819,0.00525704069786014,-0.0738605114693878,-0.053252911933776,1.32671972861437e-33
PLA2G1B,Phospholipase A2,Physical measures,X21021.Pulse wave Arterial Stiffness index,17256,-0.0183594531206157,0.00382638761748614,-0.0258591728508885,-0.0108597333903428,1.6150517649749e-06
PLA2G1B,Phospholipase A2,Health and medical history,X21025.Frequency of discomfort or pain in abdomen in last 3 months,18006,-0.00392030965830765,0.0303989803650407,-0.0635023111737874,0.0556616918571721,0.897389254120863
PLA2G1B,Phospholipase A2,Health and medical history,X21033.Frequency of hard or lumpy stools in the last 3 months,18023,0.0459626697190195,0.0313472292286137,-0.0154778995690633,0.107403239007102,0.142599436672094
PLA2G1B,Phospholipase A2,Health and medical history,X21034.Frequency of loose or mushy or watery stools in the last 3 months,18025,0.0169028255070471,0.0309565746809559,-0.0437720608676265,0.0775777118817206,0.58506080522573
PLA2G1B,Phospholipase A2,Health and medical history,X21040.Satisfaction with bowel habits,17948,-0.033506060195943,0.0286213788822528,-0.0896039628051585,0.0225918424132726,0.241748829461187
PLA2G1B,Phospholipase A2,Health and medical history,X21041.Degree to which abdominal pain or discomfort or altered bowel habits affect or interfere with life in general,17929,-0.052470947776328,0.0307854957770453,-0.112810519499337,0.00786862394668086,0.0883228302260615
PLA2G1B,Phospholipase A2,Health and medical history,X21042.Greatest number of times bowels opened per day,17939,-0.00825617380310017,0.0309355364932237,-0.0688898253298186,0.0523774777236183,0.789562191496869
PLA2G1B,Phospholipase A2,Health and medical history,X21043.Least number of times bowels opened per week,17810,0.0427671818057544,0.0309006514004606,-0.0177980949391484,0.103332458550657,0.166369071398641
PLA2G1B,Phospholipase A2,Health and medical history,X21044.Average number of times bowels opened per day,17874,-0.0483055822226022,0.0346769081039094,-0.116272322106265,0.0196611576610601,0.163631474845472
PLA2G1B,Phospholipase A2,Health and medical history,X21048.Degree bothered by back pain in the past 3 months,18034,0.0103107656413692,0.0311331625817533,-0.0507102330188672,0.0713317643016056,0.740510318807767
PLA2G1B,Phospholipase A2,Health and medical history,X21049.Degree bothered by pain in arms or legs or joints in the past 3 months,18024,0.0591039093385468,0.0312724320337163,-0.00219005744753706,0.120397876124631,0.0587782260505863
PLA2G1B,Phospholipase A2,Health and medical history,X21050.Degree bothered by menstrual cramps or other problems with period in the last 3 months,10132,0.0078674694111804,0.04930035186709,-0.088761220248316,0.104496159070677,0.873213214702347
PLA2G1B,Phospholipase A2,Health and medical history,X21051.Degree bothered by headaches in the last 3 months,18029,-0.044087304988981,0.0340863224252449,-0.110896496942461,0.0227218869644989,0.195888771605518
PLA2G1B,Phospholipase A2,Health and medical history,X21052.Degree bothered by chest pain in the last 3 months,18026,0.0318352808579181,0.0466261633740939,-0.0595519993553058,0.123222561071142,0.494756426196845
PLA2G1B,Phospholipase A2,Health and medical history,X21053.Degree bothered by dizziness in the last 3 months,18027,-0.0132867786106894,0.0366175958645136,-0.0850572665051361,0.0584837092837573,0.716719483913023
PLA2G1B,Phospholipase A2,Health and medical history,X21054.Degree bothered by fainting spells in the last 3 months,18025,-0.000305169998159943,0.0908184895223322,-0.178309409461931,0.177699069465611,0.997318975540192
PLA2G1B,Phospholipase A2,Health and medical history,X21055.Degree bothered by feeling heart pound or race in the last 3 months,18033,0.079397262823504,0.0357566563109433,0.00931421645405521,0.149480309192953,0.0263979804483488
PLA2G1B,Phospholipase A2,Health and medical history,X21056.Degree bothered by shortness of breath in the last 3 months,18029,0.0522510783278305,0.0353742892557206,-0.0170825286133819,0.121584685269043,0.139668469132363
PLA2G1B,Phospholipase A2,Health and medical history,X21057.Degree bothered by pain or problems during intercourse in the last 3 months,17619,0.00675467842145317,0.0325730516941549,-0.0570885028990905,0.0705978597419968,0.835723196159366
PLA2G1B,Phospholipase A2,Health and medical history,X21058.Degree bothered by urinary frequency or bladder irritability in the last 3 months,18023,0.028999902116188,0.0321297703313302,-0.0339744477332192,0.0919742519655951,0.366757381054229
PLA2G1B,Phospholipase A2,Health and medical history,X21059.Degree bothered by nausea in the last 3 months,18030,-0.0649277223192459,0.0465116886598725,-0.156090632092596,0.0262351874541042,0.162748499435793
PLA2G1B,Phospholipase A2,Health and medical history,X21060.Degree bothered by feeling tired all the time in the last 3 months,18033,0.0166265977350165,0.0312407498201531,-0.0446052719124836,0.0778584673825165,0.594588044991006
PLA2G1B,Phospholipase A2,Health and medical history,X21061.Degree bothered by trouble sleeping in the last 3 months,18030,-0.00843107413772952,0.0311248256449651,-0.0694357324018612,0.0525735841264021,0.78648689167367
PLA2G1B,Phospholipase A2,Working and living environment,X21100.Water hardness (USGS classification),51540,0.0230516974023119,0.017323600648177,-0.010902559868115,0.0570059546727389,0.183309175065785
PLA2G1B,Phospholipase A2,Lifestyle factors,X2139.Age first had sexual intercourse,44976,0.00943711388593216,0.00238866252366456,0.00475533533954962,0.0141188924323147,7.80111240267962e-05
PLA2G1B,Phospholipase A2,Health and medical history,X2149.Lifetime number of sexual partners,41725,-0.0932929611431921,0.0197849349504519,-0.132071433646078,-0.0545144886403064,2.42070750832191e-06
PLA2G1B,Phospholipase A2,Physical activities,X22032.IPAQ activity group,41687,0.0151005657140988,0.0192328236163954,-0.0225957685740362,0.0527969000022337,0.43237270436468
PLA2G1B,Phospholipase A2,Physical activities,X22033.Summed days activity,42790,-0.0019261743631695,0.00234741533570045,-0.00652710842114237,0.00267475969480337,0.411906552670332
PLA2G1B,Phospholipase A2,Physical activities,X22034.Summed minutes activity,41687,-0.00100951804784541,0.00236399900632396,-0.00564295610024037,0.00362392000454955,0.669353659069833
PLA2G1B,Phospholipase A2,Physical activities,X22037.MET minutes per week for walking,39904,-0.00267301535852144,0.00240127054751084,-0.00737950563164269,0.00203347491459981,0.26564337988534
PLA2G1B,Phospholipase A2,Physical activities,X22038.MET minutes per week for moderate activity,41687,-0.0055736104601652,0.00236732182483364,-0.0102135612368391,-0.00093365968349127,0.0185575022406596
PLA2G1B,Phospholipase A2,Physical activities,X22039.MET minutes per week for vigorous activity,41687,0.0242491116035773,0.019217050837264,-0.0134163080374601,0.0619145312446148,0.20700840571464
PLA2G1B,Phospholipase A2,Physical activities,X22040.Summed MET minutes per week for all activity,39904,-0.00220851474231039,0.00241082083635764,-0.00693372358157137,0.0025166940969506,0.359628301413895
PLA2G1B,Phospholipase A2,Eye measures,X2217.Age started wearing glasses or contact lenses,44246,-0.00395514445427178,0.0023432727324952,-0.00854795900996237,0.000637670101418808,0.0914428508652984
PLA2G1B,Phospholipase A2,Working and living environment,X22501.Year ended full time education,12640,0.025815564573415,0.0101643626170948,0.00589341384390907,0.0457377153029208,0.0111031083804017
PLA2G1B,Phospholipase A2,Lifestyle factors,X22506.Tobacco smoking,12558,0.120307707228623,0.0745065280159694,-0.0257250876826772,0.266340502139923,0.106394968620783
PLA2G1B,Phospholipase A2,Lifestyle factors,X2277.Frequency of solarium or sunlamp use,48638,-0.149998063251514,0.0460682151685617,-0.240291764981895,-0.0597043615211327,0.0011307145260776
PLA2G1B,Phospholipase A2,Physical measures,X23098.Weight,50976,-0.0627965597550767,0.00529327763838415,-0.0731713839263096,-0.0524217355838437,2.0219725490404e-32
PLA2G1B,Phospholipase A2,Physical measures,X23099.Body fat percentage,50946,-0.0335352311817004,0.00508661817529636,-0.0435050028052813,-0.0235654595581195,4.35709716939044e-11
PLA2G1B,Phospholipase A2,Physical measures,X23100.Whole body fat mass,50896,-0.0521294685689326,0.0049075200345166,-0.0617482078365852,-0.0425107293012801,2.49935461634161e-26
PLA2G1B,Phospholipase A2,Physical measures,X23101.Whole body fat-free mass,50970,-0.0301994950686733,0.00443121658715131,-0.0388846795794899,-0.0215143105578568,9.51964051260797e-12
PLA2G1B,Phospholipase A2,Physical measures,X23102.Whole body water mass,50976,-0.0302030127073176,0.00443748216098809,-0.0389004777428543,-0.021505547671781,1.01217364416312e-11
PLA2G1B,Phospholipase A2,Physical measures,X23104.Body mass index (BMI),50976,-0.0859892387729882,0.00936043333544508,-0.104335688110461,-0.0676427894355158,4.20749556229188e-20
PLA2G1B,Phospholipase A2,Physical measures,X23105.Basal metabolic rate,50974,-0.0378812820613917,0.00474074935192277,-0.0471731507911603,-0.028589413331623,1.37114276465676e-15
PLA2G1B,Phospholipase A2,Physical measures,X23106.Impedance of whole body,50970,-0.00481815607583997,0.0036291652131165,-0.0119313198935483,0.00229500774186838,0.184309279438287
PLA2G1B,Phospholipase A2,Physical measures,X23107.Impedance of leg (right),50973,0.000823598914950907,0.00296209061442499,-0.00498209868932208,0.00662929651922389,0.780977795124216
PLA2G1B,Phospholipase A2,Physical measures,X23108.Impedance of leg (left),50972,0.000339259267240586,0.00294078589863473,-0.00542468109408349,0.00610319962856466,0.908157486481339
PLA2G1B,Phospholipase A2,Physical measures,X23109.Impedance of arm (right),50963,-0.0052727632127159,0.00361717726939939,-0.0123624306607387,0.00181690423530689,0.144929117664732
PLA2G1B,Phospholipase A2,Physical measures,X23110.Impedance of arm (left),50971,-0.00537430718810224,0.00362133858436179,-0.0124721308134514,0.00172351643724687,0.137797471261865
PLA2G1B,Phospholipase A2,Physical measures,X23111.Leg fat percentage (right),50972,-0.0229692320805444,0.00615586628393104,-0.0350347299970492,-0.0109037341640395,0.000190719544237868
PLA2G1B,Phospholipase A2,Physical measures,X23112.Leg fat mass (right),50971,-0.0492291248952307,0.00654374082764668,-0.0620548569174182,-0.0364033928730432,5.43748979510195e-14
PLA2G1B,Phospholipase A2,Physical measures,X23113.Leg fat-free mass (right),50970,-0.0334202746412886,0.00463620528202073,-0.0425072369940492,-0.0243333122885279,5.73372996531348e-13
PLA2G1B,Phospholipase A2,Physical measures,X23114.Leg predicted mass (right),50969,-0.0341091949735652,0.00465918422076179,-0.0432411960462583,-0.0249771939008721,2.50027676134567e-13
PLA2G1B,Phospholipase A2,Physical measures,X23115.Leg fat percentage (left),50966,-0.0295704720604143,0.00641004667478085,-0.0421341635429848,-0.0170067805778438,3.97585881182422e-06
PLA2G1B,Phospholipase A2,Physical measures,X23116.Leg fat mass (left),50966,-0.0565449886353405,0.00682005490960231,-0.069912296258161,-0.04317768101252,1.15021250079661e-16
PLA2G1B,Phospholipase A2,Physical measures,X23117.Leg fat-free mass (left),50963,-0.0356848051495194,0.00483971835820691,-0.045170653131605,-0.0261989571674339,1.68945878735714e-13
PLA2G1B,Phospholipase A2,Physical measures,X23118.Leg predicted mass (left),50962,-0.0353861015335097,0.00486435088918361,-0.0449202292763096,-0.0258519737907098,3.52490584448762e-13
PLA2G1B,Phospholipase A2,Physical measures,X23119.Arm fat percentage (right),50962,-0.0376660972766151,0.00565198210990593,-0.0487439822120307,-0.0265882123411995,2.68762233275458e-11
PLA2G1B,Phospholipase A2,Physical measures,X23120.Arm fat mass (right),50958,-0.0605128585991387,0.00558970142032098,-0.0714686733829678,-0.0495570438153096,2.78276225908698e-27
PLA2G1B,Phospholipase A2,Physical measures,X23121.Arm fat-free mass (right),50958,-0.0247811602350957,0.00446421702520556,-0.0335310256044986,-0.0160312948656928,2.85344719341379e-08
PLA2G1B,Phospholipase A2,Physical measures,X23122.Arm predicted mass (right),50957,-0.0238725003512731,0.00447127277331676,-0.032636194986974,-0.0151088057155723,9.3816427001179e-08
PLA2G1B,Phospholipase A2,Physical measures,X23123.Arm fat percentage (left),50952,-0.0378530073667328,0.00579464688599163,-0.0492105152632764,-0.0264954994701892,6.53275754900071e-11
PLA2G1B,Phospholipase A2,Physical measures,X23124.Arm fat mass (left),50951,-0.0636802515408039,0.00557809673543436,-0.0746133211422553,-0.0527471819393526,3.78006131855626e-30
PLA2G1B,Phospholipase A2,Physical measures,X23125.Arm fat-free mass (left),50947,-0.030571655623101,0.00454941310371109,-0.0394885053063748,-0.0216548059398273,1.83743052151371e-11
PLA2G1B,Phospholipase A2,Physical measures,X23126.Arm predicted mass (left),50944,-0.027909489205242,0.00456402502709124,-0.0368549782583408,-0.0189640001521432,9.71933753203096e-10
PLA2G1B,Phospholipase A2,Physical measures,X23127.Trunk fat percentage,50940,-0.0252371601238852,0.00364514493487509,-0.0323816441962403,-0.01809267605153,4.4582276292596e-12
PLA2G1B,Phospholipase A2,Physical measures,X23128.Trunk fat mass,50936,-0.0407576862894314,0.00400897268371759,-0.0486152727495179,-0.0329000998293449,2.94773266124255e-24
PLA2G1B,Phospholipase A2,Physical measures,X23129.Trunk fat-free mass,50929,-0.0249875317022015,0.00401776496618894,-0.0328623510359318,-0.0171127123684711,5.03369658889397e-10
PLA2G1B,Phospholipase A2,Physical measures,X23130.Trunk predicted mass,50924,-0.0250007265550945,0.00402012491478835,-0.0328801713880797,-0.0171212817221094,5.04553263929675e-10
PLA2G1B,Phospholipase A2,NMR metabolomics,X23400.Total Cholesterol,29787,-0.0191993783805573,0.00293260788570262,-0.0249472898365345,-0.0134514669245802,5.9713776104953e-11
PLA2G1B,Phospholipase A2,NMR metabolomics,X23401.Total Cholesterol Minus HDL-C,29787,-0.00973288219177863,0.00284347983725527,-0.015306102672799,-0.0041596617107583,0.000620454143940707
PLA2G1B,Phospholipase A2,NMR metabolomics,"X23402.Remnant Cholesterol (Non-HDL, Non-LDL -Cholesterol)",29787,-0.0103586940150187,0.00284854911456418,-0.0159418502795645,-0.00477553775047292,0.000276854356294649
PLA2G1B,Phospholipase A2,NMR metabolomics,X23403.VLDL Cholesterol,29787,-0.00300932313840501,0.00285615892156644,-0.00860739462467522,0.00258874834786521,0.292062756993601
PLA2G1B,Phospholipase A2,NMR metabolomics,X23404.Clinical LDL Cholesterol,29787,-0.00688318988654895,0.00284693884168515,-0.0124631900162518,-0.00130318975684606,0.0156227137615138
PLA2G1B,Phospholipase A2,NMR metabolomics,X23405.LDL Cholesterol,29787,-0.0089104402544612,0.00283872118830328,-0.0144743337835356,-0.00334654672538677,0.00169753311917115
PLA2G1B,Phospholipase A2,NMR metabolomics,X23406.HDL Cholesterol,29787,-0.0384141858611152,0.00329608551955089,-0.044874513479435,-0.0319538582427955,2.54620054849408e-31
PLA2G1B,Phospholipase A2,NMR metabolomics,X23407.Total Triglycerides,29787,-0.0188444160388122,0.00302296250214948,-0.0247694225430252,-0.0129194095345992,4.61480493932879e-10
PLA2G1B,Phospholipase A2,NMR metabolomics,X23408.Triglycerides in VLDL,29787,-0.0155323872934646,0.00304644976473091,-0.0215034288323372,-0.00956134575459204,3.44412813011512e-07
PLA2G1B,Phospholipase A2,NMR metabolomics,X23409.Triglycerides in LDL,29787,-0.0220249094704092,0.00292773020463981,-0.0277632606715033,-0.0162865582693152,5.51009008042328e-14
PLA2G1B,Phospholipase A2,NMR metabolomics,X23410.Triglycerides in HDL,29787,-0.0306594357321625,0.00291069686545523,-0.0363644015884548,-0.0249544698758703,6.73365341267307e-26
PLA2G1B,Phospholipase A2,NMR metabolomics,X23411.Total Phospholipids in Lipoprotein Particles,29787,-0.0390274949558332,0.00297022449649182,-0.0448491349689571,-0.0332058549427092,2.51343111987842e-39
PLA2G1B,Phospholipase A2,NMR metabolomics,X23412.Phospholipids in VLDL,29787,-0.00762010613376151,0.00292211144242266,-0.0133474445609099,-0.0018927677066131,0.00911877012792733
PLA2G1B,Phospholipase A2,NMR metabolomics,X23413.Phospholipids in LDL,29787,-0.00876226287579508,0.00283233296573439,-0.0143136354886345,-0.00321089026295567,0.00197889833163225
PLA2G1B,Phospholipase A2,NMR metabolomics,X23414.Phospholipids in HDL,29787,-0.0527827273459024,0.00317190506038717,-0.0589996612642613,-0.0465657934275436,6.7335616869038e-62
PLA2G1B,Phospholipase A2,NMR metabolomics,X23415.Total Esterified Cholesterol,29787,-0.0205309085018582,0.00294711632774888,-0.026307256504246,-0.0147545604994704,3.31815229447368e-12
PLA2G1B,Phospholipase A2,NMR metabolomics,X23416.Cholesteryl Esters in VLDL,29787,-0.000881094934443162,0.00283977422636737,-0.0064470524181232,0.00468486254923688,0.756358300383878
PLA2G1B,Phospholipase A2,NMR metabolomics,X23417.Cholesteryl Esters in LDL,29787,-0.00988321058451312,0.00283303179090406,-0.0154359528946851,-0.00433046827434117,0.000486325039458753
PLA2G1B,Phospholipase A2,NMR metabolomics,X23418.Cholesteryl Esters in HDL,29787,-0.0357100231043497,0.00328621268942595,-0.0421509999756245,-0.0292690462330748,1.8720793134458e-27
PLA2G1B,Phospholipase A2,NMR metabolomics,X23419.Total Free Cholesterol,29787,-0.0155813919694109,0.00289842665694631,-0.0212623082170257,-0.00990047572179614,7.68119452852648e-08
PLA2G1B,Phospholipase A2,NMR metabolomics,X23420.Free Cholesterol in VLDL,29787,-0.00566990284188917,0.0028946799878731,-0.0113434756181205,3.66993434211538e-06,0.0501534808657477
PLA2G1B,Phospholipase A2,NMR metabolomics,X23421.Free Cholesterol in LDL,29787,-0.00579139209080312,0.00286658865725497,-0.0114099058590229,-0.000172878322583386,0.0433603826500205
PLA2G1B,Phospholipase A2,NMR metabolomics,X23422.Free Cholesterol in HDL,29787,-0.0446197496121441,0.00329164214300258,-0.0510713682124292,-0.0381681310118591,9.78341398183693e-42
PLA2G1B,Phospholipase A2,NMR metabolomics,X23423.Total Lipids in Lipoprotein Particles,29787,-0.0278984000748228,0.00287118332003487,-0.0335259193820911,-0.0222708807675544,2.76250986124187e-22
PLA2G1B,Phospholipase A2,NMR metabolomics,X23424.Total Lipids in VLDL,29787,-0.0109607801274239,0.00295955441074822,-0.0167615067724904,-0.00516005348235738,0.000213009229961148
PLA2G1B,Phospholipase A2,NMR metabolomics,X23425.Total Lipids in LDL,29787,-0.0100105853130568,0.00283456293305211,-0.0155663286618389,-0.00445484196427466,0.000413654283089278
PLA2G1B,Phospholipase A2,NMR metabolomics,X23426.Total Lipids in HDL,29787,-0.048501345973225,0.003218978595682,-0.0548105440207617,-0.0421921479256882,4.10265845999698e-51
PLA2G1B,Phospholipase A2,NMR metabolomics,X23427.Total Concentration of Lipoprotein Particles,29787,-0.0457476176193003,0.00301987398225311,-0.0516665706245164,-0.0398286646140842,1.20174627295197e-51
PLA2G1B,Phospholipase A2,NMR metabolomics,X23428.Concentration of VLDL Particles,29787,-0.00526981204991732,0.00288048398880983,-0.0109155606679846,0.000375936568149935,0.0673364702066874
PLA2G1B,Phospholipase A2,NMR metabolomics,X23429.Concentration of LDL Particles,29787,0.00122022586594438,0.00282782401388227,-0.00432230920126486,0.00676276093315363,0.666102885970993
PLA2G1B,Phospholipase A2,NMR metabolomics,X23430.Concentration of HDL Particles,29787,-0.0476681652148764,0.00302954254939331,-0.0536060686116873,-0.0417302618180655,1.47129897679794e-55
PLA2G1B,Phospholipase A2,NMR metabolomics,X23431.Average Diameter for VLDL Particles,29787,-0.00833491373826846,0.00316502123256884,-0.0145383553541034,-0.00213147212243354,0.00845668552329835
PLA2G1B,Phospholipase A2,NMR metabolomics,X23432.Average Diameter for LDL Particles,29787,0.00999342404276893,0.00295676027843302,0.00419817389704021,0.0157886741884976,0.00072616878255468
PLA2G1B,Phospholipase A2,NMR metabolomics,X23433.Average Diameter for HDL Particles,29787,-0.0154905722015336,0.00338101510812638,-0.0221173618134613,-0.00886378258960588,4.6322764118851e-06
PLA2G1B,Phospholipase A2,NMR metabolomics,X23434.Phosphoglycerides,29763,-0.0474726127545739,0.00298632561829543,-0.0533258109664329,-0.0416194145427148,1.14436075990792e-56
PLA2G1B,Phospholipase A2,NMR metabolomics,X23435.Triglycerides to Phosphoglycerides ratio,29763,0.00200520893199422,0.00321185574312505,-0.00429002832453087,0.00830044618851931,0.532425683138666
PLA2G1B,Phospholipase A2,NMR metabolomics,X23436.Total Cholines,29763,-0.0424500306339386,0.00301538741524865,-0.0483601899678259,-0.0365398713000512,7.24714261406249e-45
PLA2G1B,Phospholipase A2,NMR metabolomics,X23437.Phosphatidylcholines,29763,-0.0489068264783096,0.00302369404017369,-0.05483326679705,-0.0429803861595691,1.35718822339251e-58
PLA2G1B,Phospholipase A2,NMR metabolomics,X23438.Sphingomyelins,29762,-0.0230942285672456,0.0030437531814529,-0.0290599848028933,-0.017128472331598,3.35869360097471e-14
PLA2G1B,Phospholipase A2,NMR metabolomics,X23439.Apolipoprotein B,29787,-0.00146717325325001,0.00283134440925858,-0.00701660829539684,0.00408226178889681,0.604329834371345
PLA2G1B,Phospholipase A2,NMR metabolomics,X23440.Apolipoprotein A1,29787,-0.0504621099717389,0.00313118752682063,-0.0565992375243073,-0.0443249824191705,3.4758395922894e-58
PLA2G1B,Phospholipase A2,NMR metabolomics,X23441.Apolipoprotein B to Apolipoprotein A1 ratio,29787,0.0233395049518954,0.00288745644408002,0.0176800903214986,0.0289989195822923,6.55304972116416e-16
PLA2G1B,Phospholipase A2,NMR metabolomics,X23442.Total Fatty Acids,29763,-0.0308203892193264,0.00287857779505639,-0.036462401697637,-0.0251783767410159,1.05777105672483e-26
PLA2G1B,Phospholipase A2,NMR metabolomics,X23443.Degree of Unsaturation,29763,0.0209284166368618,0.00311709303613524,0.0148189142860367,0.0270379189876868,1.92655317857935e-11
PLA2G1B,Phospholipase A2,NMR metabolomics,X23444.Omega-3 Fatty Acids,29763,-0.0209157022444002,0.00293857279184976,-0.0266753049164257,-0.0151560995723746,1.12276573948506e-12
PLA2G1B,Phospholipase A2,NMR metabolomics,X23445.Omega-6 Fatty Acids,29763,-0.0135870763905698,0.00288523964657856,-0.0192421460978637,-0.00793200668327578,2.49851878844228e-06
PLA2G1B,Phospholipase A2,NMR metabolomics,X23446.Polyunsaturated Fatty Acids,29763,-0.0165710596396748,0.00289928633225924,-0.0222536608509029,-0.0108884584284467,1.10384163165492e-08
PLA2G1B,Phospholipase A2,NMR metabolomics,X23447.Monounsaturated Fatty Acids,29763,-0.0246004523265324,0.00295213952827806,-0.0303866458019574,-0.0188142588511074,8.21042951138923e-17
PLA2G1B,Phospholipase A2,NMR metabolomics,X23448.Saturated Fatty Acids,29763,-0.0438651698521936,0.00288807448576116,-0.0495257958442855,-0.0382045438601017,6.61376612992156e-52
PLA2G1B,Phospholipase A2,NMR metabolomics,X23449.Linoleic Acid,29763,-0.00298544747723883,0.00287488760934586,-0.00862022719155671,0.00264933223707906,0.299065733574301
PLA2G1B,Phospholipase A2,NMR metabolomics,X23450.Docosahexaenoic Acid,29763,-0.0132060801871032,0.00302292408968266,-0.0191310114028812,-0.00728114897132521,1.25442764262655e-05
PLA2G1B,Phospholipase A2,NMR metabolomics,X23451.Omega-3 Fatty Acids to Total Fatty Acids percentage,29763,-0.00668808654054348,0.0029646926823487,-0.0124988841979469,-0.000877288883140028,0.0240833583938494
PLA2G1B,Phospholipase A2,NMR metabolomics,X23452.Omega-6 Fatty Acids to Total Fatty Acids percentage,29763,0.0452772987409769,0.00307559241650634,0.0392491376046245,0.0513054598773293,6.97488408547698e-49
PLA2G1B,Phospholipase A2,NMR metabolomics,X23453.Polyunsaturated Fatty Acids to Total Fatty Acids percentage,29763,0.0441555107971837,0.00313583429792283,0.0380092755732549,0.0503017460211124,6.93404842601968e-45
PLA2G1B,Phospholipase A2,NMR metabolomics,X23454.Monounsaturated Fatty Acids to Total Fatty Acids percentage,29763,-0.00462216443243097,0.0032004041504827,-0.0108949565673771,0.00165062770251513,0.148680888574369
PLA2G1B,Phospholipase A2,NMR metabolomics,X23455.Saturated Fatty Acids to Total Fatty Acids percentage,29763,-0.0668801329842917,0.0028722634937824,-0.0725097694321053,-0.0612504965364782,7.31981338234702e-119
PLA2G1B,Phospholipase A2,NMR metabolomics,X23456.Linoleic Acid to Total Fatty Acids percentage,29763,0.051242313876969,0.0030677937651,0.045229438097373,0.057255189656565,2.38636520124453e-62
PLA2G1B,Phospholipase A2,NMR metabolomics,X23457.Docosahexaenoic Acid to Total Fatty Acids percentage,29763,0.00675282240738679,0.0030388060298753,0.00079676258883119,0.0127088822259424,0.026277558255594
PLA2G1B,Phospholipase A2,NMR metabolomics,X23458.Polyunsaturated Fatty Acids to Monounsaturated Fatty Acids ratio,29763,0.0232932731105592,0.00319963975549104,0.0170219791897968,0.0295645670313216,3.42168313172506e-13
PLA2G1B,Phospholipase A2,NMR metabolomics,X23459.Omega-6 Fatty Acids to Omega-3 Fatty Acids ratio,29761,0.017442606408891,0.00293244903864863,0.0116950062931397,0.0231902065246423,2.74239844077423e-09
PLA2G1B,Phospholipase A2,NMR metabolomics,X23460.Alanine,29777,-0.015914570796316,0.00287444586352726,-0.0215484846888295,-0.0102806569038026,3.11053023519972e-08
PLA2G1B,Phospholipase A2,NMR metabolomics,X23461.Glutamine,29691,-0.0016282149657654,0.00286212522861497,-0.00723798041385074,0.00398155048231994,0.569439710493184
PLA2G1B,Phospholipase A2,NMR metabolomics,X23462.Glycine,29752,0.035903546694624,0.00301443491149448,0.0299952542680948,0.0418118391211532,1.23753098245302e-32
PLA2G1B,Phospholipase A2,NMR metabolomics,X23463.Histidine,29749,0.00843021975545335,0.0028418035875351,0.00286028472388456,0.0140001547870221,0.0030144658768539
PLA2G1B,Phospholipase A2,NMR metabolomics,X23464.Total Concentration of Branched-Chain Amino Acids (Leucine + Isoleucine + Valine),29766,-0.0185050940897394,0.00301175542595772,-0.0244081347246166,-0.0126020534548623,8.13406565230343e-10
PLA2G1B,Phospholipase A2,NMR metabolomics,X23465.Isoleucine,29781,-0.0169648761670528,0.00293935396010046,-0.0227260099288497,-0.0112037424052559,7.92846589800182e-09
PLA2G1B,Phospholipase A2,NMR metabolomics,X23466.Leucine,29782,-0.0141400972649287,0.00300515495076226,-0.0200302009684227,-0.00824999356143462,2.54655356557429e-06
PLA2G1B,Phospholipase A2,NMR metabolomics,X23467.Valine,29766,-0.0206738185309933,0.00301579685653063,-0.0265847803697934,-0.0147628566921933,7.26140957352193e-12
PLA2G1B,Phospholipase A2,NMR metabolomics,X23468.Phenylalanine,29775,0.00584157379854967,0.0028735549392263,0.00020940611766611,0.0114737414794332,0.0420741584914665
PLA2G1B,Phospholipase A2,NMR metabolomics,X23469.Tyrosine,29753,-0.0286027153045756,0.00291554372380762,-0.0343171810032385,-0.0228882496059126,1.09923884535986e-22
PLA2G1B,Phospholipase A2,NMR metabolomics,X23470.Glucose,29731,-0.0439775426604787,0.00287853168299301,-0.049619464759145,-0.0383356205618124,1.70356623091745e-52
PLA2G1B,Phospholipase A2,NMR metabolomics,X23471.Lactate,29732,-0.0077837025393141,0.00286299493656302,-0.0133951726149776,-0.00217223246365058,0.00655716350362191
PLA2G1B,Phospholipase A2,NMR metabolomics,X23472.Pyruvate,29690,-0.00901339200736843,0.00286301991384001,-0.0146249110384949,-0.003401872976242,0.00164435511360118
PLA2G1B,Phospholipase A2,NMR metabolomics,X23473.Citrate,29782,0.0208447587442889,0.00289656610630941,0.0151674891759225,0.0265220283126553,6.32986065619506e-13
PLA2G1B,Phospholipase A2,NMR metabolomics,X23474.3-Hydroxybutyrate,29304,-0.00296416771012058,0.00290479252653913,-0.00865756106213728,0.00272922564189612,0.307528059869887
PLA2G1B,Phospholipase A2,NMR metabolomics,X23475.Acetate,29761,0.00115343304557642,0.00285525108577784,-0.00444285908254815,0.00674972517370099,0.686238388557704
PLA2G1B,Phospholipase A2,NMR metabolomics,X23476.Acetoacetate,29785,-0.019073987308603,0.00285899329157892,-0.0246776141600977,-0.0134703604571083,2.57504719556702e-11
PLA2G1B,Phospholipase A2,NMR metabolomics,X23477.Acetone,29785,-0.0145489075994227,0.00285669236348696,-0.0201480246318571,-0.00894979056698823,3.54737857257855e-07
PLA2G1B,Phospholipase A2,NMR metabolomics,X23478.Creatinine,29037,0.126762086707604,0.00330572211348385,0.120282871365175,0.133241302050032,1.66880717584083e-308
PLA2G1B,Phospholipase A2,NMR metabolomics,X23479.Albumin,29783,-0.0102509900176029,0.00289253599324493,-0.0159203605643629,-0.00458161947084282,0.000394790325478687
PLA2G1B,Phospholipase A2,NMR metabolomics,X23480.Glycoprotein Acetyls,29787,0.0118571553692932,0.00303893584480314,0.00590084111347909,0.0178134696251074,9.57113012498196e-05
PLA2G1B,Phospholipase A2,NMR metabolomics,X23481.Concentration of Chylomicrons and Extremely Large VLDL Particles,29787,-0.0179479827037871,0.00305657405564869,-0.0239388678528586,-0.0119570975547157,4.35323003227922e-09
PLA2G1B,Phospholipase A2,NMR metabolomics,X23482.Total Lipids in Chylomicrons and Extremely Large VLDL,29787,-0.0184251208020517,0.0030496877010803,-0.024402508696169,-0.0124477329079343,1.5436217714512e-09
PLA2G1B,Phospholipase A2,NMR metabolomics,X23483.Phospholipids in Chylomicrons and Extremely Large VLDL,29787,-0.017213502259301,0.0030681256703282,-0.0232270285731443,-0.0111999759454578,2.0361638015047e-08
PLA2G1B,Phospholipase A2,NMR metabolomics,X23484.Cholesterol in Chylomicrons and Extremely Large VLDL,29787,-0.015930721351712,0.00303988512173816,-0.0218888961903188,-0.00997254651310526,1.61173727743775e-07
PLA2G1B,Phospholipase A2,NMR metabolomics,X23485.Cholesteryl Esters in Chylomicrons and Extremely Large VLDL,29787,-0.0152023569497149,0.00302844836522435,-0.0211381157455546,-0.00926659815387514,5.20097731276191e-07
PLA2G1B,Phospholipase A2,NMR metabolomics,X23486.Free Cholesterol in Chylomicrons and Extremely Large VLDL,29787,-0.0173982959107009,0.00304121007970771,-0.023359067666928,-0.0114375241544738,1.0700962411388e-08
PLA2G1B,Phospholipase A2,NMR metabolomics,X23487.Triglycerides in Chylomicrons and Extremely Large VLDL,29787,-0.020823027786382,0.00303475448021725,-0.0267711465676078,-0.0148749090051562,6.94647443069135e-12
PLA2G1B,Phospholipase A2,NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,29787,-0.0137979511757755,0.00307172854106128,-0.0198185391162556,-0.00777736323529534,7.08499442567123e-06
PLA2G1B,Phospholipase A2,NMR metabolomics,X23489.Total Lipids in Very Large VLDL,29787,-0.013867071399502,0.00306723423705867,-0.019878850504137,-0.00785529229486697,6.1775179725704e-06
PLA2G1B,Phospholipase A2,NMR metabolomics,X23490.Phospholipids in Very Large VLDL,29787,-0.0120039965697652,0.00304913818474829,-0.0179803074118719,-0.00602768572765859,8.27462341875733e-05
PLA2G1B,Phospholipase A2,NMR metabolomics,X23491.Cholesterol in Very Large VLDL,29787,-0.00638404975264653,0.00298565843636316,-0.0122359402879183,-0.000532159217374741,0.0325055086642441
PLA2G1B,Phospholipase A2,NMR metabolomics,X23492.Cholesteryl Esters in Very Large VLDL,29787,-0.00272799288965189,0.00294500731418377,-0.00850020722545208,0.00304422144614829,0.35429185063994
PLA2G1B,Phospholipase A2,NMR metabolomics,X23493.Free Cholesterol in Very Large VLDL,29787,-0.0100096704647555,0.00302394382594398,-0.0159366003636057,-0.0040827405659053,0.000933608473591717
PLA2G1B,Phospholipase A2,NMR metabolomics,X23494.Triglycerides in Very Large VLDL,29787,-0.0179199887298846,0.00309548060627998,-0.0239871307181934,-0.0118528467415759,7.14822793616416e-09
PLA2G1B,Phospholipase A2,NMR metabolomics,X23495.Concentration of Large VLDL Particles,29787,-0.0101465999989126,0.00303414474058263,-0.0160935236904545,-0.00419967630737064,0.000826403690699398
PLA2G1B,Phospholipase A2,NMR metabolomics,X23496.Total Lipids in Large VLDL,29787,-0.0104441396054388,0.0030281887917435,-0.0163793896372561,-0.00450888957362159,0.000563502789211296
PLA2G1B,Phospholipase A2,NMR metabolomics,X23497.Phospholipids in Large VLDL,29787,-0.00996583873786566,0.00304479333746099,-0.0159336336792892,-0.00399804379644211,0.00106505230717543
PLA2G1B,Phospholipase A2,NMR metabolomics,X23498.Cholesterol in Large VLDL,29787,-0.00294844704177072,0.00297177889422094,-0.00877313367444377,0.00287623959090233,0.321132978063043
PLA2G1B,Phospholipase A2,NMR metabolomics,X23499.Cholesteryl Esters in Large VLDL,29787,0.00232919056982329,0.00291812696403553,-0.00339033827968634,0.00804871941933292,0.424772410199308
PLA2G1B,Phospholipase A2,NMR metabolomics,X23500.Free Cholesterol in Large VLDL,29787,-0.00798846481188405,0.00303062415927188,-0.0139284881640569,-0.00204844145971116,0.0083954488104083
PLA2G1B,Phospholipase A2,NMR metabolomics,X23501.Triglycerides in Large VLDL,29787,-0.014806772506637,0.00304027779997213,-0.0207657169945824,-0.0088478280186916,1.12054715758822e-06
PLA2G1B,Phospholipase A2,NMR metabolomics,X23502.Concentration of Medium VLDL Particles,29787,-0.000634414319498516,0.00285390139498654,-0.00622806105367214,0.00495923241467511,0.824084048165499
PLA2G1B,Phospholipase A2,NMR metabolomics,X23503.Total Lipids in Medium VLDL,29787,-0.00396072734635561,0.00287790149096549,-0.00960141426864796,0.00167995957593675,0.168752939461629
PLA2G1B,Phospholipase A2,NMR metabolomics,X23504.Phospholipids in Medium VLDL,29787,-0.00104933077977921,0.00284704637632071,-0.0066295416773678,0.00453088011780937,0.712452216952615
PLA2G1B,Phospholipase A2,NMR metabolomics,X23505.Cholesterol in Medium VLDL,29787,0.00679995763100379,0.00283811002259097,0.00123726198672549,0.0123626532752821,0.016583677501316
PLA2G1B,Phospholipase A2,NMR metabolomics,X23506.Cholesteryl Esters in Medium VLDL,29787,0.0102718129441179,0.00286552613413739,0.00465538172120863,0.0158882441670272,0.000338112975889341
PLA2G1B,Phospholipase A2,NMR metabolomics,X23507.Free Cholesterol in Medium VLDL,29787,0.00193569409078808,0.00283584844008116,-0.00362256885177099,0.00749395703334715,0.494877438430316
PLA2G1B,Phospholipase A2,NMR metabolomics,X23508.Triglycerides in Medium VLDL,29787,-0.0107786114372315,0.00298597310044997,-0.0166311187141134,-0.00492610416034954,0.000306996960216432
PLA2G1B,Phospholipase A2,NMR metabolomics,X23509.Concentration of Small VLDL Particles,29787,0.000341481470888119,0.00291585230314724,-0.00537358904328047,0.0060565519850567,0.906772042670894
PLA2G1B,Phospholipase A2,NMR metabolomics,X23510.Total Lipids in Small VLDL,29787,-0.00171588344000382,0.00290488182710592,-0.00740945182113142,0.00397768494112377,0.554732911465576
PLA2G1B,Phospholipase A2,NMR metabolomics,X23511.Phospholipids in Small VLDL,29787,0.00196913023948917,0.00285490095302833,-0.00362647562844635,0.0075647361074247,0.490365096789066
PLA2G1B,Phospholipase A2,NMR metabolomics,X23512.Cholesterol in Small VLDL,29787,0.00417801871618113,0.00284680060585649,-0.00140171047129758,0.00975774790365985,0.142218301859676
PLA2G1B,Phospholipase A2,NMR metabolomics,X23513.Cholesteryl Esters in Small VLDL,29787,0.00439028591604197,0.00285937145971266,-0.00121408214499485,0.00999465397707879,0.12469563080879
PLA2G1B,Phospholipase A2,NMR metabolomics,X23514.Free Cholesterol in Small VLDL,29787,0.00370444193668886,0.00283373479942197,-0.0018496782701782,0.00925856214355591,0.191132868346786
PLA2G1B,Phospholipase A2,NMR metabolomics,X23515.Triglycerides in Small VLDL,29787,-0.00849051313812441,0.00299504650979723,-0.014360804297327,-0.00262022197892184,0.00458778139780633
PLA2G1B,Phospholipase A2,NMR metabolomics,X23516.Concentration of Very Small VLDL Particles,29787,-0.00821632671560665,0.00287359205796259,-0.0138485671492133,-0.00258408628199997,0.00424934919701525
PLA2G1B,Phospholipase A2,NMR metabolomics,X23517.Total Lipids in Very Small VLDL,29787,-0.00972819055744207,0.00288331183667252,-0.0153794817573202,-0.00407689935756392,0.000741885058839818
PLA2G1B,Phospholipase A2,NMR metabolomics,X23518.Phospholipids in Very Small VLDL,29787,-0.00610486809199532,0.00287952153490001,-0.0117487303003993,-0.000461005883591303,0.0340060222877874
PLA2G1B,Phospholipase A2,NMR metabolomics,X23519.Cholesterol in Very Small VLDL,29787,-0.00849350470839325,0.00291847620586341,-0.0142137180718855,-0.00277329134490098,0.00361403520246774
PLA2G1B,Phospholipase A2,NMR metabolomics,X23520.Cholesteryl Esters in Very Small VLDL,29787,-0.00958183132685598,0.00294047913518064,-0.01534517043181,-0.00381849222190193,0.00112090776839973
PLA2G1B,Phospholipase A2,NMR metabolomics,X23521.Free Cholesterol in Very Small VLDL,29787,-0.00547052565238804,0.00288320405710544,-0.0111216056043147,0.000180554299538632,0.0577878378677602
PLA2G1B,Phospholipase A2,NMR metabolomics,X23522.Triglycerides in Very Small VLDL,29787,-0.0132812109869921,0.00294725637208531,-0.0190578334762794,-0.00750458849770493,6.62197884171325e-06
PLA2G1B,Phospholipase A2,NMR metabolomics,X23523.Concentration of IDL Particles,29787,-0.00907500730603976,0.00286287195502844,-0.0146862363378955,-0.00346377827418402,0.00152647707627271
PLA2G1B,Phospholipase A2,NMR metabolomics,X23524.Total Lipids in IDL,29787,-0.0167519513186414,0.00293481749937173,-0.02250419361741,-0.0109997090198729,1.15393458545413e-08
PLA2G1B,Phospholipase A2,NMR metabolomics,X23525.Phospholipids in IDL,29787,-0.0110486276023568,0.00293934316730884,-0.0168097402102821,-0.00528751499443144,0.000171004052298153
PLA2G1B,Phospholipase A2,NMR metabolomics,X23526.Cholesterol in IDL,29787,-0.0164965176198422,0.00294659876566154,-0.0222718512005388,-0.0107211840391455,2.1812398706828e-08
PLA2G1B,Phospholipase A2,NMR metabolomics,X23527.Cholesteryl Esters in IDL,29787,-0.0189280344791484,0.0029449729020563,-0.0247001813671787,-0.013155887591118,1.31909528044657e-10
PLA2G1B,Phospholipase A2,NMR metabolomics,X23528.Free Cholesterol in IDL,29787,-0.00908130658475538,0.00294622032278131,-0.0148558984174067,-0.00330671475210401,0.0020555507440421
PLA2G1B,Phospholipase A2,NMR metabolomics,X23529.Triglycerides in IDL,29787,-0.0203825644670674,0.00291837475783178,-0.0261025789924177,-0.0146625499417172,2.92459213256606e-12
PLA2G1B,Phospholipase A2,NMR metabolomics,X23530.Concentration of Large LDL Particles,29787,0.00340916681988954,0.00283219791258647,-0.00214194108877993,0.00896027472855902,0.228708270364628
PLA2G1B,Phospholipase A2,NMR metabolomics,X23531.Total Lipids in Large LDL,29787,-0.0112605971669714,0.00285536134090333,-0.0168571053951419,-0.00566408893880083,8.04283757365918e-05
PLA2G1B,Phospholipase A2,NMR metabolomics,X23532.Phospholipids in Large LDL,29787,-0.0107130109083933,0.00285184234085952,-0.0163026218964779,-0.00512339992030861,0.000172618768855604
PLA2G1B,Phospholipase A2,NMR metabolomics,X23533.Cholesterol in Large LDL,29787,-0.00980831712976272,0.00286266743639792,-0.0154191453051026,-0.00419748895442279,0.000612721991202675
PLA2G1B,Phospholipase A2,NMR metabolomics,X23534.Cholesteryl Esters in Large LDL,29787,-0.0102335633148169,0.0028529088180632,-0.0158252645982208,-0.00464186203141309,0.000334959459928335
PLA2G1B,Phospholipase A2,NMR metabolomics,X23535.Free Cholesterol in Large LDL,29787,-0.00835679194950159,0.00289551281652523,-0.014031997069891,-0.00268158682911214,0.00390306024428687
PLA2G1B,Phospholipase A2,NMR metabolomics,X23536.Triglycerides in Large LDL,29787,-0.0238463634783639,0.00291536712984172,-0.0295604830528537,-0.0181322439038742,2.96154969199134e-16
PLA2G1B,Phospholipase A2,NMR metabolomics,X23537.Concentration of Medium LDL Particles,29787,-0.00310375016442797,0.00283195627705953,-0.00865438446746465,0.00244688413860872,0.273099061719651
PLA2G1B,Phospholipase A2,NMR metabolomics,X23538.Total Lipids in Medium LDL,29787,-0.00907263722236734,0.00282873812097304,-0.0146169639394745,-0.00352831050526018,0.00134124626750396
PLA2G1B,Phospholipase A2,NMR metabolomics,X23539.Phospholipids in Medium LDL,29787,-0.00797757517137866,0.00282586413924528,-0.0135162688842994,-0.00243888145845792,0.00475996856217579
PLA2G1B,Phospholipase A2,NMR metabolomics,X23540.Cholesterol in Medium LDL,29787,-0.00823063228948646,0.00282706285989616,-0.0137716754948829,-0.00268958908409,0.00360111926817283
PLA2G1B,Phospholipase A2,NMR metabolomics,X23541.Cholesteryl Esters in Medium LDL,29787,-0.00974584371398753,0.00283496742491945,-0.0153023798668297,-0.00418930756114541,0.000587420915114608
PLA2G1B,Phospholipase A2,NMR metabolomics,X23542.Free Cholesterol in Medium LDL,29787,-0.00347929321228008,0.0028323246751646,-0.0090306495756027,0.00207206315104253,0.219297870374854
PLA2G1B,Phospholipase A2,NMR metabolomics,X23543.Triglycerides in Medium LDL,29787,-0.0192091799459705,0.00294380655840834,-0.0249790408004508,-0.0134393190914901,6.8960792902786e-11
PLA2G1B,Phospholipase A2,NMR metabolomics,X23544.Concentration of Small LDL Particles,29787,6.48164906823544e-06,0.00282979140277108,-0.00553990950036307,0.00555287279849954,0.998172459013156
PLA2G1B,Phospholipase A2,NMR metabolomics,X23545.Total Lipids in Small LDL,29787,-0.00415951471196478,0.0028258990944138,-0.00969827693701584,0.00137924751308627,0.141051396868671
PLA2G1B,Phospholipase A2,NMR metabolomics,X23546.Phospholipids in Small LDL,29787,-0.000942028108149232,0.00282354424747204,-0.00647617483319443,0.00459211861689597,0.738658710476555
PLA2G1B,Phospholipase A2,NMR metabolomics,X23547.Cholesterol in Small LDL,29787,-0.00382597276173507,0.00282446263045463,-0.00936191951742615,0.00170997399395601,0.17556031442173
PLA2G1B,Phospholipase A2,NMR metabolomics,X23548.Cholesteryl Esters in Small LDL,29787,-0.00646669754996017,0.00283040597035378,-0.0120142932518536,-0.000919101848066751,0.0223359952619131
PLA2G1B,Phospholipase A2,NMR metabolomics,X23549.Free Cholesterol in Small LDL,29787,0.00349436227394188,0.00283242396119847,-0.00205718869000711,0.00904591323789088,0.217324343190918
PLA2G1B,Phospholipase A2,NMR metabolomics,X23550.Triglycerides in Small LDL,29787,-0.0150760449532191,0.00297768740294945,-0.020912312263,-0.00923977764343815,4.15157995632489e-07
PLA2G1B,Phospholipase A2,NMR metabolomics,X23551.Concentration of Very Large HDL Particles,29787,-0.00492202695660802,0.00332574322384943,-0.0114404836753529,0.00159642976213686,0.138889686600727
PLA2G1B,Phospholipase A2,NMR metabolomics,X23552.Total Lipids in Very Large HDL,29787,-0.00238004698380946,0.00334038196807261,-0.00892719564123178,0.00416710167361285,0.476156193386658
PLA2G1B,Phospholipase A2,NMR metabolomics,X23553.Phospholipids in Very Large HDL,29787,-0.00255057572081771,0.00333204722937902,-0.00908138829040058,0.00398023684876517,0.44399894792302
PLA2G1B,Phospholipase A2,NMR metabolomics,X23554.Cholesterol in Very Large HDL,29787,0.000722514130254642,0.00334652136786786,-0.00583666775076636,0.00728169601127564,0.829067137231476
PLA2G1B,Phospholipase A2,NMR metabolomics,X23555.Cholesteryl Esters in Very Large HDL,29787,-6.64350811526577e-05,0.00338346570258026,-0.00669802785820996,0.00656515769590465,0.984334502217464
PLA2G1B,Phospholipase A2,NMR metabolomics,X23556.Free Cholesterol in Very Large HDL,29787,0.00306171095695,0.0031772183312211,-0.00316563697224336,0.00928905888614336,0.335231701317252
PLA2G1B,Phospholipase A2,NMR metabolomics,X23557.Triglycerides in Very Large HDL,29787,-0.0153893106106474,0.00287758753246378,-0.0210293821742764,-0.00974923904701838,8.95911703148928e-08
PLA2G1B,Phospholipase A2,NMR metabolomics,X23558.Concentration of Large HDL Particles,29787,-0.0221502059434632,0.00343825160866701,-0.0288891790964505,-0.0154112327904758,1.19481229971361e-10
PLA2G1B,Phospholipase A2,NMR metabolomics,X23559.Total Lipids in Large HDL,29787,-0.0261894827203078,0.00341326061932981,-0.0328794735341942,-0.0194994919064213,1.73328815451429e-14
PLA2G1B,Phospholipase A2,NMR metabolomics,X23560.Phospholipids in Large HDL,29787,-0.0318318138495633,0.00337287274941672,-0.03844264443842,-0.0252209832607065,4.08251765006348e-21
PLA2G1B,Phospholipase A2,NMR metabolomics,X23561.Cholesterol in Large HDL,29787,-0.0169089277051588,0.00343812398929874,-0.0236476507241843,-0.0101702046861332,8.78678345858656e-07
PLA2G1B,Phospholipase A2,NMR metabolomics,X23562.Cholesteryl Esters in Large HDL,29787,-0.0142885145711669,0.00343855673286059,-0.0210280857675737,-0.00754894337476017,3.25651685275228e-05
PLA2G1B,Phospholipase A2,NMR metabolomics,X23563.Free Cholesterol in Large HDL,29787,-0.0243765063366752,0.00341716488279617,-0.0310741495069557,-0.0176788631663947,1.00047250303815e-12
PLA2G1B,Phospholipase A2,NMR metabolomics,X23564.Triglycerides in Large HDL,29787,-0.0285033818728541,0.00293972603456251,-0.0342652449005966,-0.0227415188451116,3.38410260854837e-22
PLA2G1B,Phospholipase A2,NMR metabolomics,X23565.Concentration of Medium HDL Particles,29787,-0.0510538561878455,0.00310271052487744,-0.0571351688166052,-0.0449725435590857,1.43980606832952e-60
PLA2G1B,Phospholipase A2,NMR metabolomics,X23566.Total Lipids in Medium HDL,29787,-0.0540424156118939,0.00306206258490255,-0.0600440582783029,-0.0480407729454849,2.33720360859343e-69
PLA2G1B,Phospholipase A2,NMR metabolomics,X23567.Phospholipids in Medium HDL,29787,-0.0569674669807433,0.00302508667716348,-0.0628966368679837,-0.0510382970935029,1.19127848434306e-78
PLA2G1B,Phospholipase A2,NMR metabolomics,X23568.Cholesterol in Medium HDL,29787,-0.0471793803378995,0.00312735712870074,-0.0533090003101529,-0.041049760365646,3.09694683532895e-51
PLA2G1B,Phospholipase A2,NMR metabolomics,X23569.Cholesteryl Esters in Medium HDL,29787,-0.0456818116578002,0.00311762859209174,-0.0517923636983,-0.0395712596173004,1.90870304876519e-48
PLA2G1B,Phospholipase A2,NMR metabolomics,X23570.Free Cholesterol in Medium HDL,29787,-0.0515390806690567,0.00315227828348206,-0.0577175461046815,-0.0453606152334319,7.96078660121929e-60
PLA2G1B,Phospholipase A2,NMR metabolomics,X23571.Triglycerides in Medium HDL,29787,-0.0358107091048175,0.00291052946034289,-0.0415153468470895,-0.0301060713625454,1.04883116113448e-34
PLA2G1B,Phospholipase A2,NMR metabolomics,X23572.Concentration of Small HDL Particles,29787,-0.0401941488881159,0.00282687106031874,-0.0457348161663406,-0.0346534816098912,9.91868208510536e-46
PLA2G1B,Phospholipase A2,NMR metabolomics,X23573.Total Lipids in Small HDL,29787,-0.0507728934284898,0.00284072904110174,-0.0563407223490492,-0.0452050645079304,4.49065455681814e-71
PLA2G1B,Phospholipase A2,NMR metabolomics,X23574.Phospholipids in Small HDL,29787,-0.0559579186044395,0.00285091602773788,-0.0615457140188057,-0.0503701231900733,3.08433739444324e-85
PLA2G1B,Phospholipase A2,NMR metabolomics,X23575.Cholesterol in Small HDL,29787,-0.0397692165992253,0.00282780512246267,-0.0453117146392521,-0.0342267185591985,8.84085502451848e-45
PLA2G1B,Phospholipase A2,NMR metabolomics,X23576.Cholesteryl Esters in Small HDL,29787,-0.0359019131810851,0.00282154010085204,-0.0414321317787551,-0.0303716945834151,5.4158272890112e-37
PLA2G1B,Phospholipase A2,NMR metabolomics,X23577.Free Cholesterol in Small HDL,29787,-0.0461925228506768,0.00287188741767005,-0.0518214221893101,-0.0405636235120435,5.76577515776321e-58
PLA2G1B,Phospholipase A2,NMR metabolomics,X23578.Triglycerides in Small HDL,29787,-0.0241304947738406,0.00305360870151289,-0.0301155678288058,-0.0181454217188753,2.83226428318856e-15
PLA2G1B,Phospholipase A2,NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,28522,0.0138944454731181,0.00289462239553598,0.00822098557786754,0.0195679053683686,1.59398049518293e-06
PLA2G1B,Phospholipase A2,NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,28522,0.0194316433666245,0.00293317748239927,0.0136826155011219,0.025180671232127,3.5396308849158e-11
PLA2G1B,Phospholipase A2,NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,28522,0.016794303617033,0.002904265185636,0.0111019438531865,0.0224866633808796,7.43068956974298e-09
PLA2G1B,Phospholipase A2,NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,28522,0.0201663558466914,0.00296694636953724,0.0143511409623985,0.0259815707309844,1.08918012009759e-11
PLA2G1B,Phospholipase A2,NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,28522,-0.0188844396699406,0.00289275893282012,-0.024554247178268,-0.0132146321616132,6.76932269302952e-11
PLA2G1B,Phospholipase A2,NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,29476,0.0185993426750286,0.00282833400835034,0.013055808018662,0.0241428773313953,4.91097002985956e-11
PLA2G1B,Phospholipase A2,NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,29476,0.0298443608122418,0.00308418707392527,0.0237993541473482,0.0358893674771353,4.09085348757912e-22
PLA2G1B,Phospholipase A2,NMR metabolomics,X23586.Cholesteryl Esters to Total Lipids in Very Large VLDL percentage,29476,0.0277757778005368,0.00307998684016605,0.0217390035938114,0.0338125520072623,2.0259526133087e-19
PLA2G1B,Phospholipase A2,NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,29476,0.0313142801043609,0.00299299935075895,0.0254480013768733,0.0371805588318484,1.42380882939272e-25
PLA2G1B,Phospholipase A2,NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,29476,-0.0314364734594397,0.00300702939492868,-0.0373302510734999,-0.0255426958453794,1.55166669638148e-25
PLA2G1B,Phospholipase A2,NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,29782,0.00333836243446377,0.00300711013855383,-0.00255557343710174,0.00923229830602927,0.266940623301319
PLA2G1B,Phospholipase A2,NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,29782,0.0332037937625479,0.00291216689132556,0.0274959466555498,0.038911640869546,4.731314530017e-30
PLA2G1B,Phospholipase A2,NMR metabolomics,X23591.Cholesteryl Esters to Total Lipids in Large VLDL percentage,29782,0.0358079026794315,0.00301792652437471,0.0298927666916571,0.0417230386672059,2.12699176081218e-32
PLA2G1B,Phospholipase A2,NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,29782,0.0208598550039935,0.00285384129650748,0.0152663260628389,0.0264533839451482,2.7509402710236e-13
PLA2G1B,Phospholipase A2,NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,29782,-0.0280605890205002,0.00282402389964745,-0.0335956758638092,-0.0225255021771912,3.1425588864317e-23
PLA2G1B,Phospholipase A2,NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,29787,0.0140518085114329,0.00298149233116237,0.00820808354235467,0.0198955334805112,2.45184790018705e-06
PLA2G1B,Phospholipase A2,NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,29787,0.02044721,0.003109891,0.01435182,0.02654259,4.949224e-11
PLA2G1B,Phospholipase A2,NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,29787,0.0202083835986439,0.00313185332625017,0.0140699510791935,0.0263468161180942,1.116852130403e-10
PLA2G1B,Phospholipase A2,NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,29787,0.0195932350766586,0.00303817019833793,0.0136384214879162,0.0255480486654009,1.14296470276436e-10
PLA2G1B,Phospholipase A2,NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,29787,-0.0196519138911739,0.00308524295452071,-0.0256989900820345,-0.0136048377003133,1.92225664832394e-10
PLA2G1B,Phospholipase A2,NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,29787,0.0138227804796881,0.00302805746254226,0.00788778785310525,0.0197577731062709,5.01728802210151e-06
PLA2G1B,Phospholipase A2,NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,29787,0.0160446287052452,0.00294042851906738,0.0102813888078731,0.0218078686026172,4.89309355263034e-08
PLA2G1B,Phospholipase A2,NMR metabolomics,X23601.Cholesteryl Esters to Total Lipids in Small VLDL percentage,29787,0.0178966063427675,0.00287138216670477,0.0122686972960262,0.0235245153895089,4.64457170957761e-10
PLA2G1B,Phospholipase A2,NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,29787,0.011152560391132,0.00304614464579594,0.00518211688537195,0.017123003896892,0.000251465871996738
PLA2G1B,Phospholipase A2,NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,29787,-0.0156503018100957,0.00296864751638126,-0.021468850942203,-0.00983175267798843,1.35986910595379e-07
PLA2G1B,Phospholipase A2,NMR metabolomics,X23604.Phospholipids to Total Lipids in Very Small VLDL percentage,29787,0.0286394437405529,0.00295905580664769,0.0228396943595234,0.0344391931215824,4.00861237761762e-22
PLA2G1B,Phospholipase A2,NMR metabolomics,X23605.Cholesterol to Total Lipids in Very Small VLDL percentage,29787,0.000959704774038301,0.00309382327954437,-0.00510418885386866,0.00702359840194526,0.756410846904702
PLA2G1B,Phospholipase A2,NMR metabolomics,X23606.Cholesteryl Esters to Total Lipids in Very Small VLDL percentage,29787,-0.00310712616822703,0.00312438450458828,-0.00923091979722006,0.003016667460766,0.319999147191877
PLA2G1B,Phospholipase A2,NMR metabolomics,X23607.Free Cholesterol to Total Lipids in Very Small VLDL percentage,29787,0.0236062101393407,0.00286594703423844,0.0179889539522333,0.029223466326448,1.84057157267141e-16
PLA2G1B,Phospholipase A2,NMR metabolomics,X23608.Triglycerides to Total Lipids in Very Small VLDL percentage,29787,-0.00769640229366892,0.00307263573816534,-0.013718768340473,-0.00167403624686485,0.0122566399896007
PLA2G1B,Phospholipase A2,NMR metabolomics,X23609.Phospholipids to Total Lipids in IDL percentage,29787,0.0369983404567761,0.00281715748423543,0.0314767117876746,0.0425199691258775,2.73244761388841e-39
PLA2G1B,Phospholipase A2,NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,29787,-0.0117361922106859,0.00297139651596386,-0.0175601293819751,-0.00591225503939673,7.84218971411475e-05
PLA2G1B,Phospholipase A2,NMR metabolomics,X23611.Cholesteryl Esters to Total Lipids in IDL percentage,29787,-0.0250639869179051,0.00294502857603525,-0.0308362429269342,-0.019291730908876,1.81019824171353e-17
PLA2G1B,Phospholipase A2,NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,29787,0.0242946692127318,0.00288839480502587,0.0186334153948811,0.0299559230305825,4.23974841186573e-17
PLA2G1B,Phospholipase A2,NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,29787,-0.00367078025840687,0.00303366102824771,-0.00961675587377237,0.00227519535695864,0.226282122926315
PLA2G1B,Phospholipase A2,NMR metabolomics,X23614.Phospholipids to Total Lipids in Large LDL percentage,29787,0.00703246802629931,0.0028432512964732,0.00145969548521184,0.0126052405673868,0.0133893541521854
PLA2G1B,Phospholipase A2,NMR metabolomics,X23615.Cholesterol to Total Lipids in Large LDL percentage,29787,0.0100905790524405,0.003020850161188,0.00416971273651207,0.016011445368369,0.000837874173628734
PLA2G1B,Phospholipase A2,NMR metabolomics,X23616.Cholesteryl Esters to Total Lipids in Large LDL percentage,29787,0.00400758196588333,0.00282857619102973,-0.00153642736853493,0.00955159130030159,0.156546163734971
PLA2G1B,Phospholipase A2,NMR metabolomics,X23617.Free Cholesterol to Total Lipids in Large LDL percentage,29787,0.00501267803672492,0.00311882098517921,-0.00110021109422634,0.0111255671676762,0.10801344569191
PLA2G1B,Phospholipase A2,NMR metabolomics,X23618.Triglycerides to Total Lipids in Large LDL percentage,29787,-0.0129172048576242,0.00298700644063654,-0.0187717374812718,-0.00706267223397663,1.53399210864648e-05
PLA2G1B,Phospholipase A2,NMR metabolomics,X23619.Phospholipids to Total Lipids in Medium LDL percentage,29787,0.00962716158254718,0.00285246757472969,0.00403632513607699,0.0152179980290174,0.00073902052742121
PLA2G1B,Phospholipase A2,NMR metabolomics,X23620.Cholesterol to Total Lipids in Medium LDL percentage,29787,0.00477264660291831,0.00288154552262138,-0.000875182621419588,0.0104204758272562,0.0976756395242165
PLA2G1B,Phospholipase A2,NMR metabolomics,X23621.Cholesteryl Esters to Total Lipids in Medium LDL percentage,29787,-0.00982293368508051,0.0029077066042549,-0.0155220386294201,-0.00412382874074091,0.000730445653523412
PLA2G1B,Phospholipase A2,NMR metabolomics,X23622.Free Cholesterol to Total Lipids in Medium LDL percentage,29787,0.0162240799649898,0.00309451931810733,0.0101588221014994,0.0222893378284802,1.59198938349093e-07
PLA2G1B,Phospholipase A2,NMR metabolomics,X23623.Triglycerides to Total Lipids in Medium LDL percentage,29787,-0.0124588680860709,0.00292731020299313,-0.0181963960839374,-0.00672134008820433,2.08677765822584e-05
PLA2G1B,Phospholipase A2,NMR metabolomics,X23624.Phospholipids to Total Lipids in Small LDL percentage,29787,0.0151770665949125,0.00286138268711536,0.00956875652816639,0.0207853766616586,1.14036435991105e-07
PLA2G1B,Phospholipase A2,NMR metabolomics,X23625.Cholesterol to Total Lipids in Small LDL percentage,29787,3.75441830848582e-05,0.00285471374882987,-0.00555769476462168,0.00563278313079139,0.989506895761062
PLA2G1B,Phospholipase A2,NMR metabolomics,X23626.Cholesteryl Esters to Total Lipids in Small LDL percentage,29787,-0.0151538464467175,0.00285952732103317,-0.0207585199959425,-0.00954917289749253,1.16994650474027e-07
PLA2G1B,Phospholipase A2,NMR metabolomics,X23627.Free Cholesterol to Total Lipids in Small LDL percentage,29787,0.0190093430281868,0.00298738183355833,0.0131540746344125,0.0248646114219611,2.00449098103436e-10
PLA2G1B,Phospholipase A2,NMR metabolomics,X23628.Triglycerides to Total Lipids in Small LDL percentage,29787,-0.014920459066947,0.0029981880481044,-0.0207969076412317,-0.00904401049266241,6.51076993161014e-07
PLA2G1B,Phospholipase A2,NMR metabolomics,X23629.Phospholipids to Total Lipids in Very Large HDL percentage,29772,-0.00689730207151535,0.0032019198571243,-0.013173064991479,-0.00062153915155171,0.0312391946019972
PLA2G1B,Phospholipase A2,NMR metabolomics,X23630.Cholesterol to Total Lipids in Very Large HDL percentage,29772,0.016207207884346,0.00298413273981717,0.0103583077143043,0.0220561080543876,5.64369805205415e-08
PLA2G1B,Phospholipase A2,NMR metabolomics,X23631.Cholesteryl Esters to Total Lipids in Very Large HDL percentage,29772,0.0078004643243597,0.00286769658084015,0.00217977902591301,0.0134211496228064,0.00652971126698212
PLA2G1B,Phospholipase A2,NMR metabolomics,X23632.Free Cholesterol to Total Lipids in Very Large HDL percentage,29772,0.0123137266371183,0.00337156622652054,0.00570545683313806,0.0189219964410986,0.000260421260380813
PLA2G1B,Phospholipase A2,NMR metabolomics,X23633.Triglycerides to Total Lipids in Very Large HDL percentage,29772,-0.00965372757772637,0.00315575009276066,-0.0158389977595373,-0.00346845739591547,0.00222206821096811
PLA2G1B,Phospholipase A2,NMR metabolomics,X23634.Phospholipids to Total Lipids in Large HDL percentage,29787,-0.0392050014226752,0.00313088470973061,-0.0453415354537472,-0.0330684673916032,6.96819698531281e-36
PLA2G1B,Phospholipase A2,NMR metabolomics,X23635.Cholesterol to Total Lipids in Large HDL percentage,29787,0.0252840886744668,0.003216700344933,0.0189793559983981,0.0315888213505355,3.96225112746208e-15
PLA2G1B,Phospholipase A2,NMR metabolomics,X23636.Cholesteryl Esters to Total Lipids in Large HDL percentage,29787,0.0291775666278062,0.00316534706700507,0.0229734863764763,0.0353816468791361,3.22601767834667e-20
PLA2G1B,Phospholipase A2,NMR metabolomics,X23637.Free Cholesterol to Total Lipids in Large HDL percentage,29787,-0.00649379728364414,0.00310894394259512,-0.0125873274111306,-0.000400267156157701,0.0367389766605371
PLA2G1B,Phospholipase A2,NMR metabolomics,X23638.Triglycerides to Total Lipids in Large HDL percentage,29787,-0.00394611095650247,0.00310338661873593,-0.0100287487292249,0.00213652681621996,0.203543018543316
PLA2G1B,Phospholipase A2,NMR metabolomics,X23639.Phospholipids to Total Lipids in Medium HDL percentage,29787,-0.0104272826140621,0.00317690550428121,-0.0166540174024532,-0.00420054782567088,0.00103114096978414
PLA2G1B,Phospholipase A2,NMR metabolomics,X23640.Cholesterol to Total Lipids in Medium HDL percentage,29787,0.00746913286672385,0.00312668535173649,0.00134082957732032,0.0135974361561274,0.0169081174666752
PLA2G1B,Phospholipase A2,NMR metabolomics,X23641.Cholesteryl Esters to Total Lipids in Medium HDL percentage,29787,0.0144638537533077,0.0030403396833331,0.00850478797397483,0.0204229195326406,1.97103681012375e-06
PLA2G1B,Phospholipase A2,NMR metabolomics,X23642.Free Cholesterol to Total Lipids in Medium HDL percentage,29787,-0.028774252323516,0.00331342935619362,-0.0352685738616555,-0.0222799307853766,4.00790539686945e-18
PLA2G1B,Phospholipase A2,NMR metabolomics,X23643.Triglycerides to Total Lipids in Medium HDL percentage,29787,-0.0053066279243571,0.00305604050489806,-0.0112964673139573,0.000683211465243098,0.0824965848630529
PLA2G1B,Phospholipase A2,NMR metabolomics,X23644.Phospholipids to Total Lipids in Small HDL percentage,29787,-0.0403394666579812,0.00291091493313165,-0.0460448599269193,-0.0346340733890432,1.55396892578385e-43
PLA2G1B,Phospholipase A2,NMR metabolomics,X23645.Cholesterol to Total Lipids in Small HDL percentage,29787,0.0265364975440725,0.00291379049198083,0.0208254681797901,0.032247526908355,8.96697218937455e-20
PLA2G1B,Phospholipase A2,NMR metabolomics,X23646.Cholesteryl Esters to Total Lipids in Small HDL percentage,29787,0.0234520276572443,0.00289677273039606,0.017774353105668,0.0291297022088206,5.89841037879923e-16
PLA2G1B,Phospholipase A2,NMR metabolomics,X23647.Free Cholesterol to Total Lipids in Small HDL percentage,29787,0.00934968687054391,0.0030390792730921,0.0033930914952834,0.0153062822458044,0.00209645645794469
PLA2G1B,Phospholipase A2,NMR metabolomics,X23648.Triglycerides to Total Lipids in Small HDL percentage,29787,9.50522933994883e-05,0.00310850944798241,-0.00599762622464603,0.00618773081144501,0.975606217574575
PLA2G1B,Phospholipase A2,Working and living environment,X24003.Nitrogen dioxide air pollution; 2010,51297,0.00486418965799294,0.00243634158522042,8.89601509609069e-05,0.00963941916502497,0.0458832993033793
PLA2G1B,Phospholipase A2,Working and living environment,X24004.Nitrogen oxides air pollution; 2010,51297,0.00281248682370838,0.00237729943917766,-0.00184702007707983,0.0074719937244966,0.236791028691344
PLA2G1B,Phospholipase A2,Working and living environment,X24005.Particulate matter air pollution (pm10); 2010,47840,-0.000936708939382786,0.00227395408501043,-0.00539365894600323,0.00352024106723766,0.680392888985685
PLA2G1B,Phospholipase A2,Working and living environment,X24006.Particulate matter air pollution (pm2.5); 2010,47840,0.00322019115392863,0.00247602581933715,-0.00163281945197219,0.00807320175982945,0.193419382207877
PLA2G1B,Phospholipase A2,Working and living environment,X24007.Particulate matter air pollution (pm2.5) absorbance; 2010,47840,0.00193731668721694,0.00244125018347634,-0.00284753367239668,0.00672216704683057,0.427446453128107
PLA2G1B,Phospholipase A2,Working and living environment,X24008.Particulate matter air pollution 2.5-10um; 2010,47840,-0.00206780679943324,0.00223993702105066,-0.00645808336069253,0.00232246976182605,0.35593161905843
PLA2G1B,Phospholipase A2,Working and living environment,X24009.Traffic intensity on the nearest road,51297,-0.0323410913100714,0.0375797779523224,-0.105997456096623,0.0413152734764804,0.389463371044673
PLA2G1B,Phospholipase A2,Working and living environment,X24010.Inverse distance to the nearest road,51297,-0.00199758712072503,0.00212735226637969,-0.00616719756282923,0.00217202332137917,0.347734360072991
PLA2G1B,Phospholipase A2,Working and living environment,X24011.Traffic intensity on the nearest major road,51297,-4.00976324363291e-05,0.0021281507945703,-0.00421127318979411,0.00413107792492145,0.984967591073991
PLA2G1B,Phospholipase A2,Working and living environment,X24012.Inverse distance to the nearest major road,51297,-0.00196832959916515,0.00216084867662533,-0.0062035930053508,0.00226693380702051,0.362349289241014
PLA2G1B,Phospholipase A2,Working and living environment,X24013.Total traffic load on major roads,51297,-0.051716036788759,0.0261701223446567,-0.103009476584286,-0.000422596993231897,0.0481433598321407
PLA2G1B,Phospholipase A2,Working and living environment,X24015.Sum of road length of major roads within 100m,51297,-0.0431915550906238,0.0253891313842324,-0.0929542526037193,0.00657114242247179,0.0889147179802906
PLA2G1B,Phospholipase A2,Working and living environment,X24016.Nitrogen dioxide air pollution; 2005,51297,0.00510195859434815,0.00243312592438515,0.000333031782553264,0.00987088540614303,0.0360096117877994
PLA2G1B,Phospholipase A2,Working and living environment,X24017.Nitrogen dioxide air pollution; 2006,51297,0.00453445720148781,0.00243017651760728,-0.000228688773022453,0.00929760317599808,0.0620615896594931
PLA2G1B,Phospholipase A2,Working and living environment,X24018.Nitrogen dioxide air pollution; 2007,51297,0.00471207425211257,0.00240457530026648,-8.93336409727406e-07,0.00942504184063487,0.0500446378698844
PLA2G1B,Phospholipase A2,Working and living environment,X24019.Particulate matter air pollution (pm10); 2007,51193,0.00292741678015671,0.00236077259296723,-0.00169969750205905,0.00755453106237247,0.214971872561727
PLA2G1B,Phospholipase A2,Working and living environment,X24020.Average daytime sound level of noise pollution,51297,-0.00384430240389708,0.0021348161703608,-0.00802854209780424,0.000339937290010074,0.0717457885548423
PLA2G1B,Phospholipase A2,Working and living environment,X24021.Average evening sound level of noise pollution,51297,-0.00386054003367586,0.00213478576292073,-0.00804472012900049,0.000323640061648785,0.0705505993506005
PLA2G1B,Phospholipase A2,Working and living environment,X24022.Average night-time sound level of noise pollution,51297,-0.00384235451148101,0.00213483220042425,-0.00802662562431253,0.000341916601350514,0.0718919198351902
PLA2G1B,Phospholipase A2,Working and living environment,X24023.Average 16-hour sound level of noise pollution,51297,-0.00386450333940467,0.00213472477270629,-0.008048563893909,0.000319557215099661,0.0702543227291194
PLA2G1B,Phospholipase A2,Working and living environment,X24024.Average 24-hour sound level of noise pollution,51297,-0.00386882091244377,0.00213473722217387,-0.00805290586790455,0.000315264043017007,0.0699430491699155
PLA2G1B,Phospholipase A2,Health and medical history,X2405.Number of children fathered,23627,-0.0564751124751375,0.0283655865374,-0.112071662088441,-0.000878562861833555,0.0464953773818508
PLA2G1B,Phospholipase A2,Working and living environment,"X24500.Greenspace percentage, buffer 1000m",45781,-0.00536333506208383,0.00250688421656043,-0.0102768281265423,-0.000449841997625381,0.0324051080896601
PLA2G1B,Phospholipase A2,Working and living environment,"X24501.Domestic garden percentage, buffer 1000m",45781,0.00752906748832418,0.00227043354644709,0.00307901773728788,0.0119791172393605,0.00091342238517549
PLA2G1B,Phospholipase A2,Working and living environment,"X24502.Water percentage, buffer 1000m",45781,-0.00182992539613963,0.00225572616472793,-0.00625114867900637,0.00259129788672711,0.417234596869344
PLA2G1B,Phospholipase A2,Working and living environment,"X24503.Greenspace percentage, buffer 300m",45781,-0.00479577191073835,0.00235902138851046,-0.00941945383221886,-0.000172089989257839,0.0420633607594707
PLA2G1B,Phospholipase A2,Working and living environment,"X24504.Domestic garden percentage, buffer 300m",45781,0.0056310452334982,0.00229021802091377,0.00114221791250721,0.0101198725544892,0.0139463217462965
PLA2G1B,Phospholipase A2,Working and living environment,"X24505.Water percentage, buffer 300m",45781,-0.00116896494796422,0.00226761188525535,-0.00561348424306471,0.00327555434713627,0.606202764190079
PLA2G1B,Phospholipase A2,Working and living environment,"X24506.Natural environment percentage, buffer 1000m",51541,-0.00616834108372936,0.0024004500997298,-0.0108732232791998,-0.00146345888825895,0.0101826165540607
PLA2G1B,Phospholipase A2,Working and living environment,"X24507.Natural environment percentage, buffer 300m",51541,-0.00849667877204801,0.00225518529121099,-0.0129168419428216,-0.00407651560127447,0.000164995427699385
PLA2G1B,Phospholipase A2,Working and living environment,X24508.Distance (Euclidean) to coast,51541,0.00224461182137892,0.00214282262719661,-0.00195532052792643,0.00644454417068427,0.294872844292491
PLA2G1B,Phospholipase A2,Health and medical history,X2684.Years since last breast cancer screening  or  mammogram,11320,-0.0616649933290082,0.0384386718807005,-0.137004790215181,0.0136748035571647,0.108688299192101
PLA2G1B,Phospholipase A2,Health and medical history,X2704.Years since last cervical smear test,21293,-0.0566914162712155,0.028624916870283,-0.11279625333697,-0.000586579205460791,0.0476611390360866
PLA2G1B,Phospholipase A2,Health and medical history,X2714.Age when periods started (menarche),27161,-0.0267114362281165,0.0242736018680811,-0.0742876958895555,0.0208648234333225,0.271153915601863
PLA2G1B,Phospholipase A2,Health and medical history,X2734.Number of live births,27999,-0.0235549424176816,0.0233417419452781,-0.0693047566304267,0.0221948717950634,0.312919162752904
PLA2G1B,Phospholipase A2,Health and medical history,X2744.Birth weight of first child,22193,-0.0652620563092077,0.0261308465083412,-0.116478515465556,-0.014045597152859,0.0125140765973842
PLA2G1B,Phospholipase A2,Health and medical history,X2754.Age at first live birth,18908,0.00840212360798231,0.00359707897220834,0.00135184882245396,0.0154523983935107,0.0195111072625201
PLA2G1B,Phospholipase A2,Health and medical history,X2764.Age at last live birth,18857,0.00606443185047774,0.0034676351710966,-0.000732133084871594,0.0128609967858271,0.0803303363288434
PLA2G1B,Phospholipase A2,Health and medical history,X2794.Age started oral contraceptive pill,21483,0.00224572532941264,0.00391372588734977,-0.00542517740979291,0.00991662806861818,0.566104072833172
PLA2G1B,Phospholipase A2,Health and medical history,X2804.Age when last used oral contraceptive pill,19483,0.00606105821634491,0.00337689586127354,-0.000557657671751241,0.0126797741044411,0.0726913759551812
PLA2G1B,Phospholipase A2,Lifestyle factors,X2867.Age started smoking in former smokers,12729,-0.00437897119956024,0.00443856466488362,-0.0130785579427321,0.00432061554361165,0.32387043747095
PLA2G1B,Phospholipase A2,Mental health,"X28735.Feeling anxious, nervous or on edge over the last 2 weeks",19793,0.0404701540143554,0.0357949568140613,-0.0296879613412048,0.110628269369916,0.258232776906592
PLA2G1B,Phospholipase A2,Mental health,X28736.Not being able to stop or control worrying over the last 2 weeks,19785,0.0688866743007406,0.0394727354740953,-0.00847988722848615,0.146253235829967,0.0809706400630524
PLA2G1B,Phospholipase A2,Mental health,X28737.Little interest or pleasure in doing things over the last 2 weeks,19822,0.0068154604245739,0.0407121709170793,-0.0729803945729015,0.0866113154220493,0.867052337937001
PLA2G1B,Phospholipase A2,Mental health,"X28738.Feeling down, depressed or hopeless over the last 2 weeks",19767,0.00362354993053991,0.0396744617827351,-0.0741383951636209,0.0813854950247007,0.927229678326982
PLA2G1B,Phospholipase A2,Mental health,X28739.Difficulty with standing for long periods,19839,-0.0516222880900375,0.0342426381167653,-0.118737858798897,0.0154932826188225,0.131687177758702
PLA2G1B,Phospholipase A2,Mental health,X28740.Difficulty with taking care of household responsibilities,19885,-0.056624394754826,0.0380228695601258,-0.131149219092673,0.0179004295830206,0.136445478227855
PLA2G1B,Phospholipase A2,Mental health,X28741.Difficulty learning a new task,19727,-0.0470313610522518,0.0434788184353617,-0.132249845185561,0.0381871230810571,0.279395783638433
PLA2G1B,Phospholipase A2,Mental health,X28742.Difficulty with joining in community activities,19010,0.0160222810471176,0.0435170043755545,-0.0692710475289692,0.101315609623204,0.712739863620105
PLA2G1B,Phospholipase A2,Mental health,X28743.Difficulty with being emotionally affected by health problems,19752,0.0261380542174535,0.0370301959051941,-0.046441129756727,0.0987172381916339,0.480284878137379
PLA2G1B,Phospholipase A2,Mental health,X28744.Difficulty with concentrating on doing something for ten minutes,19885,-0.0367419837554118,0.052715993122516,-0.140065330275543,0.0665813627647195,0.485823573408416
PLA2G1B,Phospholipase A2,Lifestyle factors,X2887.Number of cigarettes previously smoked daily,12092,-0.048967690331515,0.0371870549439374,-0.121854318021632,0.0239189373586023,0.187932675117921
PLA2G1B,Phospholipase A2,Lifestyle factors,X2897.Age stopped smoking,12733,-0.0106346611522018,0.00462684915054895,-0.0197032854872778,-0.00156603681712591,0.0215513507749671
PLA2G1B,Phospholipase A2,Mental health,X29001#0.Mental health conditions experienced by first degree blood relatives_None of the above,17743,-0.00623316871602411,0.00725383435587567,-0.0204506840535404,0.0079843466214922,0.390190531457544
PLA2G1B,Phospholipase A2,Mental health,X29001#1.Mental health conditions experienced by first degree blood relatives_Depression,17743,-0.0015222582550653,0.00789810165022014,-0.0170025374894968,0.0139580209793662,0.847166970357953
PLA2G1B,Phospholipase A2,Mental health,X29001#3.Mental health conditions experienced by first degree blood relatives_Schizophrenia,17743,0.0138031092720154,0.0264083612775958,-0.0379572788320724,0.0655634973761032,0.601203832346387
PLA2G1B,Phospholipase A2,Mental health,X29001#4.Mental health conditions experienced by first degree blood relatives_Any other type of psychosis or psychotic illness,17743,-0.00634282993459497,0.0271283783635439,-0.059514451527141,0.0468287916579511,0.815136794094706
PLA2G1B,Phospholipase A2,Mental health,X29001#5.Mental health conditions experienced by first degree blood relatives_A personality disorder,17743,-0.0283966530243036,0.0300821563540803,-0.087357679478301,0.0305643734296938,0.345197844351346
PLA2G1B,Phospholipase A2,Mental health,X29001#7.Mental health conditions experienced by first degree blood relatives_Attention deficit or attention deficit and hyperactivity disorder,17743,0.0440143674359957,0.0254434496727352,-0.00585479392256527,0.0938835287945567,0.0836673461384161
PLA2G1B,Phospholipase A2,Mental health,X29001#8.Mental health conditions experienced by first degree blood relatives_An anxiety disorder,17743,-0.00437730635072822,0.0113966003531387,-0.0267146430428801,0.0179600303414236,0.700917251827715
PLA2G1B,Phospholipase A2,Mental health,X29001#9.Mental health conditions experienced by first degree blood relatives_An eating disorder,17743,-0.0226158710792335,0.0205188373325045,-0.0628327922509422,0.0176010500924753,0.27038951254504
PLA2G1B,Phospholipase A2,Mental health,X29002.Recent lack of interest or pleasure in doing things,17624,-0.0840980475324064,0.0409994712850516,-0.164457011251108,-0.00373908381370515,0.0402623986810611
PLA2G1B,Phospholipase A2,Mental health,X29003.Recent feelings of depression,17608,-0.0548972907662381,0.0398153422352319,-0.132935361547293,0.0231407800148164,0.167974756301584
PLA2G1B,Phospholipase A2,Mental health,"X29004.Trouble falling or staying asleep, or sleeping too much",17631,-0.002391185742724,0.0321619678399719,-0.0654286427090689,0.0606462712236209,0.940734136509977
PLA2G1B,Phospholipase A2,Mental health,X29005.Recent feelings of tiredness or low energy,17641,-0.0754811274614583,0.032333437529003,-0.138854665018304,-0.0121075899046123,0.0195828025296757
PLA2G1B,Phospholipase A2,Mental health,X29006.Recent poor appetite or overeating,17653,-0.08719790809084,0.0447672023163961,-0.174941624630976,0.000545808449296345,0.0514538028826101
PLA2G1B,Phospholipase A2,Mental health,X29007.Recent feelings of inadequacy,17582,0.0160169239662948,0.0435076091299545,-0.069257989928416,0.101291837861006,0.712772721180756
PLA2G1B,Phospholipase A2,Mental health,X29008.Recent trouble concentrating on things,17649,0.0164405554891423,0.0429044887772628,-0.0676522425142929,0.100533353492577,0.701583780374053
PLA2G1B,Phospholipase A2,Mental health,X29009.Recent changes in speed or amount of moving or speaking,17633,0.0951460436277425,0.0746512030760157,-0.0511703144012483,0.241462401656733,0.202488445962578
PLA2G1B,Phospholipase A2,Mental health,X29010.Recent thoughts of suicide or self-harm,17547,-0.0461226783578451,0.0827591606030812,-0.208330633139884,0.116085276424194,0.577321351917952
PLA2G1B,Phospholipase A2,Mental health,X29038#0.Substances taken for depression_None of options listed,16230,0.0417748582928138,0.0148108011651382,0.0127456880091429,0.0708040285764847,0.00479970533680128
PLA2G1B,Phospholipase A2,Mental health,X29038#1.Substances taken for depression_Drugs or alcohol (more than once),16230,0.000650072412338368,0.0286849465513859,-0.055572422828378,0.0568725676530547,0.981919772902996
PLA2G1B,Phospholipase A2,Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),16230,0.0327787288267052,0.0146858782754836,0.00399440740675738,0.061563050246653,0.0256292500711034
PLA2G1B,Phospholipase A2,Mental health,X29038#3.Substances taken for depression_Unprescribed medication (more than once),16230,0.02428596913789,0.0431219217872226,-0.0602329975650662,0.108804935840846,0.573311182522648
PLA2G1B,Phospholipase A2,Mental health,X29039#1.Use of specific medications_Citalopram (sometimes called Cipramil),16230,0.00851787143106893,0.0276328007194233,-0.0456424179790008,0.0626781608411386,0.757894399478008
PLA2G1B,Phospholipase A2,Mental health,X29039#2.Use of specific medications_Fluoxetine (Prozac or Oxactin),16230,0.0345100176441391,0.0295547779163044,-0.0234173470718175,0.0924373823600957,0.242959936177795
PLA2G1B,Phospholipase A2,Mental health,X29039#3.Use of specific medications_Sertraline (Lustral),16230,-0.0132262628582924,0.0328960317775826,-0.0777024851423543,0.0512499594257695,0.687643282495798
PLA2G1B,Phospholipase A2,Mental health,X29039#5.Use of specific medications_Amitriptyline (Elavil),16230,0.0400442064571092,0.0382974742268728,-0.0350188430275615,0.11510725594178,0.295756903792254
PLA2G1B,Phospholipase A2,Mental health,X29039#7.Use of specific medications_Other antidepressant(s),16230,0.0186615606222067,0.0286259892986367,-0.0374453784031212,0.0747684996475345,0.514468654591531
PLA2G1B,Phospholipase A2,Mental health,X29047#0.Activities undertaken to treat depression_None of options listed,16230,0.0238197077862157,0.0145034113008859,-0.00460697836352079,0.0522463939359521,0.100536448520934
PLA2G1B,Phospholipase A2,Mental health,X29051#0.Manifestations of mania or irritability_None of options listed,16230,0.0292099979086601,0.0226019032757867,-0.0150897325118818,0.0735097283292021,0.196247821064252
PLA2G1B,Phospholipase A2,Mental health,X29051#1.Manifestations of mania or irritability_More active than usual,16230,-0.0172139632599911,0.0351944061585186,-0.0861949993306876,0.0517670728107054,0.624769888909284
PLA2G1B,Phospholipase A2,Mental health,X29051#2.Manifestations of mania or irritability_More confident than usual,16230,-0.0164725521205273,0.0455126058533264,-0.105677259593047,0.0727321553519925,0.717406188601077
PLA2G1B,Phospholipase A2,Mental health,X29051#3.Manifestations of mania or irritability_Easily distracted,16230,0.0384746925068443,0.0283752397975331,-0.0171407774963205,0.0940901625100092,0.175141963973921
PLA2G1B,Phospholipase A2,Mental health,X29051#4.Manifestations of mania or irritability_More creative or had more ideas than usual,16230,0.00644195921725283,0.0461154250260245,-0.0839442738337552,0.0968281922682609,0.888905026413587
PLA2G1B,Phospholipase A2,Mental health,X29051#5.Manifestations of mania or irritability_Neded less sleep than usual,16230,-0.0300756311653955,0.0449299982474883,-0.118138427730473,0.0579871653996815,0.503257115942345
PLA2G1B,Phospholipase A2,Mental health,X29051#6.Manifestations of mania or irritability_Thoughts were racing,16230,-0.0054787763449399,0.0244275484318935,-0.0533567712714512,0.0423992185815714,0.822536982723387
PLA2G1B,Phospholipase A2,Mental health,X29051#7.Manifestations of mania or irritability_More restless than usual,16230,-0.0112040094499714,0.0236168139593728,-0.0574929648103421,0.0350849459103994,0.635215257470587
PLA2G1B,Phospholipase A2,Mental health,X29051#8.Manifestations of mania or irritability_More talkative than usual,16230,0.0311164831420672,0.033821773393786,-0.0351741927097534,0.0974071589938879,0.357579466779586
PLA2G1B,Phospholipase A2,Mental health,X29058.Recent feelings or nervousness or anxiety,17366,-0.00608015078062723,0.0376764324149642,-0.0799259583139571,0.0677656567527026,0.871797499494977
PLA2G1B,Phospholipase A2,Mental health,X29059.Recent inability to stop or control worrying,17384,0.013959717583354,0.0390813674461949,-0.062639762611188,0.090559197777896,0.720949238937737
PLA2G1B,Phospholipase A2,Mental health,X29060.Recent worrying too much about different things,17373,-0.00415113260081812,0.03598814499727,-0.0746878967954674,0.0663856315938311,0.908171243585669
PLA2G1B,Phospholipase A2,Mental health,X29061.Recent trouble relaxing,17376,-0.00325887001459313,0.038156355992725,-0.0780453277603341,0.0715275877311478,0.931937769016186
PLA2G1B,Phospholipase A2,Mental health,X29062.Recent restlessness,17397,0.0360503252110809,0.0545064756155099,-0.0707823669953184,0.14288301741748,0.508367625096739
PLA2G1B,Phospholipase A2,Mental health,X29063.Recent easy annoyance or irritability,17349,-0.0172351950524862,0.0387813486878736,-0.0932466384807185,0.0587762483757461,0.656744727296355
PLA2G1B,Phospholipase A2,Mental health,X29064.Recent feelings of foreboding,17341,-0.0383258335579134,0.0440563968001267,-0.124676371286162,0.0480247041703349,0.384352544205552
PLA2G1B,Phospholipase A2,Mental health,X29065#1.Symptoms of panic attack_Heart was pounding or racing,16230,-0.000790263864809424,0.0155243936440911,-0.031218075407228,0.0296375476776091,0.959402125081086
PLA2G1B,Phospholipase A2,Mental health,X29065#11.Symptoms of panic attack_Felt like things weren't real or detached from self,16230,0.048840090743165,0.0260809257953893,-0.00227852381579808,0.0999587053021281,0.0611365920351229
PLA2G1B,Phospholipase A2,Mental health,X29065#12.Symptoms of panic attack_Afraid of losing control or 'going crazy',16230,0.0371151058452246,0.0336072880952795,-0.0287551788215232,0.102985390511972,0.269446151273533
PLA2G1B,Phospholipase A2,Mental health,X29065#13.Symptoms of panic attack_Afraid I was going to die,16230,0.0258992941368643,0.0356455651557377,-0.0439660135683815,0.0957646018421101,0.467494813036548
PLA2G1B,Phospholipase A2,Mental health,X29065#2.Symptoms of panic attack_Sweating,16230,0.00596092534771807,0.0234033168863534,-0.0399095757495346,0.0518314264449707,0.798954727893885
PLA2G1B,Phospholipase A2,Mental health,X29065#3.Symptoms of panic attack_Trembling or shaking,16230,0.0545868094749462,0.0252100679236001,0.00517507634468994,0.103998542605202,0.030380923999764
PLA2G1B,Phospholipase A2,Mental health,X29065#6.Symptoms of panic attack_Pain or discomfort in chest,16230,-0.00691829995263346,0.0252700323420405,-0.0564475633430329,0.0426109634377659,0.784261119714941
PLA2G1B,Phospholipase A2,Mental health,X29065#7.Symptoms of panic attack_Nauseous or felt sick in the stomach,16230,0.0028349340637127,0.0233847497804305,-0.042999175505931,0.0486690436333564,0.903510336134224
PLA2G1B,Phospholipase A2,Mental health,X29065#9.Symptoms of panic attack_Felt hot or cold,16230,-0.006759396435549,0.0311656628273654,-0.0678440955771853,0.0543253027060873,0.828299904550802
PLA2G1B,Phospholipase A2,Mental health,X29076.Felt loved as a child,17310,0.0434956648309548,0.03343586054878,-0.0220386218446539,0.109029951506563,0.193320730935931
PLA2G1B,Phospholipase A2,Mental health,X29077.Physically abused by family as a child,17336,-0.104723503910186,0.0448265101640554,-0.192583463831734,-0.0168635439886372,0.0194923861311147
PLA2G1B,Phospholipase A2,Mental health,X29078.Felt hated by family member as a child,17308,-0.0305983610548202,0.04533167662978,-0.119448447249189,0.0582517251395487,0.499692087603638
PLA2G1B,Phospholipase A2,Mental health,X29079.Sexually molested as a child,17183,-0.0338079711149896,0.0606527120538751,-0.152687286740585,0.0850713445106057,0.577259750670314
PLA2G1B,Phospholipase A2,Mental health,X29080.Someone to take to doctor when needed as a child,17276,0.0420551597419635,0.04821239218598,-0.0524411289425573,0.136551448426484,0.383062641161269
PLA2G1B,Phospholipase A2,Mental health,X29081.Stopped from seeing friends or family by partner or ex-partner as an adult,17316,-0.0605429292003298,0.0632789806602751,-0.184569731294469,0.0634838728938094,0.338700724300716
PLA2G1B,Phospholipase A2,Mental health,X29082.Belittlement by partner or ex-partner as an adult,17208,-0.0288390904064278,0.049519559168713,-0.125897426377105,0.0682192455642497,0.560319889074346
PLA2G1B,Phospholipase A2,Mental health,X29083.Physical violence by partner or ex-partner as an adult,17329,0.0047184305928979,0.0558321168475738,-0.104712518428347,0.114149379614143,0.932651097941528
PLA2G1B,Phospholipase A2,Mental health,X29084.Sexual interference by partner or ex-partner without consent as an adult,17279,0.0560716083056668,0.0777985607159978,-0.0964135706976889,0.208556787309022,0.471086583118598
PLA2G1B,Phospholipase A2,Mental health,X29085.Sexual intercourse by partner or ex-partner without consent as an adult,17278,-0.0131163774411838,0.0743405565347294,-0.158823868249253,0.132591113366886,0.859953208626418
PLA2G1B,Phospholipase A2,Mental health,X29086.Experienced a violent or sexual assault,17329,0.00840605603982097,0.063262756956581,-0.115588947595078,0.13240105967472,0.894293567684844
PLA2G1B,Phospholipase A2,Mental health,X29087.Experienced a life-threatening injury or illness,17330,0.00356296906007891,0.0389963497356075,-0.0728698764217119,0.0799958145418697,0.927202251581642
PLA2G1B,Phospholipase A2,Mental health,X29088.Experienced a marital separation or divorce,17338,-0.0928050432065456,0.0366122662156567,-0.164565084989233,-0.0210450014238585,0.0112596414334794
PLA2G1B,Phospholipase A2,Mental health,X29089.Experienced the death of a spouse or partner,17355,-0.0744958966712255,0.0489478147826732,-0.170433613645265,0.021441820302814,0.128041021864417
PLA2G1B,Phospholipase A2,Mental health,X29090.Experienced the death of a close friend or family member due to suicide,17332,-0.000440733215949229,0.0457952566501518,-0.0901994362502467,0.0893179698183483,0.992321394203752
PLA2G1B,Phospholipase A2,Lifestyle factors,X29091.Frequency of drinking alcohol,17340,-0.422923821814671,0.0309750846174254,-0.483634987664825,-0.362212655964517,3.17511063280529e-42
PLA2G1B,Phospholipase A2,Lifestyle factors,X29092.Amount of alcohol drunk on a typical drinking day,15456,-0.312226993001942,0.035626268827215,-0.382054479903283,-0.242399506100601,2.07861415658157e-18
PLA2G1B,Phospholipase A2,Lifestyle factors,X29093.Frequency of consuming six or more units of alcohol,15494,-0.334429308906463,0.0359301135286477,-0.404852331422613,-0.264006286390314,1.47710726442661e-20
PLA2G1B,Phospholipase A2,Mental health,X29104.Ever used cannabis,17327,0.0508944422405379,0.0440409485874782,-0.0354258169909193,0.137214701471995,0.247854049271249
PLA2G1B,Phospholipase A2,Mental health,X29108.Ever thought that life not worth living,17247,-0.0105851395632917,0.038403761429199,-0.0858565119645217,0.0646862328379382,0.782837354351391
PLA2G1B,Phospholipase A2,Mental health,X29109.Ever contemplated self-harm,17289,0.0430704480381809,0.0522229842435151,-0.0592866010791086,0.14542749715547,0.40952990932048
PLA2G1B,Phospholipase A2,Mental health,X29111.Ever self-harmed,17316,0.113821408091216,0.0844885585045077,-0.0517761665776191,0.279418982760051,0.177939485173595
PLA2G1B,Phospholipase A2,Diet and food preferences,X29132.Ever had recurrent episodes of excessive overeating or binge eating,17310,0.113730603984968,0.0548157503272295,0.00629173334359812,0.221169474626338,0.0380217123600921
PLA2G1B,Phospholipase A2,Diet and food preferences,X29136#1.Actions and feelings during periods of overeating or binge eating_Eaten much more rapidly than normal,17565,-0.000308232049915637,0.0329006306871022,-0.0647934681966359,0.0641770040968046,0.992525173900325
PLA2G1B,Phospholipase A2,Diet and food preferences,X29136#2.Actions and feelings during periods of overeating or binge eating_Eaten until feeling uncomfortably full,17565,0.0276613796690026,0.0252440253627679,-0.0218169100420224,0.0771396693800277,0.27319908833623
PLA2G1B,Phospholipase A2,Diet and food preferences,X29136#3.Actions and feelings during periods of overeating or binge eating_Eaten large amounts of food when not physically hungry,17565,-0.010944072539964,0.0270654167626749,-0.0639922893948067,0.0421041443148788,0.685955636966213
PLA2G1B,Phospholipase A2,Diet and food preferences,X29136#4.Actions and feelings during periods of overeating or binge eating_Eaten alone because of feeling embarrassed by overeating,17565,0.00617012509801587,0.0365505360343138,-0.0654689255292391,0.0778091757252709,0.865947411197415
PLA2G1B,Phospholipase A2,Diet and food preferences,X29149.Dependency of self-esteem on body shape or weight currently,17293,0.0709914237581495,0.0343892813825805,0.00358843224829167,0.138394415268007,0.0389996802404999
PLA2G1B,Phospholipase A2,Health and medical history,X29153.Pain or discomfort today,17319,-0.0448541312049007,0.0323900129094465,-0.108338556507416,0.0186302940976144,0.166127319574672
PLA2G1B,Phospholipase A2,Mental health,X29154.Anxiety or depression today,17319,0.03840641344935,0.0403260821876579,-0.0406327076384595,0.117445534537159,0.340909314693504
PLA2G1B,Phospholipase A2,Mental health,X29166.Frequency of confiding in someone close,16894,-0.0491491491171293,0.0316457842355787,-0.111174886218864,0.012876587984605,0.120417381917889
PLA2G1B,Phospholipase A2,Lifestyle factors,X29167#0.Sports and social activities attended in person at least once a week_None of the above,17267,-0.00551153558210792,0.00734092080347146,-0.019899740356912,0.00887666919269614,0.452785544883051
PLA2G1B,Phospholipase A2,Lifestyle factors,X29167#1.Sports and social activities attended in person at least once a week_Sports club or gym or fitness class,17267,0.0122537841089477,0.00737164177262218,-0.00219463376539174,0.0267022019832872,0.0964734138121478
PLA2G1B,Phospholipase A2,Lifestyle factors,X29167#2.Sports and social activities attended in person at least once a week_Pub or social club,17267,-0.0603916102941776,0.00918372747667762,-0.0783917161484658,-0.0423915044398895,4.97351350723065e-11
PLA2G1B,Phospholipase A2,Lifestyle factors,X29167#3.Sports and social activities attended in person at least once a week_Religious group,17267,0.0357739037407935,0.00992466466850199,0.0163215609905296,0.0552262464910574,0.000313580565866194
PLA2G1B,Phospholipase A2,Lifestyle factors,X29167#4.Sports and social activities attended in person at least once a week_Adult education class,17267,0.0264705722475162,0.016104261480448,-0.00509378025416191,0.0580349247491944,0.100256436804257
PLA2G1B,Phospholipase A2,Lifestyle factors,X29167#5.Sports and social activities attended in person at least once a week_Other group activity,17267,0.0141931244179426,0.00757954004035409,-0.000662774061151412,0.0290490228970366,0.0611464165802176
PLA2G1B,Phospholipase A2,Lifestyle factors,X29168#0.Sports and social activities attended virtually at least once a week_None of the above,17264,0.00696676427684147,0.00825163447038715,-0.00920643928511735,0.0231399678388003,0.39851963575178
PLA2G1B,Phospholipase A2,Lifestyle factors,X29168#1.Sports and social activities attended virtually at least once a week_Sports club or gym or fitness class,17264,-0.0119566696243331,0.0120618510003847,-0.035597897585087,0.0116845583364209,0.321562862745109
PLA2G1B,Phospholipase A2,Lifestyle factors,X29168#2.Sports and social activities attended virtually at least once a week_Pub or social club,17264,-0.0983735985729505,0.0187048514321813,-0.135035107380026,-0.0617120897658752,1.46366064326608e-07
PLA2G1B,Phospholipase A2,Lifestyle factors,X29168#3.Sports and social activities attended virtually at least once a week_Religious group,17264,0.0289528374890569,0.0167045174086439,-0.00378801663188509,0.0616936916099988,0.0830719564171986
PLA2G1B,Phospholipase A2,Lifestyle factors,X29168#4.Sports and social activities attended virtually at least once a week_Adult education class,17264,-0.0284364193075366,0.0247141404426896,-0.0768761345752081,0.020003295960135,0.249907298249915
PLA2G1B,Phospholipase A2,Lifestyle factors,X29168#5.Sports and social activities attended virtually at least once a week_Other group activity,17264,0.0212619309458323,0.0118438490350266,-0.00195201316281995,0.0444758750544845,0.0726413133283213
PLA2G1B,Phospholipase A2,Mental health,X29171.Frequency of feeling 'in tune' with people,16974,-0.023781598948961,0.0392781935411853,-0.100766858289684,0.0532036603917621,0.54487771056761
PLA2G1B,Phospholipase A2,Mental health,X29172.Freuency of feeling that lacks companionship,17196,0.0639761509209728,0.035675331812118,-0.00594749943077841,0.133899801272724,0.0729444374798033
PLA2G1B,Phospholipase A2,Mental health,X29173.Frequency of feeling left out,17107,0.0347889093107136,0.0371154207185673,-0.0379573152976783,0.107535133919106,0.348608840856082
PLA2G1B,Phospholipase A2,Mental health,X29174.Frequency of feeling isolated from others,17172,0.0521375754708467,0.038431254569629,-0.0231876834856261,0.12746283442732,0.174911835337961
PLA2G1B,Phospholipase A2,Mental health,X29175.Tendency to bounce back quickly after hard times,17297,-0.0246947513433405,0.0316800632558446,-0.0867876753247959,0.0373981726381148,0.435693273125404
PLA2G1B,Phospholipase A2,Mental health,X29176.Ability to make it through stressful events,17297,0.0422309941096803,0.0307587014308152,-0.0180560606947175,0.102518048914078,0.16977726764724
PLA2G1B,Phospholipase A2,Mental health,X29177.Quick recovery from stressful events,17297,-0.0294707345969988,0.0313150895148105,-0.0908483100460274,0.0319068408520297,0.346665071829971
PLA2G1B,Phospholipase A2,Mental health,X29178.Hard to snap back when something bad happens,17297,0.0492573587052659,0.0309188583842304,-0.0113436037278257,0.109858321138357,0.111152237949951
PLA2G1B,Phospholipase A2,Mental health,X29179.Comes through difficult times with little trouble,17297,-0.0610711346217816,0.0313134472285209,-0.122445491189682,0.000303221946119259,0.0511545460914209
PLA2G1B,Phospholipase A2,Mental health,X29180.Tendency to take a long time to get over setbacks,17297,0.038724394635895,0.0311167469319982,-0.0222644293508214,0.0997132186226114,0.213337169931016
PLA2G1B,Phospholipase A2,Mental health,X29181.General happiness,17197,0.0150629907813273,0.0322617449016246,-0.048170029225857,0.0782960107885116,0.640577743774175
PLA2G1B,Phospholipase A2,Mental health,X29182.Belief that own life is meaningful,17000,0.00491571788449552,0.0321448237244557,-0.0580881366154377,0.0679195723844288,0.87845995582409
PLA2G1B,Phospholipase A2,Lifestyle factors,X2926.Number of unsuccessful stop-smoking attempts,11587,-0.0507150214118908,0.0349225093589382,-0.11916313975541,0.017733096931628,0.146468710211873
PLA2G1B,Phospholipase A2,Health and medical history,X2946.Father's age,11336,0.0183529293841256,0.00654887625157549,0.00551713193103761,0.0311887268372136,0.00508015042704689
PLA2G1B,Phospholipase A2,Health and medical history,X2966.Age high blood pressure diagnosed,12990,-0.0196634757873872,0.00584751948790575,-0.0311246139836824,-0.00820233759109192,0.000774062607259032
PLA2G1B,Phospholipase A2,Blood and urine assays,X30000.White blood cell (leukocyte) count,50343,-0.0080631587975503,0.0022706528216853,-0.0125136383280535,-0.00361267926704711,0.000384075177624009
PLA2G1B,Phospholipase A2,Blood and urine assays,X30010.Red blood cell (erythrocyte) count,50344,0.0182311181538732,0.00253378905366014,0.0132648916086993,0.0231973446990471,6.32369702889484e-13
PLA2G1B,Phospholipase A2,Blood and urine assays,X30020.Haemoglobin concentration,50344,0.000333182308098966,0.00271094996094056,-0.00498027961534453,0.00564664423154246,0.902184860764774
PLA2G1B,Phospholipase A2,Blood and urine assays,X30030.Haematocrit percentage,50344,0.00837975073289419,0.00264841555489601,0.00318885624529801,0.0135706452204904,0.0015567623624886
PLA2G1B,Phospholipase A2,Blood and urine assays,X30040.Mean corpuscular volume,50344,-0.0166779453630255,0.00223827478458594,-0.0210649639408139,-0.012290926785237,9.39367855269855e-14
PLA2G1B,Phospholipase A2,Blood and urine assays,X30050.Mean corpuscular haemoglobin,50343,-0.0245494242723387,0.00224422939982985,-0.0289481138960052,-0.0201507346486722,8.0719103100409e-28
PLA2G1B,Phospholipase A2,Blood and urine assays,X30060.Mean corpuscular haemoglobin concentration,50343,-0.0178389865180264,0.00219280554038068,-0.0221368853771725,-0.0135410876588803,4.20452540228237e-16
PLA2G1B,Phospholipase A2,Blood and urine assays,X30070.Red blood cell (erythrocyte) distribution width,50344,0.0177561345849077,0.00218916085191926,0.013465379315146,0.0220468898546695,5.13569444828931e-16
PLA2G1B,Phospholipase A2,Blood and urine assays,X30080.Platelet count,50344,-0.00767172002008583,0.00223949418444462,-0.0120611286215973,-0.00328231141857438,0.000613822828895448
PLA2G1B,Phospholipase A2,Blood and urine assays,X30090.Platelet crit,50344,-0.00604727619599476,0.00228788235362166,-0.0105315256090932,-0.0015630267828963,0.00821577185759997
PLA2G1B,Phospholipase A2,Blood and urine assays,X30100.Mean platelet (thrombocyte) volume,50344,0.00454401880233628,0.0021509064869526,0.000328242087909185,0.00875979551676337,0.0346393817636101
PLA2G1B,Phospholipase A2,Blood and urine assays,X30110.Platelet distribution width,50344,-0.00534923230618588,0.00217611883064908,-0.00961442521425808,-0.00108403939811368,0.0139687234866239
PLA2G1B,Phospholipase A2,Blood and urine assays,X30120.Lymphocyte count,50267,-0.0133459962913362,0.00223464731958847,-0.0177259050377296,-0.00896608754494279,2.35491180770807e-09
PLA2G1B,Phospholipase A2,Blood and urine assays,X30130.Monocyte count,50267,-0.00411406045083337,0.00225422212377795,-0.00853233581343815,0.000304214911771409,0.0679999287565131
PLA2G1B,Phospholipase A2,Blood and urine assays,X30140.Neutrophill count,50267,-0.00527098710401642,0.0022452369309585,-0.00967165148869508,-0.00087032271933776,0.0188971013550482
PLA2G1B,Phospholipase A2,Blood and urine assays,X30150.Eosinophill count,50267,0.00223603907343598,0.00218567503012317,-0.00204788398560544,0.0065199621324774,0.306292540864672
PLA2G1B,Phospholipase A2,Blood and urine assays,X30160.Basophill count,50267,-0.0109831421771345,0.0189051673858458,-0.0480372702533922,0.0260709858991232,0.561270155907489
PLA2G1B,Phospholipase A2,Blood and urine assays,X30170.Nucleated red blood cell count,50267,0.155088402673333,0.0851311939123596,-0.0117687373948913,0.321945542741558,0.0684977099220424
PLA2G1B,Phospholipase A2,Blood and urine assays,X30180.Lymphocyte percentage,50268,-0.0056290180285331,0.00220056745939247,-0.00994213024894235,-0.00131590580812386,0.0105309768190086
PLA2G1B,Phospholipase A2,Blood and urine assays,X30190.Monocyte percentage,50268,0.00145305366629054,0.00222797563485441,-0.00291377857802411,0.00581988591060519,0.514284419574895
PLA2G1B,Phospholipase A2,Blood and urine assays,X30200.Neutrophill percentage,50268,0.00337016937694045,0.00217844578860714,-0.00089958436872955,0.00763992312261044,0.121856952831215
PLA2G1B,Phospholipase A2,Blood and urine assays,X30210.Eosinophill percentage,50268,0.00557971696996694,0.00216304841769115,0.00134014207129229,0.0098192918686416,0.00989539043867927
PLA2G1B,Phospholipase A2,Blood and urine assays,X30220.Basophill percentage,50268,-0.00271159958672062,0.00215406939040926,-0.00693357559192277,0.00151037641848153,0.208098861431118
PLA2G1B,Phospholipase A2,Blood and urine assays,X30230.Nucleated red blood cell percentage,50266,0.153116275702101,0.0852301229949772,-0.0139347653680543,0.320167316772256,0.0724203656624598
PLA2G1B,Phospholipase A2,Blood and urine assays,X30240.Reticulocyte percentage,49466,-0.0311921823588596,0.00231433970225362,-0.0357282881752767,-0.0266560765424426,2.50066898348149e-41
PLA2G1B,Phospholipase A2,Blood and urine assays,X30250.Reticulocyte count,49466,-0.0279895198166522,0.00236492167324872,-0.0326247662962197,-0.0233542733370847,2.83564416002914e-32
PLA2G1B,Phospholipase A2,Blood and urine assays,X30260.Mean reticulocyte volume,49466,-0.00335535467332727,0.00220732684990451,-0.00768171529914012,0.000971005952485579,0.128492564776085
PLA2G1B,Phospholipase A2,Blood and urine assays,X30270.Mean sphered cell volume,49466,-0.015788732535972,0.00222658886295297,-0.0201528467073599,-0.0114246183645842,1.34929859742175e-12
PLA2G1B,Phospholipase A2,Blood and urine assays,X30280.Immature reticulocyte fraction,49466,-0.016062144514429,0.00231466729503982,-0.0205988924127071,-0.011525396616151,3.98915221936067e-12
PLA2G1B,Phospholipase A2,Blood and urine assays,X30290.High light scatter reticulocyte percentage,49466,-0.0317567656739559,0.00236280736054496,-0.036387868100624,-0.0271256632472878,4.1472749212615e-41
PLA2G1B,Phospholipase A2,Blood and urine assays,X30300.High light scatter reticulocyte count,49466,-0.0293746816816497,0.00239919175937494,-0.0340770975300246,-0.0246722658332748,2.039834029981e-34
PLA2G1B,Phospholipase A2,Blood and urine assays,X30500.Microalbumin in urine,16378,0.0259829865567703,0.00406988642332246,0.0180060091670583,0.0339599639464823,1.76929712723591e-10
PLA2G1B,Phospholipase A2,Blood and urine assays,X30510.Creatinine (enzymatic) in urine,50457,0.00729427940715422,0.00233907763067336,0.00270968725103444,0.011878871563274,0.0018191180887886
PLA2G1B,Phospholipase A2,Blood and urine assays,X30520.Potassium in urine,50357,-0.00529139579618622,0.00218015760293672,-0.0095645046979422,-0.00101828689443025,0.0152247901743135
PLA2G1B,Phospholipase A2,Blood and urine assays,X30530.Sodium in urine,50339,-0.0363374515564716,0.00227310878265735,-0.04079274477048,-0.0318821583424632,2.22331864956376e-57
PLA2G1B,Phospholipase A2,Blood and urine assays,X30600.Albumin,45386,0.00330052543682398,0.00234347778930316,-0.00129269103021021,0.00789374190385817,0.159023133376849
PLA2G1B,Phospholipase A2,Blood and urine assays,X30610.Alkaline phosphatase,49523,-0.00430136323270629,0.00225094860356723,-0.00871322249569807,0.000110496030285483,0.056021743462755
PLA2G1B,Phospholipase A2,Blood and urine assays,X30620.Alanine aminotransferase,49516,-0.0169621950461942,0.00237837584655894,-0.0216238117054497,-0.0123005783869387,1.00388888867177e-12
PLA2G1B,Phospholipase A2,Blood and urine assays,X30630.Apolipoprotein A,45109,-0.032188994671162,0.00256757387785679,-0.0372214394717613,-0.0271565498705627,5.39697452812282e-36
PLA2G1B,Phospholipase A2,Blood and urine assays,X30640.Apolipoprotein B,49257,-0.0133512158042581,0.00217754210886194,-0.0176191983376275,-0.00908323327088867,8.78111640871045e-10
PLA2G1B,Phospholipase A2,Blood and urine assays,X30650.Aspartate aminotransferase,49368,-0.00326190484729953,0.00225941909567946,-0.00769036627483127,0.00116655658023222,0.148832033134508
PLA2G1B,Phospholipase A2,Blood and urine assays,X30660.Direct bilirubin,42018,0.00275875192117154,0.00246054786505013,-0.00206392189432671,0.00758142573666979,0.26221163059743
PLA2G1B,Phospholipase A2,Blood and urine assays,X30670.Urea,49499,0.0787513050088817,0.00227043921973577,0.0743012441381996,0.0832013658795638,1.76018984217813e-260
PLA2G1B,Phospholipase A2,Blood and urine assays,X30680.Calcium,45384,0.0195995191335726,0.00227076368234659,0.0151488223161732,0.0240502159509719,6.26209489644078e-18
PLA2G1B,Phospholipase A2,Blood and urine assays,X30690.Cholesterol,49535,-0.0151534310067005,0.00220905981678815,-0.0194831882476053,-0.0108236737657958,6.98258528684019e-12
PLA2G1B,Phospholipase A2,Blood and urine assays,X30700.Creatinine,49514,0.162793313767551,0.00256154333847856,0.157772688824133,0.167813938710969,0
PLA2G1B,Phospholipase A2,Blood and urine assays,X30710.C-reactive protein,49386,-0.025361329311472,0.00243834458312723,-0.0301404846944013,-0.0205821739285426,2.60464479811808e-25
PLA2G1B,Phospholipase A2,Blood and urine assays,X30720.Cystatin C,49535,0.120525304238366,0.00248821241322659,0.115648407908441,0.12540220056829,0
PLA2G1B,Phospholipase A2,Blood and urine assays,X30730.Gamma glutamyltransferase,49514,-0.0353592916368786,0.00242092075600381,-0.0401042963186461,-0.0306142869551111,3.25450316006603e-48
PLA2G1B,Phospholipase A2,Blood and urine assays,X30740.Glucose,45333,-0.051456293419195,0.00232280373333841,-0.0560089887365383,-0.0469035981018518,3.69691441777848e-108
PLA2G1B,Phospholipase A2,Blood and urine assays,X30750.Glycated haemoglobin (HbA1c),49226,-0.0173172948935278,0.00236195062923894,-0.0219467181268361,-0.0126878716602194,2.30602025423396e-13
PLA2G1B,Phospholipase A2,Blood and urine assays,X30760.HDL cholesterol,45358,-0.0183924213417999,0.00268225124010043,-0.0236496337723967,-0.0131352089112031,7.11782943749002e-12
PLA2G1B,Phospholipase A2,Blood and urine assays,X30770.IGF-1,49274,0.0534774318237453,0.00226421436959373,0.0490395716593415,0.057915291988149,1.19864976212032e-122
PLA2G1B,Phospholipase A2,Blood and urine assays,X30780.LDL direct,49424,-0.00795332876077553,0.00218013728350403,-0.0122263978364434,-0.00368025968510763,0.000264472612737848
PLA2G1B,Phospholipase A2,Blood and urine assays,X30790.Lipoprotein A,39581,0.00957042088201185,0.00243713971479808,0.0047936270410076,0.0143472147230161,8.61910322678133e-05
PLA2G1B,Phospholipase A2,Blood and urine assays,X30810.Phosphate,45282,0.0335462302594218,0.00234884574813569,0.0289424925930759,0.0381499679257678,3.57067571278241e-46
PLA2G1B,Phospholipase A2,Blood and urine assays,X30830.SHBG,44958,0.0161567250883949,0.00270451895314234,0.0108558679402359,0.0214575822365539,2.33280021245202e-09
PLA2G1B,Phospholipase A2,Blood and urine assays,X30840.Total bilirubin,49337,0.00572629243111542,0.00231499898946939,0.00118889441175541,0.0102636904504754,0.0133807183328735
PLA2G1B,Phospholipase A2,Blood and urine assays,X30850.Testosterone,44750,-0.00224971167787267,0.003775567565737,-0.00964982410671719,0.00515040075097184,0.551271419699595
PLA2G1B,Phospholipase A2,Blood and urine assays,X30860.Total protein,45350,0.0121556835862508,0.00230591476647403,0.00763609064396166,0.0166752765285399,1.35914240186352e-07
PLA2G1B,Phospholipase A2,Blood and urine assays,X30870.Triglycerides,49496,-0.0177546948040964,0.00237142792490447,-0.0224026935369091,-0.0131066960712836,7.16754355263817e-14
PLA2G1B,Phospholipase A2,Blood and urine assays,X30880.Urate,49463,0.0316572967002383,0.00272250944364195,0.0263211781907,0.0369934152097765,3.26180205084326e-31
PLA2G1B,Phospholipase A2,Blood and urine assays,X30890.Vitamin D,47288,0.0272598403797594,0.00245415661967585,0.0224496934051947,0.0320699873543241,1.2498902657808e-28
PLA2G1B,Phospholipase A2,Physical measures,X3137.Number of measurements made,47074,-0.0160235018755089,0.0220962443853178,-0.0593321408707319,0.0272851371197141,0.468352229706687
PLA2G1B,Phospholipase A2,Physical measures,X3143.Ankle spacing width,29474,-0.0208276978337675,0.00388887714311368,-0.0284498970342703,-0.0132054986332647,8.58590480469044e-08
PLA2G1B,Phospholipase A2,Physical measures,"X3144.Heel Broadband ultrasound attenuation, direct entry",29472,0.000983773161865996,0.00299545526496499,-0.00488731915746539,0.00685486548119738,0.742595007815661
PLA2G1B,Phospholipase A2,Physical measures,X3146.Speed of sound through heel,29474,0.00821604252216067,0.00289373914987114,0.00254431378841323,0.0138877712559081,0.00452509719886565
PLA2G1B,Phospholipase A2,Physical measures,"X3147.Heel quantitative ultrasound index (QUI), direct entry",29474,0.00588013589455175,0.00292398476951476,0.000149125746302817,0.0116111460428007,0.0443344580536218
PLA2G1B,Phospholipase A2,Physical measures,X3148.Heel bone mineral density (BMD),29452,0.00595101206027597,0.00292840174683206,0.000211344636485134,0.0116906794840668,0.0421453431449562
PLA2G1B,Phospholipase A2,Health and medical history,X3526.Mother's age at death,30959,0.002958804,0.002918067,-0.002760608,0.008678216,0.3106098
PLA2G1B,Phospholipase A2,Health and medical history,X3581.Age at menopause (last menstrual period),16009,0.00338920329272415,0.00380643148631759,-0.00407140242045833,0.0108498090059066,0.373270639937801
PLA2G1B,Phospholipase A2,Health and medical history,"X3761.Age hay fever, rhinitis or eczema diagnosed",10227,0.00234030153521579,0.0048044332363549,-0.00707638760803981,0.0117569906784714,0.626188760434512
PLA2G1B,Phospholipase A2,Physical measures,X4100.Ankle spacing width (left),16702,-0.0118699933813244,0.00512823071803861,-0.02192132558868,-0.00181866117396868,0.020644873153421
PLA2G1B,Phospholipase A2,Physical measures,X4101.Heel broadband ultrasound attenuation (left),16698,0.00588540077936469,0.00394863240275024,-0.00185391873002577,0.0136247202887552,0.136114104193906
PLA2G1B,Phospholipase A2,Physical measures,X4103.Speed of sound through heel (left),16702,0.0114209717842951,0.00381986416129899,0.0039340380281491,0.0189079055404411,0.00279485274759814
PLA2G1B,Phospholipase A2,Physical measures,"X4104.Heel quantitative ultrasound index (QUI), direct entry (left)",16702,0.0099267518568837,0.00385952725603549,0.00236207843505415,0.0174914252787132,0.0101194986836618
PLA2G1B,Phospholipase A2,Physical measures,X4105.Heel bone mineral density (BMD) (left),16689,0.00950413877372035,0.00386493047453559,0.0019288750436306,0.0170794025038101,0.0139397855278121
PLA2G1B,Phospholipase A2,Physical measures,"X4106.Heel bone mineral density (BMD) T-score, automated (left)",16702,0.00992539420790931,0.00385953402150385,0.00236070752576176,0.0174900808900569,0.0101299130259321
PLA2G1B,Phospholipase A2,Physical measures,X4119.Ankle spacing width (right),16691,-0.0135153089887185,0.00504327807740037,-0.0234001340204232,-0.00363048395701372,0.00737239891973944
PLA2G1B,Phospholipase A2,Physical measures,X4120.Heel broadband ultrasound attenuation (right),16690,0.00480102001330945,0.00396109487010063,-0.00296272593208778,0.0125647659587067,0.225512832069708
PLA2G1B,Phospholipase A2,Physical measures,X4122.Speed of sound through heel (right),16691,0.00834390368562464,0.00382204688059893,0.000852691799650728,0.0158351155715985,0.0290424726238344
PLA2G1B,Phospholipase A2,Physical measures,"X4123.Heel quantitative ultrasound index (QUI), direct entry (right)",16691,0.00707555503783327,0.0038651561300879,-0.000500150977139025,0.0146512610528056,0.0671780949728541
PLA2G1B,Phospholipase A2,Physical measures,X4124.Heel bone mineral density (BMD) (right),16676,0.0074118149511351,0.00387223040503919,-0.000177756642741717,0.0150013865450119,0.0556251925475056
PLA2G1B,Phospholipase A2,Physical measures,"X4125.Heel bone mineral density (BMD) T-score, automated (right)",16691,0.00707592312529125,0.00386516552080226,-0.000499801295481183,0.0146516475460637,0.0671645350601105
PLA2G1B,Phospholipase A2,Physical measures,X4194.Pulse rate,17344,-0.0355373023118632,0.00369374896350795,-0.0427770502803388,-0.0282975543433876,7.39844897680695e-22
PLA2G1B,Phospholipase A2,Physical measures,X4195.Pulse wave reflection index,17344,0.00888565082511689,0.00379423627584826,0.00144894772445431,0.0163223539257795,0.0191980805944791
PLA2G1B,Phospholipase A2,Physical measures,X4196.Pulse wave peak to peak time,17333,0.0162619163361665,0.00377765122727967,0.00885771993069829,0.0236661127416346,1.68078217968677e-05
PLA2G1B,Phospholipase A2,Physical measures,X4198.Position of the pulse wave peak,17344,-0.0273573267749812,0.00380671028763112,-0.0348184789387382,-0.0198961746112242,6.91241328385044e-13
PLA2G1B,Phospholipase A2,Physical measures,X4199.Position of pulse wave notch,17344,-0.0234567563945324,0.00369476577034268,-0.0306984973044041,-0.0162150154846607,2.22617931687477e-10
PLA2G1B,Phospholipase A2,Physical measures,X4200.Position of the shoulder on the pulse waveform,17344,-0.0249881343387917,0.00382817557578591,-0.0324913584673321,-0.0174849102102513,6.87653624110159e-11
PLA2G1B,Phospholipase A2,Physical measures,X4269.Number of triplets attempted (left),17018,-0.147556366260954,0.0929302614612696,-0.329699678725042,0.0345869462031348,0.112346048944271
PLA2G1B,Phospholipase A2,Physical measures,X4270.Volume level set by participant (left),16842,0.0148485287174408,0.0294661594532022,-0.0429051438108356,0.0726022012457172,0.614325585308958
PLA2G1B,Phospholipase A2,Physical measures,X4276.Number of triplets attempted (right),17023,0.0191219070870011,0.0910382938999778,-0.159313148956955,0.197556963130957,0.833637052568985
PLA2G1B,Phospholipase A2,Physical measures,X4277.Volume level set by participant (right),16824,0.0514633260160359,0.0294748904371417,-0.00630745924076173,0.109234111272834,0.0808282360740162
PLA2G1B,Phospholipase A2,Cognitive function,X4288.Time to answer,17379,0.0072214167396496,0.00428962910290985,-0.0011862563020537,0.0156290897813529,0.0923041535225452
PLA2G1B,Phospholipase A2,Cognitive function,X4290.Duration screen displayed,17379,-0.00246292015127696,0.00390364524065451,-0.0101140648229598,0.00518822452040589,0.528095727923346
PLA2G1B,Phospholipase A2,Physical measures,X46.Hand grip strength (left),51786,-0.012368764040475,0.00307439315927156,-0.0183945746326472,-0.00634295344830273,5.75048519255151e-05
PLA2G1B,Phospholipase A2,Physical measures,X47.Hand grip strength (right),51791,-0.0123683356610645,0.00304616405203901,-0.0183388172030609,-0.006397854119068,4.90819942896271e-05
PLA2G1B,Phospholipase A2,Physical measures,X48.Waist circumference,51936,-0.0803170422193903,0.0047298988555582,-0.0895876439762844,-0.0710464404624963,1.70487133124839e-64
PLA2G1B,Phospholipase A2,Health and medical history,X4803.Tinnitus,17067,-0.0143802304956862,0.0342098996043735,-0.0814316337202583,0.0526711727288859,0.674232968045171
PLA2G1B,Phospholipase A2,Working and living environment,X4825.Noisy workplace,17283,-0.0751301214278637,0.038234209355266,-0.150069171764185,-0.00019107109154233,0.0494305477816451
PLA2G1B,Phospholipase A2,Working and living environment,X4836.Loud music exposure frequency,17178,0.0146668125406525,0.0498899948113021,-0.0831175772894995,0.112451202370805,0.768774415282528
PLA2G1B,Phospholipase A2,Physical measures,X49.Hip circumference,51927,-0.0109723426236142,0.00379844041488531,-0.0184172858367894,-0.00352739941043898,0.00387066604664382
PLA2G1B,Phospholipase A2,Physical measures,X50.Standing height,51881,-0.0275932210987378,0.00301206220364634,-0.0334968630178846,-0.021689579179591,5.32809153844284e-20
PLA2G1B,Phospholipase A2,Health and medical history,X5057.Number of older siblings,15249,0.0728891197470416,0.0318380560368877,0.0104865299147417,0.135291709579342,0.0220714237498715
PLA2G1B,Phospholipase A2,Physical measures,X51.Seated height,51648,-0.0142374396087058,0.00280331838265522,-0.0197319436387101,-0.0087429355787016,3.81183680106249e-07
PLA2G1B,Phospholipase A2,Eye measures,X5181.Ever had eye surgery,11714,-0.0940777442816166,0.0698459032737873,-0.23097571469824,0.0428202261350065,0.17802794002754
PLA2G1B,Phospholipase A2,Eye measures,X5186.Duration visual-acuity screen displayed (right),11684,-0.00124518869631127,0.00455228640676522,-0.0101676700535711,0.00767729266094857,0.784450372068551
PLA2G1B,Phospholipase A2,Eye measures,X5188.Duration visual-acuity screen displayed (left),11682,0.00301317937865144,0.00459502037215431,-0.00599306055077102,0.0120194193080739,0.511998654012162
PLA2G1B,Phospholipase A2,Eye measures,X5190.Duration at which refractometer first shown (right),11554,0.00694729771832016,0.00462228676677084,-0.00211238434455068,0.016006979781191,0.132866368138787
PLA2G1B,Phospholipase A2,Eye measures,X5193.Duration at which refractometer first shown (left),11551,0.00658182605775669,0.00464341928313071,-0.00251927573717949,0.0156829278526929,0.156377691214851
PLA2G1B,Phospholipase A2,Eye measures,"X5199.logMAR, initial (right)",11644,-0.0794223541106854,0.0371121953598457,-0.152162257015983,-0.00668245120538781,0.032370599424229
PLA2G1B,Phospholipase A2,Eye measures,X5200.Final number of letters displayed (right),11644,-0.0937204144854295,0.237193412031802,-0.558619502067762,0.371178673096903,0.692759854997815
PLA2G1B,Phospholipase A2,Eye measures,"X5201.logMAR, final (right)",11533,-0.00665479709490745,0.00463727823061055,-0.0157438624269041,0.00243426823708923,0.151295639372132
PLA2G1B,Phospholipase A2,Eye measures,X5202.Number of rounds to result (right),11644,-0.0563051435770155,0.0348885003560215,-0.124686604274818,0.0120763171207866,0.106585024022461
PLA2G1B,Phospholipase A2,Eye measures,"X5206.logMAR, initial (left)",11639,-0.0488692408086174,0.0370832214098006,-0.121552354771827,0.0238138731545919,0.187587805306951
PLA2G1B,Phospholipase A2,Eye measures,X5207.Final number of letters displayed (left),11639,-0.0550378837673374,0.217112623604571,-0.480578626032296,0.370502858497621,0.799886936657389
PLA2G1B,Phospholipase A2,Eye measures,"X5208.logMAR, final (left)",11527,-0.0101673072753369,0.00463002308682712,-0.019242152525518,-0.00109246202515571,0.0281152727472642
PLA2G1B,Phospholipase A2,Eye measures,X5209.Number of rounds to result (left),11633,0.0320044988875667,0.0347011562353833,-0.0360097673337846,0.100018765108918,0.356396955523061
PLA2G1B,Phospholipase A2,Eye measures,"X5254.Intra-ocular pressure, corneal-compensated (right)",11136,0.00694732978999332,0.00457288523418352,-0.00201552526900637,0.015910184848993,0.128729441144131
PLA2G1B,Phospholipase A2,Eye measures,"X5255.Intra-ocular pressure, Goldmann-correlated (right)",11136,0.00142591887667846,0.00455016743631539,-0.0074924092984997,0.0103442470518566,0.753999956361402
PLA2G1B,Phospholipase A2,Eye measures,X5256.Corneal hysteresis (right),11136,-0.0102874629896411,0.00461536447770205,-0.0193335773659371,-0.00124134861334512,0.025836463486424
PLA2G1B,Phospholipase A2,Eye measures,X5257.Corneal resistance factor (right),11136,-0.00701978415672047,0.00458825609729483,-0.0160127661074183,0.00197319779397739,0.12605853044577
PLA2G1B,Phospholipase A2,Eye measures,"X5262.Intra-ocular pressure, corneal-compensated (left)",11108,0.00199035715848208,0.00458227620583257,-0.00699090420494977,0.0109716185219139,0.664035540274487
PLA2G1B,Phospholipase A2,Eye measures,"X5263.Intra-ocular pressure, Goldmann-correlated (left)",11108,0.00180584534365352,0.00454860954242627,-0.00710942935950196,0.010721120046809,0.691367420447172
PLA2G1B,Phospholipase A2,Eye measures,X5264.Corneal hysteresis (left),11108,-0.000418572834240387,0.00462769474255745,-0.00948885452965298,0.00865170886117221,0.92793162819497
PLA2G1B,Phospholipase A2,Eye measures,X5265.Corneal resistance factor (left),11108,0.00120946445061806,0.00458783629215067,-0.00778269468199726,0.0102016235832334,0.792074442539157
PLA2G1B,Phospholipase A2,Lifestyle factors,X5364.Average weekly intake of other alcoholic drinks,11627,0.0711728566235656,0.165173506411816,-0.252567215943593,0.394912929190725,0.666550874602898
PLA2G1B,Phospholipase A2,Diet and food preferences,"X6144#1.Never eat eggs, dairy, wheat, sugar_Eggs or foods containing eggs",51774,-0.0144722313337767,0.0122813732047945,-0.0385437228151739,0.00959926014762042,0.238647100184741
PLA2G1B,Phospholipase A2,Diet and food preferences,"X6144#2.Never eat eggs, dairy, wheat, sugar_Dairy products",51774,-0.0408461898590717,0.0133689426416575,-0.0670493174367205,-0.014643062281423,0.00224946527098893
PLA2G1B,Phospholipase A2,Diet and food preferences,"X6144#3.Never eat eggs, dairy, wheat, sugar_Wheat products",51774,-0.0343416400366041,0.012748781722331,-0.0593292522123729,-0.00935402786083524,0.00706824056064673
PLA2G1B,Phospholipase A2,Diet and food preferences,"X6144#4.Never eat eggs, dairy, wheat, sugar_Sugar or foods or drinks containing sugar",51774,-0.0338058466619166,0.00546304031008051,-0.0445134056696744,-0.0230982876541588,6.13482250366571e-10
PLA2G1B,Phospholipase A2,Diet and food preferences,"X6144#5.Never eat eggs, dairy, wheat, sugar_I eat all of the above",51774,0.0341663486363358,0.00502624129929144,0.0243149156897245,0.044017781582947,1.07530198167851e-11
PLA2G1B,Phospholipase A2,Mental health,"X6145#3.Illness, injury, bereavement, stress in last 2 years_Death of a close relative",23412,0.00153919824089844,0.00647443656713718,-0.0111506974306904,0.0142290939124873,0.812088949286104
PLA2G1B,Phospholipase A2,Mental health,"X6145#4.Illness, injury, bereavement, stress in last 2 years_Death of a spouse or partner",23412,-0.022501312581218,0.0176412237508571,-0.0570781111328979,0.0120754859704619,0.202146357067615
PLA2G1B,Phospholipase A2,Mental health,"X6145#5.Illness, injury, bereavement, stress in last 2 years_Marital separation or divorce",23412,-0.0160423876213055,0.0125783191581128,-0.0406958931712065,0.00861111792859554,0.202180379087529
PLA2G1B,Phospholipase A2,Mental health,"X6145#6.Illness, injury, bereavement, stress in last 2 years_Financial difficulties",23412,-0.0214385192060065,0.00766068076951293,-0.0364534535142518,-0.00642358489776112,0.00513803981794909
PLA2G1B,Phospholipase A2,Eye measures,X6147#1.Reason for glasses or contact lenses_For short-sightedness,51931,0.019076366634522,0.00841397388555128,0.00258497781884149,0.0355677554502025,0.0233806160850386
PLA2G1B,Phospholipase A2,Eye measures,X6147#2.Reason for glasses or contact lenses_For long-sightedness,51931,-0.004267204081485,0.010813953071956,-0.0254625521025188,0.0169281439395488,0.693138492245591
PLA2G1B,Phospholipase A2,Eye measures,X6147#3.Reason for glasses or contact lenses_For just reading or near work as you are getting older (called 'presbyopia'),51931,-0.00324434794235355,0.00832008985259254,-0.0195517240534349,0.0130630281687278,0.696581438525501
PLA2G1B,Phospholipase A2,Eye measures,X6147#4.Reason for glasses or contact lenses_For 'astigmatism',51931,0.0131020138280188,0.0136725976035517,-0.0136962774749424,0.0399003051309801,0.337932058593017
PLA2G1B,Phospholipase A2,Eye measures,X6147#5.Reason for glasses or contact lenses_For a 'squint' or 'turn' in an eye since childhood (called 'strabismus'),51931,-0.0150416149755892,0.0330444793967458,-0.079808794593211,0.0497255646420326,0.648972315508179
PLA2G1B,Phospholipase A2,Eye measures,X6147#6.Reason for glasses or contact lenses_For a 'lazy' eye or an eye with poor vision since childhood (called 'amblyopia'),51931,0.00813739059082525,0.022859032968641,-0.0366663140277111,0.0529410952093615,0.721855940011657
PLA2G1B,Phospholipase A2,Eye measures,X6147#7.Reason for glasses or contact lenses_Other eye condition,51931,-0.0479465566649062,0.0361241060608919,-0.118749804544254,0.0228566912144419,0.184424173230687
PLA2G1B,Phospholipase A2,Health and medical history,X6149#1.Mouth or teeth dental problems_Mouth ulcers,51773,0.0132273775494679,0.00697670838235942,-0.000446970879956538,0.0269017259788924,0.0579743571969059
PLA2G1B,Phospholipase A2,Health and medical history,X6149#2.Mouth or teeth dental problems_Painful gums,51773,-0.00675436813595903,0.0119218367409084,-0.0301211681481395,0.0166124318762214,0.571019472678283
PLA2G1B,Phospholipase A2,Health and medical history,X6149#3.Mouth or teeth dental problems_Bleeding gums,51773,-0.0121749431166892,0.00626785984590998,-0.0244599484146728,0.000110062181294363,0.0520892457819313
PLA2G1B,Phospholipase A2,Health and medical history,X6149#4.Mouth or teeth dental problems_Loose teeth,51773,-0.00445494244732368,0.0105091392147996,-0.0250528553083308,0.0161429704136835,0.671632293547207
PLA2G1B,Phospholipase A2,Health and medical history,X6149#5.Mouth or teeth dental problems_Toothache,51773,-0.00966954076413368,0.0104174817514756,-0.0300878049970258,0.0107487234687585,0.353306460102325
PLA2G1B,Phospholipase A2,Health and medical history,X6149#6.Mouth or teeth dental problems_Dentures,51773,-0.00601885671111976,0.00585086791090374,-0.0174865578164911,0.00544884439425158,0.303619942438671
PLA2G1B,Phospholipase A2,Health and medical history,X6150#1.Vascular or heart problems diagnosed by doctor_Heart attack,16135,0.0765477321628148,0.015344151958793,0.0464731943235804,0.106622270002049,6.14121888356852e-07
PLA2G1B,Phospholipase A2,Health and medical history,X6150#2.Vascular or heart problems diagnosed by doctor_Angina,16135,0.0147280870020633,0.0132116495188346,-0.0111667460548525,0.0406229200589791,0.264961186330808
PLA2G1B,Phospholipase A2,Health and medical history,X6150#3.Vascular or heart problems diagnosed by doctor_Stroke,16135,0.0793859275829585,0.0182718715837019,0.0435730592789028,0.115198795887014,1.4031442774361e-05
PLA2G1B,Phospholipase A2,Health and medical history,X6150#4.Vascular or heart problems diagnosed by doctor_High blood pressure,16135,-0.0210028672703802,0.0145364102294288,-0.0494942313200605,0.00748849677930019,0.148520716557874
PLA2G1B,Phospholipase A2,Health and medical history,X6151#1.Fractured bone site(s)_Ankle,51717,-0.0470201317962314,0.0176965897891859,-0.0817054477830358,-0.012334815809427,0.00788597909386707
PLA2G1B,Phospholipase A2,Health and medical history,X6151#2.Fractured bone site(s)_Leg,51717,-0.0205863878801987,0.026295469226713,-0.072125507564556,0.0309527318041587,0.433696904621763
PLA2G1B,Phospholipase A2,Health and medical history,X6151#3.Fractured bone site(s)_Hip,51717,0.00751213199274086,0.0467300058945839,-0.0840786795606435,0.0991029435461252,0.872286156036128
PLA2G1B,Phospholipase A2,Health and medical history,X6151#4.Fractured bone site(s)_Spine,51717,-0.0303779627264135,0.0450450369582908,-0.118666235164664,0.0579103097118365,0.500065845940148
PLA2G1B,Phospholipase A2,Health and medical history,X6151#5.Fractured bone site(s)_Wrist,51717,0.0134388347960014,0.0154376186140161,-0.0168188976874702,0.0436965672794729,0.384017539205624
PLA2G1B,Phospholipase A2,Health and medical history,X6151#6.Fractured bone site(s)_Arm,51717,-0.0229678075246258,0.0206208451355812,-0.0633846639903648,0.0174490489411133,0.265363719639993
PLA2G1B,Phospholipase A2,Health and medical history,X6151#7.Fractured bone site(s)_Other bones,51717,-0.018559205604397,0.00949385267785946,-0.0371671568530016,4.87456442074992e-05,0.0506043215436321
PLA2G1B,Phospholipase A2,Health and medical history,"X6152#5.Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor_Blood clot in the leg (DVT)",16757,-0.0119701044765359,0.014988413614659,-0.0413473951612675,0.0174071862081957,0.424519886139878
PLA2G1B,Phospholipase A2,Health and medical history,"X6152#6.Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor_Emphysema or chronic bronchitis",16757,-0.0141881928811607,0.0161426375711592,-0.0458277625206326,0.0174513767583113,0.379453711036445
PLA2G1B,Phospholipase A2,Health and medical history,"X6152#7.Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor_Blood clot in the lung",16757,0.0485061248099852,0.0218636728231484,0.00565332607661438,0.0913589235433561,0.0265292398008736
PLA2G1B,Phospholipase A2,Health and medical history,"X6152#8.Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor_Asthma",16757,-0.0255100122709315,0.00772352527868101,-0.0406481218171462,-0.0103719027247167,0.000958919038120301
PLA2G1B,Phospholipase A2,Health and medical history,"X6154#1.Medication for pain relief, constipation, heartburn_Aspirin",23559,0.0118449171713042,0.00753460048546305,-0.00292289978020333,0.0266127341228118,0.115947823014975
PLA2G1B,Phospholipase A2,Health and medical history,"X6154#2.Medication for pain relief, constipation, heartburn_Ibuprofen",23559,-0.00459333058259013,0.00735094407475414,-0.0190011809691082,0.00981451980392798,0.532067246261189
PLA2G1B,Phospholipase A2,Health and medical history,"X6154#3.Medication for pain relief, constipation, heartburn_Paracetamol",23559,-0.00277891348410937,0.0067197153252996,-0.0159495555216966,0.0103917285534778,0.679210166018235
PLA2G1B,Phospholipase A2,Health and medical history,"X6154#4.Medication for pain relief, constipation, heartburn_Ranitidine",23560,0.010270250930836,0.0159260865219451,-0.0209448786521764,0.0414853805138484,0.519017899587805
PLA2G1B,Phospholipase A2,Health and medical history,"X6154#5.Medication for pain relief, constipation, heartburn_Omeprazole",23560,-0.0149662759295831,0.00954077262972484,-0.0336661902838438,0.00373363842467763,0.11673945965772
PLA2G1B,Phospholipase A2,Health and medical history,"X6154#6.Medication for pain relief, constipation, heartburn_Laxatives",23560,-0.0410848802699809,0.0128708279200905,-0.0663117029933582,-0.0158580575466036,0.00141431349234527
PLA2G1B,Phospholipase A2,Health and medical history,X6155#1.Vitamin and mineral supplements_Vitamin A,51773,-0.00897541198862855,0.0146564821598165,-0.0377021170218688,0.0197512930446117,0.540285656440302
PLA2G1B,Phospholipase A2,Health and medical history,X6155#2.Vitamin and mineral supplements_Vitamin B,51773,-0.00675893572127372,0.0102978178726882,-0.0269426587517425,0.0134247873091951,0.51160418502053
PLA2G1B,Phospholipase A2,Health and medical history,X6155#3.Vitamin and mineral supplements_Vitamin C,51773,0.0368655837830939,0.0282289630208409,-0.0184631837377541,0.092194351303942,0.191575732583852
PLA2G1B,Phospholipase A2,Health and medical history,X6155#4.Vitamin and mineral supplements_Vitamin D,51773,0.00781181181373557,0.0105482922103799,-0.012862840918609,0.0284864645460801,0.458953937495791
PLA2G1B,Phospholipase A2,Health and medical history,X6155#5.Vitamin and mineral supplements_Vitamin E,51773,-0.00789274711478148,0.0120288029944836,-0.0314692009839693,0.0156837067544063,0.511727964087888
PLA2G1B,Phospholipase A2,Health and medical history,X6155#6.Vitamin and mineral supplements_Folic acid or Folate (Vit B9),51773,0.00706135777647462,0.0138333034461764,-0.0200519169780311,0.0341746325309804,0.60973091688053
PLA2G1B,Phospholipase A2,Health and medical history,X6155#7.Vitamin and mineral supplements_Multivitamins + or - minerals,51773,0.0104861582998302,0.00454658251156402,0.00157485657716472,0.0193974600224957,0.0210931996961904
PLA2G1B,Phospholipase A2,Lifestyle factors,X6157#1.Why stopped smoking_Illness or ill health,10119,0.0118521297134161,0.0134964024951787,-0.0146008191771341,0.0383050786039663,0.379872592953889
PLA2G1B,Phospholipase A2,Lifestyle factors,X6157#2.Why stopped smoking_Doctor's advice,10119,-0.0226127243061534,0.0167954495778485,-0.0555318054787364,0.0103063568664296,0.178216589614806
PLA2G1B,Phospholipase A2,Lifestyle factors,X6157#3.Why stopped smoking_Health precaution,10119,0.0122591920867587,0.0119439550324053,-0.0111509597767557,0.035669343950273,0.304730934790259
PLA2G1B,Phospholipase A2,Lifestyle factors,X6157#4.Why stopped smoking_Financial reasons,10119,-0.00674568099544568,0.0106891843339456,-0.027696482289979,0.0142051202990876,0.52800551569255
PLA2G1B,Phospholipase A2,Health and medical history,X6159#1.Pain type(s) experienced in last month_Headache,52009,0.00737219613981739,0.00532708105232585,-0.00306888272274127,0.017813275002376,0.166392219129776
PLA2G1B,Phospholipase A2,Health and medical history,X6159#2.Pain type(s) experienced in last month_Facial pain,52009,-0.0166197513252953,0.0153674060354274,-0.046739867154733,0.0135003645041424,0.279482620461224
PLA2G1B,Phospholipase A2,Health and medical history,X6159#3.Pain type(s) experienced in last month_Neck or shoulder pain,52009,-0.000155448655275015,0.00497933773456998,-0.00991495061503218,0.00960405330448215,0.975095213835638
PLA2G1B,Phospholipase A2,Health and medical history,X6159#4.Pain type(s) experienced in last month_Back pain,52009,-0.0069123682214016,0.00481846163638711,-0.0163565530287203,0.00253181658591714,0.151418777075083
PLA2G1B,Phospholipase A2,Health and medical history,X6159#5.Pain type(s) experienced in last month_Stomach or abdominal pain,52009,-0.00562106774562199,0.0074624677124783,-0.0202475044620794,0.00900536897083547,0.451306012163987
PLA2G1B,Phospholipase A2,Health and medical history,X6159#6.Pain type(s) experienced in last month_Hip pain,52009,-0.000919428950807481,0.00665118493839545,-0.0139557514300626,0.0121168935284476,0.890054944660669
PLA2G1B,Phospholipase A2,Health and medical history,X6159#7.Pain type(s) experienced in last month_Knee pain,52009,-0.00854464607529533,0.00517940733557265,-0.0186962844530177,0.00160699230242707,0.0990033265016344
PLA2G1B,Phospholipase A2,Health and medical history,X6159#8.Pain type(s) experienced in last month_Pain all over the body,52009,-0.0248367369606849,0.015187405999044,-0.0546040527188112,0.00493057879744144,0.101981577423629
PLA2G1B,Phospholipase A2,Lifestyle factors,X6160#1.Leisure or social activities_Sports club or gym,35992,0.0145926595824358,0.00518979958734218,0.00442065239124514,0.0247646667736265,0.00492923373016691
PLA2G1B,Phospholipase A2,Lifestyle factors,X6160#2.Leisure or social activities_Pub or social club,35992,-0.0540946715593734,0.00541439794578368,-0.0647068915331094,-0.0434824515856374,1.79270332288708e-23
PLA2G1B,Phospholipase A2,Lifestyle factors,X6160#3.Leisure or social activities_Religious group,35992,0.0247777004920705,0.00611207988382168,0.01279802391978,0.036757377064361,5.04787610512374e-05
PLA2G1B,Phospholipase A2,Lifestyle factors,X6160#4.Leisure or social activities_Adult education class,35993,0.000425217911734649,0.00837631800798138,-0.0159923653839089,0.0168428012073782,0.959513621266547
PLA2G1B,Phospholipase A2,Lifestyle factors,X6160#5.Leisure or social activities_Other group activity,35993,0.010751507902278,0.00548264515361609,5.52340119043364e-06,0.0214974924033655,0.0498858578145648
PLA2G1B,Phospholipase A2,Physical activities,X6162#1.Types of transport used (excluding work)_Car or motor vehicle,51529,-0.00736078235940379,0.00535094586801209,-0.0178486362607075,0.0031270715418999,0.168950259083677
PLA2G1B,Phospholipase A2,Physical activities,X6162#2.Types of transport used (excluding work)_Walk,51529,0.00279146003846813,0.00426133652570498,-0.00556075955191363,0.0111436796288499,0.512427677891636
PLA2G1B,Phospholipase A2,Physical activities,X6162#3.Types of transport used (excluding work)_Public transport,51529,-0.00349458548748691,0.00472615135170412,-0.012757842136827,0.00576867116185317,0.459658625994527
PLA2G1B,Phospholipase A2,Physical activities,X6162#4.Types of transport used (excluding work)_Cycle,51529,0.010024521594808,0.00856558985635872,-0.00676403452365509,0.0268130777132711,0.241875729454813
PLA2G1B,Phospholipase A2,Physical activities,X6164#1.Types of physical activity in last 4 weeks_Walking for pleasure (not as a means of transport),51564,0.00272161242838677,0.00470793752597758,-0.00650594512252928,0.0119491699793028,0.56320576513532
PLA2G1B,Phospholipase A2,Physical activities,X6164#3.Types of physical activity in last 4 weeks_Strenuous sports,51564,0.0329940002119742,0.00733946593355681,0.0186086469822028,0.0473793534417455,6.95829588820998e-06
PLA2G1B,Phospholipase A2,Health and medical history,X6179#1.Mineral and other dietary supplements_Fish oil (including cod liver oil),51773,-0.00591565998230275,0.00464495782417067,-0.0150197773176773,0.00318845735307177,0.202823015995843
PLA2G1B,Phospholipase A2,Health and medical history,X6179#2.Mineral and other dietary supplements_Glucosamine,51773,-0.00941921206481613,0.00550055378247668,-0.0202002974784704,0.00136187334883816,0.0868268337914835
PLA2G1B,Phospholipase A2,Health and medical history,X6179#3.Mineral and other dietary supplements_Calcium,51773,0.0172864258519956,0.00829651574714158,0.00102525498759809,0.0335475967163931,0.0372035936738072
PLA2G1B,Phospholipase A2,Health and medical history,X6179#4.Mineral and other dietary supplements_Zinc,51773,0.0170868851946778,0.0105179648814755,-0.00352832597301413,0.0377020963623697,0.104266080740332
PLA2G1B,Phospholipase A2,Health and medical history,X6179#5.Mineral and other dietary supplements_Iron,51773,0.0202799953363005,0.0114540084150706,-0.00216986115723791,0.0427298518298388,0.076639984011775
PLA2G1B,Phospholipase A2,Health and medical history,X6179#6.Mineral and other dietary supplements_Selenium,51773,-0.00819921418526776,0.0136776483735027,-0.0350074049973331,0.0186089766267976,0.548868259694959
PLA2G1B,Phospholipase A2,Physical measures,"X78.Heel bone mineral density (BMD) T-score, automated",29474,0.00588004386075924,0.00292398475830193,0.000149033734487461,0.011611053987031,0.0443377821675792
PLA2G1B,Phospholipase A2,Physical activities,X864.Number of days or week walked 10+ minutes,50880,-0.015069246935794,0.017086422784108,-0.0485586355926456,0.0184201417210577,0.377811927855699
PLA2G1B,Phospholipase A2,Physical activities,X874.Duration of walks,44080,-0.00075031195582071,0.00227665880833785,-0.00521256322016289,0.00371193930852147,0.741728613678831
PLA2G1B,Phospholipase A2,Physical activities,X884.Number of days or week of moderate physical activity 10+ minutes,49195,-0.0428274859215987,0.0166600103574705,-0.0754811062222407,-0.0101738656209566,0.0101529429105323
PLA2G1B,Phospholipase A2,Physical activities,X894.Duration of moderate activity,38107,-0.04567802523918,0.0203251748011429,-0.08551536784942,-0.00584068262893998,0.0246226013244234
PLA2G1B,Phospholipase A2,Physical activities,X90087.No-wear time bias adjusted average acceleration,10888,0.00880613076330517,0.00473187544324014,-0.000468345105445502,0.0180806066320558,0.0627678450244675
PLA2G1B,Phospholipase A2,Physical activities,X904.Number of days or week of vigorous physical activity 10+ minutes,49103,0.0181119476546318,0.0171065040712559,-0.0154168003250296,0.0516406956342933,0.289707237637411
PLA2G1B,Phospholipase A2,Physical activities,X914.Duration of vigorous activity,27504,0.00540352133459039,0.00280404552275216,-9.24078900038485e-05,0.0108994505591846,0.0539843410743641
